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INTRODUCTION 
  Siddha is a system of medicine which catered the health needs to the people. 
This scientific system was originated by the spiritual scientists, they are known as 
Siddhars.  Siddha System is mostly therapeutic in nature and its origin can be traced 
back to the birth of human race on the planet. 
Siddha defines health as a perfect state of physical, psychological, social and 
spiritual wellbeing of an individual. Siddha therapy recognizes the importance of 
body, mind and vital energies. Siddha treatment is essentially aimed at restoring 
balance to the individual’s system by addressing all these aspects. It is a unique 
method which brings a person to a holistic state of existence rather than just being 
free from disease. 
In siddha literature AgathiyarRathinaSurukam classified 4448 diseases. In this 
classification the disease Gunmam was described. 
  The disease Gunmam is correlated with the modern terminology peptic ulcer 
disease. 
Peptic ulcer disease comprises ulcers in the stomach or duodenum. 
Ulceration of the gastro intestinal tract due to the combined action of 
hydrochloric acid and pepsin. This occurs most commonly in either the stomach or 
duodenum but it may also occur in the oesophagus, Meckel’s diverticulum, jejunum. 
Imbalance between the damaging effects of acid and pepsin attack and the 
body’s mucosal diffences. 
Psychological factors – Stress of modern life is often invoked as an important 
cause. 
A major causative factor (60% of gastric and up to 90% of duodenal ulcers) is 
chronic inflammation due to Helicobacter pylori that colonizes the antral mucosa.  
 Other important contributing factors are NSAIDs.  
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  Additional aggressive factors include smoking, ethanol, bile acids, aspirin, and 
steroids. 
PUD  are very common in India, with 4 Million individuals  affected per year, 
Life time prevalence of PUD in the India is approximately 12% in men and 10% in 
women. More over an estimated 15,000 deaths per year occur as a consequence of 
complicated PUD. (Agreus and Tally, 1997). 
In India the prevalence of peptic ulcer is quite high. 4 to 10 thousand 
populations suffers from peptic ulcer disease every year. Tamil Nadu, Karnataka, 
Andhra Pradesh and Jammu & Kashmir are considered to be very high risk area.  
( WHO 2011 ) 
Peptic ulcer disease had a tremendous effect on morbidity and mortality until 
the last decades of the 20th century.  According to the latest WHO data published in 
April 2011 Peptic Ulcer Disease Deaths in India reached 108,392 or 1.20% of total 
deaths. The age adjusted Death Rate is 12.37 per 100,000 of population ranks India is 
5th in the world. 
  Current treatment of ulcers in developing countries has been largely 
suppression of pain, with little or no strategy aimed at a cure.  Although a number of 
antiulcer drugs such as H2 receptor antagonists and proton pump inhibitors are 
available for ulceration all these drugs have adverse reactions such as 
hypersensitivity, arrhythmia, impotence and haemopoietic changes with is a 
possibility of increased rate of ulcer recurrence within one year after cessation of the 
treatment. (Ariyoshi et al.) 
As society continue to change with the approach of new century the caring 
values of nature remains the hallmark of its unique contribution to health. 
Anticipating and planning to live provide man a great challenge without plants. 
  Plants being the natural medicines we are bound to live with nature to be free 
from diseases. Siddha system of medicine attacks the very root cause of the disease, 
there by curing the diseases completely without any adverse effects. 
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Nature is the material cause not merely the outer view but also of our body. So 
man is the mini representation of the universe.   
 Herbal medicine is fast emerging as an alternative treatment to available 
synthetic drugs for treatment of ulcer possibly due to lower costs, availability, fewer 
adverse effects and perceived effectiveness.  The World Health Organization (WHO) 
estimates that 80 percent of the populations of some Asian countries presently use 
herbal medicine for their illness.  
A Short History of Medicine  
2000 B.C. - "Here, eat this root." 
1000 B.C. - "That root is heathen, say this prayer." 
1850 A.D. - "That prayer is superstition, drink this potion." 
1940 A.D. - "That potion is snake oil, swallow this pill." 
1985 A.D. - "That pill is ineffective, take this antibiotic." 
2000 A.D. - "That antibiotic is artificial. Here, eat this root." 
So this world starts realizing the importance of herbs and it is the right time to 
show the significance of siddha system.  
Also it is our primary duty to establish Siddha medicines with scientific datas. 
The herbal drug panai poo (Borassus flabellifer) is easily available in our 
native place.  
So I decided to treat the Peptic ulcer disease with the herbal medicine Panai 
poo (Borassus flabellifer). 
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2. AIM AND OBJECETIVES 
Aim 
Various herbal plants were used therapeutically in the treatment of Peptic 
ulcer disease. In our Siddha text book, flower of Borassus flabellifer is mentioned for 
treating peptic ulcer. Till now Panai poo chooraanam has not been scientifically 
evaluated for treating peptic ulcer. The principle aim of this study is to evaluate the 
efficacy of the drug  Panai poo Chooranam in the management of Peptic ulcer 
disease in  pre- clinical  and clinical aspects. 
Objectives: 
 In this dissertation work, the “PANAI POO CHOORANAM” is 
analyzed to assess the following aspects: 
¾ Identification of the herbal drug Panai poo 
¾ To get the authentication of the raw drug 
¾ To collect the literature review 
¾ Pharmacognostic study  for the raw drug  
¾ Phytochemical and Chemical analysis for the trial drug to identify the 
active components 
¾ Evaluation of the toxicity of test drug 
¾ Pharmacological study to evaluate the anti – ulcer activity 
¾ Clinical assessment of the Panai poo chooranam. 
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3. REVIEW OF LITERATURE 
3.1  BOTANICAL ASPECT OF Borassus flabellifer 
Botanical name: Borassus flabellifer Linn 
Scientific classification- ( Bentham and Hooker) 
Kingdom -  Plantae 
Division -  Magnoliophyta 
Class  -  Monocotyledons 
Subclass -  Arecidae 
Order  -  Arecales 
Family  -  Arecaceae 
Genus  -  Borassus Linn 
Species -  Borassus flabellifer Linn 
Vernacular names 
Eng  -  Palmyra palm, brab tree 
Tamil -  Thaalam, Karumpuram, Edagam, Kaamam, Tharuviragan, 
Thaali 
Sans  -   Tala 
Hin  -   Tar  
Tel  -  Tati 
Mal  -  Pana 
Kan  -  Pane-amra 
Beng  -  Tal 
Guj  -  Tad 
Oriya  -  Talo 
Assam  -  Tal 
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Description of the plant 
The palmyra tree is the official tree of Tamil Nadu. Highly respected in Tamil 
culture, it is called "karpaha Viruksham" ("celestial tree") because all its parts without 
exception have a use.  
 Borassus is derived from a Greek word describing the leathery covering of 
the fruit and  flabellifer means “fan-bearer”. 
  Borrasus flabellifer is a very tall, erect, magnificent dioecious palm, 20-30 m 
in height and 1.0-2.2m in girth, with a fine crown of 30-40 large leaves, found 
throughout tropical India, especially along the peninsular coast and in West Bengal 
and Bihar. 
  Trunk blackish grey, cylindric, with a dense mass of long rootlets near the 
ground, generally straight, swollen above the middle and again contracting upwards, 
old stems marked with black, narrow scars of petioles, young stems covered with dry 
leaves or with the bases of their petioles, leaves palmately divided, fan shaped, 
petioles 0.6-1.2m long, stout, semi terete, spines cent-margined, lamina 0.9-1.5m in 
diam, rigidly coriaceous, divided into lanceolate or linear 2-fid lobes, segments 60-80, 
shining, folded along the midrib, spinulose; spadices very large, stout, male spadix 
stout, cylindric, branched, or sometimes double, bracts enclosing spikelets, flowers 
yellow; female spadix sparingly branched, flowers yellow, solitary, few scattered; 
drupes 15-20cm in diam, enclosed by the enlarged perianth, distinctly trigonous when 
young, almost spherical when old; pyrenes 3-1, obcordate, fibrous outside with 
hyaline edible endosperm. 
Most tapped palm trees do not only produce sap but are multipurpose (edible 
fruits, building materials, fuel, fibres, wax, etc.) and their socio-economic importance 
can be critical for the rural poor. 
Father of our nation mahathma Gandhiji used to call Borassus flabellifer, 
as a remedy against poverty. 
Anti Ulcer Activity of Panai poo Chooranam 
 
 
P.G. Gunapadam Department  7
The palmyra probably native to India, is the most striking of the palms and is a 
grand feature in the landscape of the tropical regions. It has run wild in many parts of 
India and has also been cultivated, chiefly in the dry or sandy localities of Andhra 
Pradesh, Bihar, Karnataka, Kerala and Madhya Pradesh, Orissa, Tamil Nadu and 
West Bengal. Several large groves occur in some of these areas. It grows in isolated 
patches in other states such as Assam, Gujarat, Maharashtra and Uttar Pradesh. The 
total palm is estimated at 76,167,000 trees, and the tappable trees at 56,998,00. It is 
found in the plains along the riverbanks and coastal areas, and grows on every type of 
wasteland, including rocky areas. The most congenital situations for its favorable 
development are low sandy plains, scarcely above the sea-level, where they are 
exposed to the burning sun and at least one monsoon. It is distinctly wild and 
propagates itself readily from seed in regions where it is abundant. In such regions, it 
is capable of forming pure forests. The palmyra sometimes acts as a windbreak for the 
plains. 
Cultivation 
The palm grows naturally, and no particular cultivation is necessary.  
It requires no artificial irrigation or manuring. It is generally propagated by 
direct sowing. Poly embryony and twin seedlings have been reported in the palm, 
although in general only one seedling emerges. 
 It flowers during March-May in some areas and produces the ripe fruits during 
Aug-Sep, whereas in some other areas flowering is during Nov-Feb. 
Chemical Constituents  
 Gum, fats,  albuminoids, steroidal glycosides and carbohydrates like sucrose. 
Utilization 
 Every part of the palm is useful. It is a source of food, a sweet drink (sweet 
toddy), jaggery, sugar, vinegar, palm-wine, medicine and wood. 
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The leaves are used for thatching, umbrellas, fans, diaper articles, hats, and 
their fibres for baskets, brushes and brooms. 
   The fresh saccharin juice obtained by excision of the spadis early in the 
morning is cooling, Stimulant and antiphlogist, also acts as a laxative taken regularly 
for several mornings. It is useful for inflammatory affections and dropsy. It is also 
useful in gonorrhea. 
Sweet toddy- the spadices of palmyra, on tapping, yield a delicious sugary 
sap, known as the sweet toddy. 
  The fresh sap is a cheap, refreshing and delicious beverage, with an agreeable 
flavor. It is a nutricious supplement to diets which are deficient in iron, ascorbic acid, 
and vitamin-B complex. 
  It is cooling, diuretic, stimulant, antiphlegmatic, laxative, and is also useful in 
inflammatory affections, ulcers, and dropsy. Slightly fermented juice is given in 
diabetes. 
  The sap is given as a tonic to asthmatic and anaemic patients, and in Hansen’s 
disease. It is an excellent source of biologically available riboflavin. 
  The sap is an excellent source of vinegar of very fine quality and of very 
attractive white colour. 
The toddy poultice prepared by adding fresh drawn toddy to rice flour and 
subjected to a gentle fire till fermentation takes place, then spread on a cloth forms a 
valuable stimulant application to gangrenous and intolent ulcers, carbuncles. 
The terminal buds of the tree are regarded as nutritive, diuretic and tonic. 
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             Figure No: 3.1 FLOWER OF BORASSUS FLABELLIFER 
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The ashes of the flowering stalk are set to the useful in enlarged spleen. 
The decoction of the bark with a little salt added to it is a good astringent 
gargle for strengthening gums and teeth. 
The palm jaggery is prepared by boiling the sweet juice. The jaggery is dark, 
with a characteristic flavor. Carbohydrates are the principal constituents of palm-
jaggery. It contains of vitamins of B group and minerals. The concentration of amino 
acids in palm-jaggery is much high. It exhibits mild laxative action and is reported to 
be an effective therapeutic agent for anaemia. 
The sweet palm candy is directly produced from the sap. It is considered a 
delicacy. It is reputed to possess medicinal properties, and is used in coughs and 
pulmonary affections, and as laxative for children. 
The milky fluid from the immature seeds is sweet and cooling and prevents 
hiccup and sickness. 
The root is considered cooling, restorative, diuretic, and anthelmintic. It cures 
gonorrhoea. 
  Ash of the spathe is useful as an antacid in heart-burn and as an antiperiodic. 
  Extract of green leaves given in secondary syphilis. 
  The flower and root are reported to be used in Kampuchea as sinapism in 
tumours of uterus. Gum act as emollient in indurations. 
 [Ref: The Wealth of India,   The Indian materia medica,  Indian plants and 
drugs with their medical properties and uses,  Compendium of  Indian medicinal 
plants ] 
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3.2  GUNAPADAM ASPECT OF THE PLANT 
                Panai-  Borassus flabellifer 
Other tamil names: 
Thaalam, Karumpuram, Edagam, Kaamam, Tharuviragan, Thaali 
Useful parts: 
 Kuruthu,  leaves, flower, nongu, fruit, mattai, root tuber. 
Leaf, mattai, root 
Taste   -  Astringent, sweet  
Thanmai(Character)  -  Thatpam  
Pirivu(classification) -  Sweet 
Flower 
Taste   -  Astringent  
 Thanmai(Character) -  Thatpam 
 Pirivu(Classification) -  Sweet 
Toddy 
Taste    -  Sweet;   
Thanmai(Character)    -  Thatpam;   
Pirivu(Classification)  -  Sweet  
Actions: 
Leaf, mattai :   Astringent  
                          Aphrodisiac 
Tender palm fruit:   Diuretic 
          Demulcent 
          Nutrient 
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Sweet toddy:   Diuretic 
      Refrigerant 
Toddy:          Stimulant 
               Antiphlogistic 
General characters of Kuruthu:  
Kuruthu stimulates conditions like bleeding piles and diarrhoea. 
General characters of flower: 
Ô    
  -  
    
  ”.                        அக{திய ணவாகட 
 பைன ªவனா வாத }ம, நர¯க, ப ேநா, பழxர 
ணமா. 
Medicinal uses 
The tender nongu grown in palm trees of neithal nilam is indicated for 
viyarvai kuru. It stimulates hunger. Nongu along with its covering cures dysentery. 
If palm fruit consumed as food everyday produces eczema, scabies, 
constipation diseases related to pitha vayu. 
Dry leaf used as hard fan will cure vatha, pitha, kapa diseases and aguesia. 
Toddy develops aphrodisiac action and stamina.It purifies all types of pashanas. 
Sweet candy (panamkarkandu) relieves megasuram, heat due to small pox, 
neerchurukku and thirst. 
Jaggery cures diseases emerged due to tridoshas, delirium, aguesia and ulcer. 
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Jaggery decoction 
Jaggery and dry ginger are made as decoction and if taken during morning 
relieves fever, indigestion, venereal disease and dropsy. 
Male flower is burnt and mixed with water discarding the sediment, the water 
if heated produces salt. Process is repeated for 3 times and end salt is given in small 
amount has diuretic action. It cures splenomegaly and hepatomegaly. 
Juice of palm mattai is used in the treatment of eye diseases. 
Tender kuruthu is edible. It is sweeter but it has laxative action. 
This tree is compared to Beema. Beema is compared to mercury. So the 
decoction of root tuber is used in the calcification process of mercury (Rasa Parpam) 
Sweet toddy or patha neer consumed without any interval for 40 days cures 
meganoi. 
Toddy is used in purification of pashanas. 
Ash of the floweris used externally for wounds. If given internally has diuretic 
and laxative action. 
The unriped fruit has coolant action. It is used during summer to relieve thirst. 
The ripped fruit has hard nut and outer fleshy part. It produces indigestion. 
The poor people used to consume this fruit as burnt or boiled form. 
This root tuber gives strength.  Dried root tuber ground to flour is mixed with 
coconut milk and salt is boiled and taken regularly gives strength. In the boiled root 
tuber the skin is removed and made into pieces and dried. The flour is used in the 
preparation of snacks give strength and weight gain to the body. 
The pieces of root with two parts of water kept in suriyapudam then heated in 
deepakini then the water is collected and taken regularly during morning, noon and 
evening. 
 Ref: Siddha Materia Medica (Medicinal Plants Division) 
Anti Ulcer Activity of Panai poo Chooranam 
 
 
P.G. Gunapadam Department  14
Other Preparations of Borassus flabellifer : 
Keezhanelli girutham 
Root of  Phyllanthus amarus   - 3 parts 
Root of  Bambusa arundinaceae  
Root of  Amaranthus tricolor 
Root of  Borrasus flabellifer        Each 1 part 
Root of  Pterocarpus marsupium 
Keeda ver directed towards east side 
All above roots are dried well, and taken in a pot add 8 parts of milk and add 
equal parts of water, properly boiled and decoction is prepared. 
To the decoction add, 
 Ficus racemosa, Terminalia chebula, Terminalia bellerica, Phyllanthus 
emblica, seeds of greens, cardamomum, Ficus benghalensis, sugar, ghee are heated 
and taken in a good consistency. 
Therapeutic indications: 
• Joint disorders 
• Epilepsy 
• Heat diseases in the lower abdomen 
• Blackens the hair as that of seeds of green, and gives beauty. 
Theraiyar maga karisal, Pg no: 70 
Neerkatuku parigaaram 
Achyranthus aspera 
Flower of Borassus flabellifer 
Vazhai sarugu 
Anti Ulcer Activity of Panai poo Chooranam 
 
 
P.G. Gunapadam Department  15
All the above should be dried properly, and each ingredients should be made 
burnt and made into ash separately. Then equal parts of the  ash about 70gms is mixed 
with, 
Purified   Alum 
    “   Sodium chloride impure each 35gms 
    “   Fullers earth 
    “   Borax 
All ingredients mixed well, and kept in a air tight container. 
Dose :   2-3 kunri ; twice  daily 
Adjuvent : honey 
Therapeutic indications: Renal calculi 
 Kannusamy parambarai vaithiyam  pg no: 462 
 Decoction for vayu gunmam: 
 Dried flower of borassus flabellifer 
 Whole plant of  plambago zeylanica 
 Whole plant of Achyranthus aspera 
Each one is burnt separately, and white ash is prepared, mixed in equal 
proportion. 
Take 35gm of  above said ash and mixed with 3.9 lrs of water, stirred well 
kept throughout the night and filtered in the morning. Above filtrate is taken, added 
with horse gram and then it is allowed to boil till it becomes 1 part. Then the reduced 
filtrate is again filtered, added with honey and thirikadugu powder.                                  
Theraiyar vagadam, pg no: 162 
Root of Borassus flabellifer is one of the ingredients of following medicines. 
Bosana gudori nei  -    Theraiyar maga karisal, pg no: 169 
Peru viyadhiku nei   -    Theraiyar maga karisal, pg no: 163 
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Koovilai legiyam  -    Theraiyar maga karisal, pg no: 74 
Uthamani kashayam     -   Sarabendhira vaithiya rathnavali, pg no: 74 
Birungamala thailam    -    Sarabendhira vaithiya rathnavali,pg no: 184 
Thaalisa chooranam     -    Theraiyar maga karisal, pg no: 114 
Maga vilvaadhi legiyam  -   Sarabendhira vaithiya rathnavali,Part 2  pg no: 184 
Panai vithu    -   Neerizhivuku marundhu 
    Sarabendhira vaithiya rathnavali, pg no: 383 
Panai matai  is one of the ingredients of following medicines: 
Nayana rogathirku    Maga nirkundi thailam - sarabendhira vaithiya muraigal,  
Pg no: 31 
Birungamalaga thailam -  sarabendhira vaithiya muraigal, Pg no: 19 
Elaadhi nei   -  sarabendhira vaithiya muraigal, Pg no: 41 
Nayana rogathirku mathirai -  sarabendhira vaithiya muraigal, Pg no: 64 
Poo Padalathirku mathirai -  sarabendhira vaithiya muraigal, Pg no: 65 
Nayana viyadhiku urundai -  sarabendhira vaithiya muraigal, Pg no: 80 
Piramiyam theera  -  Agathiyar atavanai vaagadam, Pg no: 52 
Sevvatai kadiku chooranam -  Agathiyar atavanai vaagadam, Pg no: 87 
3.3  SIDDHA ASPECT OF THE DISEASE 
Peptic ulcer -  Gunmam 
The essential features of the disease are 
The food eaten will not be digested, burning sensation and pain will be 
produced. Vomiting also occurs so that the food eaten becomes useless. As a result, 
the nutritional status and strength  of body diminish day by day. Patient may also 
develop depression due to the same and may develop suicidal tendency. 
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In one type of this disease, there will be flatulence.  The air will move like a 
ball inside the abdomen and may produce great discomfort. Hence some authors call 
it as kulmam. 
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Genesis of the disease 
It is considered that the disease may develop due to the following factors: 
• By eating excessively hot substances and substances which produce belching. 
• By eating dietary items which are mixed with sand, bran, stone, and dust. 
• By drinking spring water, stagnant water, lime mixed water. 
• By eating excess of diets which will not be easily digested such as coconut 
milk. 
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• By getting angry, starvation, and depression frequently. 
• In addition, it is controllable that those who practice yoga by improper 
controlling of breath, may also develop the disease. 
Prodromal symptoms 
Anorexia and even if there is appetite,dislike to food are the main features.  
In addition, there may be nausea, frequent flatulence, excessive salivary 
secretion, regurgitation of ingested food, abdominal pain due to increased peristalsis, 
vomiting, flatulence with increased bowel sounds. 
Types of the disease 
As per the opinion of the saint Yugi the disease has been classified into eight 
types as follows: 
1. Vayu gunmam 
2. Vatha gunmam 
3. Pitha gunmam 
4. Eri gunmam 
5. Vali gunmam 
6. Sathi gunmam 
7. Sanni gunmam 
8. Sethuma gunmam 
However, another according to the saint Thirukanda munivar classified it is 
into eight different types as follows: 
1. Vatha gunmam 
2. Pitha gunmam 
3. Kapha gunmam 
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4. Vatha pitha gunmam 
5. Vatha kapha gunmam 
6. Pitha silethuma gunmam 
7. Tridosha gunmam 
8. Raththa gunmam 
Further, he has subdivided ratha gunmam into two subtypes as  
1. Ratha vatha gunmam 
2. Ratha vatha pitha gunmam. 
Some other ancient physicians have classified the disease into 3 types as follows: 
1. Saamaniya vatha gunmam 
2. Saamaniya pitha gunmam 
3. Saamaniya silethuma gunmam 
In some ancient textbooks in addition to four types of gunmams associated 
with doshas,  
 1. Paayuru gunmam 
 2. Eri gunmam 
 3. Vaandhi gunmam 
 4. Vali gunmam      have also been included, thus totaling eight. 
Of these, it appears that paayuru gunmam is the gunmam mentioned as vayu 
gunmam by the saint yugi. The term paayuru will denote anus and the disease is 
caused by the excessive activity of downward directional factor (Abana Vayu). It 
appears that because of this, the disease was also called as vayu gunmam; the signs 
and symptoms of the disease are similar to soolai gunmam, hence it may be stated that 
both are one and the same.  
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In northern text books, three gunmams associated with dosha (vatha, pitha 
and kapha) have been mentioned. In addition, vatha pitha, Vatha Pitha and pitha 
kapha which originate from the combination of two have also been mentioned.  
Besides, Sanni gunmam and the ratha gunmam developed due to 
inflammation of the ovaries in women have also been included, thus totaling eight. 
Saint Thirumoolar has mentioned that three numbers of gunmam (Vatha 
gunmam, Soolai gunmam and Vali gunmam) were developed due to vatha dosha. 
  It has also been mentioned that eri gunmam, vaanthi gunmam and azhal 
(Pitha) gunmam manifest due to pitha dosha; he has also mentioned that kapha 
gunmam and tri dosha gunmam (Muppini gunmam ) manifest due to Kapha dosha; it 
is hoped that Thirumoolar’s suggestion may help to simplify the treatment. 
The ratha gunmam mentioned above is specific to women as felt by the saint 
yugi. It is felt that it would be proper if it detailed in the section on women’s special 
diseases. 
Even though Thirumoolar considered the eight types of gunmam into four 
types only from dosha point of view, they were not detailed here in order to simplify 
things. 
Vali gunmam 
 In this disease, the food ingested will not be digested properly and produces 
stomach pain as if there is some pathology in the stomach. 
Even though the patient will not take food properly, the body will appear as 
obese. However, patient will loose his strength and will become lean; he may not 
even in a position to walk.  
There will be also pain in head and in whole of the bode; patient may also 
develop tiredness, giddiness, thirst and dryness of tongue. 
In addition, the body will become black in colour with dryness.  
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The disease mostly appears during the age of 20 to 30 years which is the vatha 
period. 
Later, may patient may develop severe abdominal pain. Vomiting may also 
follow which will reduce the pain slightly. There may be also small quantity of blood 
in the vomit which appears dark in colour. 
As the days pass, the disease will progress and produces indigestion 
throughout the life of the patient. 
Even though the patient likes to take food, he will develop unbearable pain in 
the abdomen and over the corner of the chest below the xiphisternal region within few 
hours due to the fact that the food ingested will not get digested. 
Sometimes there may be burning pain in the stomach during night. Even 
though the patient will feel like having appetite either he may not take food due to the 
fear of pain or he may eat and try to induce vomiting with finger, these clinical 
features also will continue. 
Azhal Gunmam 
Due to the formation of excessive pitha dosha in this disease, the patient will 
be having burning pain in the stomach. 
He will also develop nausea and vomiting. The vomitus may be found mixed 
with nucus and pitha. Patient may become unconscious after vomiting. As the 
vomiting increase, the burning pain in the chest and abdomen also increase. 
In addition, there will be pain in the chest and abdomen also increase. In 
addition, there will be pain in the upper abdomen and the urine will appear red in 
colour. 
Excessive thirst, vertigo are other features of the disease. 
Besides, there will be loss of body strength and impaired quality of blood as 
the foods taken or vomited out; this causes yellow colouration of the skin. 
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Sometimes, the pitha dosha causes uncontrollable pain in the inflamed 
stomach and produces uncontrollable vomiting. 
The upper abdomen will be distended with gas; the food ingested will be 
digested or indigested and come out along with blood; further the body will appear 
warm and there may be headache; burning sensation of eye and fatigue may also 
occur. 
As the disease progresses the pain in the abdomen will be severe after eating. 
The abdomen will appear heavy, the appetite will be impaired and patient will dislike 
to eat. 
Ageusia, dryness of tongue, burning pain over the upper stomach, 
regurgitation of fluid in the stomach, tiredness, laziness, head disease, insomnia and 
sour belch from the stomach are other features of the disease. 
In addition, the body will become lean and patient may develop dyspnoea. It is 
considered that the disease occurs in the age group of 30 to 50 years. 
Iya gunmam 
 The essential features of the disease are; dislike to food, atrophy of mouth, 
lean body mass due to malnutrition leading to anaemia, vertigo, irritation of the 
throat, tremors and frequent fright. 
If the disease occurs in the old age period which is the period of ‘kapha 
Period’, lot of adverse effects may develop.  
  The ingested food will not get digested and stays in the stomach; the food will 
get fermented and come out only in the vomitus with a smell of meat. 
  The food will never pass down the anus, the abdomen will be distended like a 
drum and there will be belching, the abdomen will be distended with fluids and makes 
sound when the body moves, patient may also develop vomiting of white coloured 
substances frequently. 
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  The gas accumulated in the stomach may also roll like a ball.  
Besides the above features, there may be also continuous pain in the abdomen 
and excessive haemetemesis. The body also may become lean day by day; these 
feautures will make one to suspect that patient might be having cancer in stomach. 
Tri –Dosha (Sanni) gunmam 
 In this type of disease, patient may not have the desire for food.  
There will be excessive salivary secretion, the abdomen will be distended and 
motion will be passed hot with excessive sound, the mouth will have salty taste, there 
will be also irritation of the throat, the patient will frequently develop belch, dyspnoea 
and giddiness, the body also will become cool. 
Kaal (Vayu) Gunmam 
 The disease may be also called as paayuru gunmam and soolai gunmam. 
 In thise disease, the food ingested will not be digested and will come out in 
the vomit. 
  The patient may also develop dislike to food. Even though the food ingested 
will be of small quantity, abdomen will appear distended like gas filled balloon, there 
will be loss of body strength, and the patient may also have rest due to inability to 
walk. 
  There may be also sweating of the body. Patient may also develop unbearable 
pain in the stomach due to gas in the same producing bow like pulling sensation. 
The excessive activity of Vatha dosha in this disease causes damage to the 
stomach. The downward directing factor (Abana vayu) gets stimulated and it prevents 
the digestion of ingested food, this results in abdominal pain, irritation of chest, pain 
as if the intestine is twisted. 
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Eri Gunmam 
 In this type of disease, unbearable irritation in the stomach develops within a 
short time after taking the food. 
 The patient will develop pain as if the stomach is twisted. 
  Excessive salivary secretion, pain in the head, sour belch from the stomach, 
distention of abdomen with excessive bowl sound, diarrhoea and sweating over the 
root of hair or other features of the disease. 
  Ultimately the patient will become lean. 
Vaanthi (Vomiting Gunmam): 
 In this disease, the patient will develop indigestion, vomiting,  giddiness, 
burning pain in stomach, spasm and irritation of stomach, constipation, a sensation of  
heat of fire in the body, inability to walk and ageusia. 
  In addition there will be protuberance of nerves and patient may develop 
numbness. Ultimately the patient will develop loss of strength. 
Vali Gunmam 
 In this disease, the food ingested will not be digested and the abdomen will be 
distended with gas. 
 The body skin will shrink and atrophy.  
  Depression, insomnia, dislike to food, diarrhea with excessive bowl sounds, 
pain at the rib sides as if it is pricked by thorn, pain in the hip and in the vertebral 
region, throbbing  pain of  the whole body, frequent attacks of  fever and pseudo- 
appetite are the other features of the disease. 
Besides the above features, as the kapha dosha and vatha dosha’s are 
associated in this disease, the ingested food will not be digested and also will not be 
vomited out. 
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  The food stays in the stomach and causes pricking pain in throat and twisting 
pain in stomach.  
Sometimes, the patient may not be in a position to bear the pain and even 
develop suicidal tendency, there where patients who had even commited suicide. 
General features of the disease 
The disease usually occurs in men in the age group of 25-45 years. 
 However, the disease may also occur in women and also in the older age. 
 When patients have good body strength and capacity to digest any type of 
food, may suddenly develop anorexia, nausea, bilious vomiting, belch and soar belch 
from the stomach. 
 The disease progresses gradually and other features such as indigestion, 
appearance as if the abdomen is distended, rolling pain in the abdomen may also 
appear. 
 As the disease increases in severity, patient may develop unbearable pain and 
may put the finger into the throat to induce vomiting, after vomiting the pain may be 
reduced slightly; some patients may roll over the cot and cry due to excessive pain 
and even will commit suicide. 
Doshas and other factors 
 As per the saying of ancient saint ‘Theran’ gunmam may not develop if the 
(Vadha bandha malathu gunmam varadhu) due to change in food habits, the vadha 
dosha worsens. 
 The other doshas will also be associated with it and fail to perform their 
natural functions. As a result of this, the downward directional factor (Abana vayu) 
and the upward directional factor (Udhana Vayu) were malfunctioning. 
   The food ingested will not be digested and purity of blood is also lost. 
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   In addition to the above, the downward directional factor controls the passage 
of stool and causes increase of gas in the stomach;The upward directional factor 
causes vomiting and aggravate the disease. 
Pulse  
 If the vatha pulse runs in the left side or by the side, it may denote vatha 
gunmam. 
Similarly it has been stated that if the other types of pulses do not move in 
their proper direction and move to the left or by the side, they may give glue to 
appropriate gunmam disease. 
If the vatha pulse and Pitha pulse appear to be associated and their strength 
also appears to be integrated as single strength, it can be considered that this denotes 
Eri gunmam due to mantham. 
If the vatha pulse is felt abnormally like a vibration of tightly held rope which 
has raised with a finger and then suddenly dropped, it may be suggestive of Vali 
gunma disease. 
3.4 MODERN ASPECT OF THE DISEASE 
Peptic ulcer disease 
Peptic ulcer disease comprises ulcers in the stomach or duodenum. 
Ulceration of the gastro intestinal tract due to the combined action of 
hydrochloric acid and pepsin. This occurs most commonly in either the stomach or 
duodenum but it may also occur in the oesophagus, Meckel’s diverticulum, jejunum. 
Aetiology 
1.  Imbalance between the damaging effects of acid and pepsin attack and the 
body’s mucosal diffences.  
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2.  Four factors may account for the tendency to hyper secrete acid and pepsin. 
 a.  Increased parietal cell mass 
 b.  Increased stimulation of acid secretion. 
 c.  Increased parietal cell sensitivity to stimulants 
 d.  Decreased inhibitory control of acid secretion. 
3.  Psychological factors – Stress of modern life is often invoked as an important 
cause. 
4.  Epidemiological factors:   
a.  Ulcer is more common in men than women. Ulcer is more frequent in 
women after the menopause, suggesting that sex hormones may be 
important in the aetiology of the disease.  
b.  Duodenal ulcers more common in patients with blood group “O”.  
Gastric ulcers more common in patients with blood group ‘A’  
5.  A major causative factor (60% of gastric and up to 90% of duodenal ulcers) is 
chronic inflammation due to Helicobacter pylori that colonizes the antral 
mucosa. 
6.  Other important contributing factors are NSAIDs.  
7.  Additional aggressive factors include smoking, ethanol, bile acids, aspirin, and 
steroids. 
8.  Hyper parathyroidism is also associated with increased incidence of peptic 
ulcer and it is now known that a raised serum calcium level in man stimulates 
gastric secretion. 
Pathophysiology  
 PUD develops when the mucosa of the GI Tract becomes susceptible to 
corrosive forces, the most important of which is gastric acid. 
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The DU patient is an acid hypersecretor. Meal stimulated gastric acid 
secretion was approximately 70% higher, while night (basal) secretion was 
approximately 150% higher. The presence of food appears to protect the gastric 
mucosa against the meal- induced hyperchlorhydria. 
At night, however the increased quantity of acid is left to bathe the ‘bare’ 
gastroduodenal mucosa. 
Duodenal bicarbonate secretion appears to be impaired in DU patients. 
When the balance between protective factors (Prostaglandins, mucus 
secretion, and nitric oxide) and aggressive factors (gastric acid, pepsin, and bile salts) 
is the disrupted, mucosal injury may ensue. 
The three main factors that contribute to disturbing this balance are H.pylori 
infection, NSAID use, and smoking. 
HELICOBACTER PYLORI (H. pylori) 
H. pylori is a gram negative, spiral, flagellated, urease positive bacterium that 
has the ability to colonize the gastroduodenal mucosa and cause inflammation.  
By virtue of its ability to split urea into bicarbonate and ammonia, the 
organism is able to buffer H+ ions before the intracellular pH drops below 5, allowing 
it to survive in the acidic environment of the stomach and adhere to specific receptors 
on the gastric epithelial cell. 
Once attached , the organism causes mucosal damage by various mechanisms. 
Non steroidal anti inflammatory drugs 
 NSAIDs produce topical mucosal injury due to their acidic nature, with 
additional damage due to the biliary secretion and subsequent duodenogastric reflux 
of active NSAID metabolites. 
The principal toxicity of NSAIDs occurs as a result of their systemic ability to 
impair prostaglandin synthesis. 
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Cigarettes 
 Smoking adversely affects many of the natural mucosal protective 
mechanisms and enhances aggressive factors, such as stimulating pepsin release and 
increasing the production of free radicals. 
Smoking also appears to increase the risk and virulence of H.pylori. 
Hypersecretory states 
 In some patients, the balance between protective and aggressive factors is 
disrupted because of the overproduction of acid due to hypersecretory state. 
The most noteworthy of these conditions is Zollinger- Ellison syndrome, in 
which a gastrin secreting tumor stimulates acid production that is not subject to the 
normal feedback inhibition of acid. 
Other rare causes of hypersecretory states are systemic mastocytosis, antral G-
cell  hyperplasia, and extensive small bowel resection. 
 Symptomatology 
1.  The main symptom is pain which is usually localized to the epigastrium. 
2.  Duodenal ulcers pain occurs 1-3 hours after a meal and may awaken patient 
from sleep. Pain is relieved by food, antacids. 
 3.  In Gastric ulcers food may exacerbate the pain while vomiting relieves it. 
4.  Waterbrash which seems to be caused by an increased salivary secretion. 
5.  Bloating 
6.  Dyspepsia 
7.  Belching 
8.  Nausea 
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9.  Vomiting 
10.  Hematemesis and melena may also occur in chronic condition. 
 [ Ref:  Oxford Text book of Medicine,  Ronald’s  text book of Medicine, and 
The Clinician’s guide to Acid/peptic Disorders of Gastrointestinal Tract ] 
3.5  LATERAL RESEARCH OF Borassus flabellifer 
1. Anti-inflammatory activity of ethanolic extract of Borassus flabellifer l. Male 
flowers Mahesh S. 2009  
2 . Evaluation of the analgesic and antipyretic activities of ethanolic extract of 
male flowers (inflorecences) of Borassus flabellifer l.  Mahesh s. 2009 
3. Anti nociceptive, anti inflammatory and anti bacterial properties of leaf of 
female Borassus flabellifer (Arecaceae) Sandhya S et al  2010 
4.  Preliminary studies on in vitro anti-tumor activity of tender seed of Borassus 
flabellifer Govinda Rao Duddukuri et al  
5. Antibacterial activity of methanolic seed coat extract of Borassus flabellifer l. 
Govinda Rao Duddukuri et al. 
6. Bio active saponins from the flowers of Borassus flabellifer                          
Yoshikawa masayuki et al. 
The methanolic extract from the flowers of B. flabellifer was found to show 
inhibitory effect on serum glucose elevation. By bioassay-guided separation, six new 
spirostanol saponins 1, 2, 3, 4, 5, and 6 were isolated from the active fraction (BuOH-
soluble fraction) together with 21 known furostanol and spirostanol saponins. In 
addition, the principal constituent, dioscin (7), exhibited inhibitory effect on serum 
glucose elevation in oral sucrose-loaded rats as well as protective effect on gastric 
mucosal lesions induced by ethanol in rats. 
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4.  MATERIALS AND METHODS 
 4.1. PREPARATION OF CHOORANAM 
Collection and authentication of the materials 
The plant material used in this study was collected during  the month of 
January - February (2012) from Soorapalli, Salem district, Tamilnadu, India and 
authenticated  by Botanist , Central Research Institute for Siddha and Siddha experts 
of Gunapadam Dept . The  drug “Panaipoo” was selected  from the classical  Siddha 
literature Agathiyar gunavaakadam, Gunapadam mooligai vagupu. 
Preparation of Panai poo Chooranam: 
             Panai poo was thoroughly cleaned to remove impurities. Then it was cut into 
small pieces and dried. Later they were finely powdered. The resultant powder   was 
subjected to   sieve with white cotton cloth to obtain finest physical form. 
(Vasthirakayam) 
Purification of chooranam 
The Chooranam was moistened with cow’s milk. Pot was filled with milk and 
water of equal ratio to nearly ¾ its volume. The mouth of the pot was covered and 
tied with white cotton cloth. The Chooranam moistened by milk was placed above the 
tied cloth. The mouth of the pot was closed with another mud pot. The gap between 
the two mud pots was tied with a wet cloth to avoid evaporation. Then this pot was 
subjected to heat and boiled until milk level in lower pot gets reduced to ¼ volumes. 
Then the powder was taken, sun dried, powdered finely and preserved for usage. 
Preservation 
The purified Chooranam was stored in a clean, air tight glass container. 
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Figure No:4.1  Panai poo chooranam 
                                  
 
 
 
 
 
 
Life span  
                3 Months. 
Administration of the drug 
            Form of the medicine             : Chooranam 
  Route of Administration : Enteral 
 Dose    : 1 gm 
 Anubanam (Vehicle)             : Warm water 
 Times of Administration : Two times a day; before food 
4.2.  STANDARDIZATION OF PANAI POO CHOORANAM 
Standardization of drugs means confirmation of its identity and determination 
of its quality, effectiveness and acceptability to be used as medicine. Standardization 
of plant drug is based on the concentration of their active principles, physical and 
chemical standards. Plant drug has been standardized on the basis of organoleptic 
properties, physical characteristics, and physico‐chemical properties.  The process of 
standardization can be achieved by stepwise studies. 
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Collection and identification of plant 
The plant material belongs to the family Arecaceae was collected from 
Soorapalli, Salem district, Tamilnadu. The plant was identified with the help of 
Botanist, Central Research Institute for siddha, Chennai and by the Siddha experts of  
Gunapadam Dept. A voucher specimen is deposited in the Herbarium, Department of 
Gunapadam , Govt.Siddha Medical Collage, Chennai-106. 
4.2.1. PHARMACOGNOSTIC STUDY 
Borassus flabellifer Linn 
Materials and methods for anatomical studies 
Collection of specimens  
The plant specimens for the proposed study were collected from Soorapalli, 
Salem Dist, Tamilnadu. Care was taken to select healthy plants and normal organs. 
The required samples of different organs were cut and removed from the plant and 
fixed in FAA (Farmalin-5ml+ Acetic acid-5ml + 70% Ethyl alcohol-90ml).After 24 
hrs of fixing, the specimens were dehydrated with graded series of tertiary –Butyl 
alcohol as per the schedule given by Sass, 1940. Infiltration of the specimens was 
carried by gradual addition of paraffin wax (melting point 58-60 C) until TBA 
solution attained super saturation. The specimens were cast into paraffin blocks. 
Sectioning 
The paraffin embedded specimens were sectioned with the help of Rotary 
Microtome. The thickness of the sections was 10-12 μm. Dewaxing of the sections 
was by customary procedure (Johansen, 1940). The sections were stained with 
Toluidine blue as per the method published by O’Brien et al. (1964). Since Toluidine 
blue is a polychromatic stain. The staining results were remarkably good; and some 
cytochemical reactions were also obtained. The dye rendered pink colour to the 
cellulose walls, blue to the lignified cells, dark green to suberin, violet to the 
mucilage, blue to the protein bodies etc. wherever necessary sections were also 
stained with safranin and Fast-green and IKI(for Starch) 
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For studying the stomatal morphology, venation pattern and trichome 
distribution, paradermal sections (sections taken parallel to the surface of leaf) as well 
as clearing of leaf with 5% sodium hydroxide or epidermal peeling by partial 
maceration employing Jeffrey’s maceration fluid (Sass, 1940) were prepared. 
Glycerine mounted temporary preparations were made for macerated/cleared 
materials. Powdered materials of different parts were cleared with Naoh and mounted 
in glycerine medium after staining. Different cell component were studied and 
measured.] 
Photomicrographs 
Microscopic descriptions of tissues are supplemented with micrographs 
wherever necessary. Photographs of different magnifications were taken with Nikon 
labphoto 2 microscopic Unit. For normal observations bright field was used. For the 
study of crystals, starch grains and lignified cells, polarized light was employed. 
Since these structures have birefringent property, under polarized light they appear 
bright against dark background. Magnifications of the figures are indicated by the 
scale-bars. Descriptive terms of the anatomical features are as given in the standard 
Anatomy books (Esau, 1964). 
4.2.2   Physico‐chemical  Investagations : 
           Physico‐chemical studies like total ash, water soluble ash,  acid insoluble ash, 
water and alcohol soluble extract, loss on drying  at 105°C and  PH  as per the WHO 
guide lines  in Central Research Institute For Siddha. 
Determination of Total Ash 
Incinerate about 2 to 3 g accurately weighed, of the ground drug in a tared 
platinum or silica dish at a temperature not exceeding 450º until free from carbon, 
cool and weigh. Calculate the percentage of ash with reference to the air-dried drug. 
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Determination of Acid Insoluble Ash 
Boil the ash obtained for 5 minutes with 25 ml of dilute hydrochloric acid; 
collect the insoluble matter in a Gooch crucible or on an ash less filter paper, wash 
with hot water and ignite to constant weight. Calculate the percentage of acid-
insoluble ash with reference to the air dried drug. 
Determination of Alcohol Soluble Extractive 
Macerate 5 g of the air dried drug, coarsely powdered, with 100 ml of Alcohol 
of the specified strength in a closed flask for twenty-four hours, shaking frequently 
during six hours and allowing to stand for eighteen hours. Filter rapidly, taking 
precautions against loss of solvent, evaporate 25 ml of the filtrate to dryness in a 
tarred flat bottomed shallow dish, and dry at 105º, to constant weight and weigh. 
Calculate the percentage of alcohol-soluble extractive with reference to the air-dried 
drug. 
Determination of Water Soluble Extractive 
Proceed as directed for the determination of Alcohol-soluble extractive, using 
chloroform water instead of ethanol. 
Determination of Moisture Content (Loss on Drying) 
Procedure set forth here determines the amount of volatile matter (i.e., water 
drying off from the drug). For substances appearing to contain water as the only 
volatile constituent, the procedure given below, is appropriately used. Place about 10 
g of drug (without preliminary drying) after accurately weighing (accurately weighed 
to within 0.01 g) it in a tared evaporating dish. For example, for underground or 
unpowderdd drug, prepare about 10 g of the sample by cutting shredding so that the 
parts are about 3 mm in thickness. 
            After placing the above said amount of the drug in the tared evaporating dish 
dry at 105º for 5 hours, and weigh. Continue the drying and weighing at one hour 
interval until difference between two successive weighings corresponds to not more 
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than 0.25 per cent. Constant weight is reached when two consecutive weighings after 
drying for 30 minutes and cooling for 30 minutes in a desiccator, show not more than 
0.01 g difference. 
Determination of pH 
1% solution of  plant drug  was prepared in distilled  water and pH was 
determined using pH meter, systronics digital ph meter, MK VI. 
TLC  estimation  of Panai poo Chooranam: 
Thin-layer chromatography is a technique in which a solute undergoes 
distribution between two phases, stationary phase acting through adsorption and a 
mobile phase in the form of a liquid. The adsorbent is a relatively thin, uniform layer 
of dry finely powdered material applied to a glass, plastic or metal sheet or plate. 
Glass plates are most commonly used. 
            Identification can be effected by observation of spots of identical Rf value and 
about equal magnitude obtained, respectively, with an unknown and a reference 
sample chromatographed on the same plate. A visual comparison of the size and 
intensity of  the spots usually serves for semi-quantitative estimation. 
Solvent system: 
                 Toluene : Ethyl acetate (6:1.5). 
TLC plate: 
         Aluminium plate precoated with silica gel 60F254 of 0.2 mm thickness 
(Merck). 
Developing chamber: 
           Camag’s twin trough chamber. 
Visualizing reagent: 
        Vanillin-sulphuric acid agent. 
Anti Ulcer Activity of Panai poo Chooranam 
 
 
P.G. Gunapadam Department  37
Extract Preparation:  
               4 g of the chooranam was soaked overnight in chloroform. Boiled on a water 
bath  for 10 mins, filtered and concentrated to 10 ml.  
Procedure: 
 The extract was applied on the TLC using capillary and developed in the 
solvent system.  The developed TLC plate was air dried, dipped in vanillin-sulphuric 
acid reagent and heated in an oven at 105°C until the development of coloured spots 
and photograph taken. 
4.2.2.3 Fourier transform infrared spectroscopy  (FTIR): 
Instrument details: 
Model   :  Spectrum one: FT-IR Spectrometer  
Scan Range   :  MIR 450-4000 cm-1  
Resolution   :  1.0 cm-1  
Sample required :  50 mg, solid or liquid. 
 Fourier Transform Infrared Spectroscopy (FTIR) is an analytical technique 
used to identify mainly organic materials. FTIR analysis results in absorption spectra 
which provide information about the chemical bonds and molecular structure of a 
material. The FTIR spectrum is equivalent to the "fingerprint" of the material and can 
be compared with cataloged FTIR spectra to identify the material. 
Infrared spectrum is useful in identifying the functional groups like -OH, -CN, 
-CO, -CH, -NH2, etc. Also quantitative estimation is possible in certain cases for 
chemicals, pharmaceuticals, petroleum products, etc. Resins from industries, water 
and rubber samples can be analyzed.  
             The drug sample was analyzed by the FTIR to identify the chemical bonds 
and molecular structure of a material. 
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Figure No: 4.2.2.3 
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4.2.2.4 Scanning electron microscope (SEM): 
The Scanning Electron Microscope (SEM) is a microscope that was electrons 
rather than light to form an image. There are many advantages to using the SEM 
instead of a light microscope. 
Resolution : 1.2 nm gold particle separation on a carbon substrate 
Magnification : From a min of 12 x to greater than 1, 00,000 X 
The SEM has a large depth of field, which allows a large amount of the 
sample to be in focus at one time. The SEM also produces images of high resolution, 
which means that closely spaced features can be examined at a high magnification. 
Preparation of the samples is relatively easy since most SEM one require the sample 
to be conductive. 
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The combination of higher magnification, larger depth of focus, greater 
resolution, and easy of sample observation marks the SEM one of the most heavily 
used instruments in research areas today. 
4.2.3. Qualitative phytochemical analysis: 
Table No:4.2.3 
Sl. 
No 
EXPERIMENT OBSERVATION INFERENCE 
1. Test for Alkaloids: Alkaloids are 
identified by precipitate method 
Dragendroff’s reagent: 
An aqueous plant extract of 2 ml is 
mixed with 2 ml of Dragendroff’s 
reagent. 
 
Absence of 
reddish brown 
precipitate 
 
Absence of 
alkaloids 
2. Test for Triterpenoids (Noller’s 
Test) 
To few mg of extract, add tin and 
thionyl chloride and heat in water 
bath. 
       
     Presence of 
purple colour 
 
 
Presence of  
Triterpenes 
3. Test for Tannins:A plant sample 
dried powder 0.5 gm is boiled in 20 
ml of water and filtered. The filterate 
2 ml is taken and 3-5 drops of Fecl2  
(0.1%) is slowly added to it. 
 
Forms a brownish-
green or bluish- 
black colour. 
 
Presence of 
Tannins 
4. Test for Flavonoids: An aqueous 
filterate of plant sample is mixed with 
5 ml of dilute Ammonium solution 
and few drops of concentrated H2SO4  
is slowly added through the sides of 
the test tube. 
 
Absence of  Yellow 
colour formed 
 
Absence of 
flavonoids 
5. Test for steroids:An ethonolic  
extract  of plant sample 2ml is mixed 
with  2 ml H2SO4 and 0.5 gm Acetic 
anhydride. 
  The solution turns 
in to blue to green 
colour 
 Presence of 
Steroids  
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Sl. 
No 
EXPERIMENT OBSERVATION INFERENCE 
6. Test for Saponin: A powdered 2 gm 
of plant sample is boiled with 20 ml 
of distilled water, then filtered, the 
filterate is added with fresh 5 ml of 
distilled water and shaken vigorously.
  A permenant or 
persistant froth is 
formed. The froth is 
turned in to 
emulsion by adding 
three drops of olive 
oil. 
Presence  of 
saponin 
7. Test for Phenolic compounds: 
  About 2 ml of aqueous plant extract 
is mixed with 2 ml of Fecl3 solution.  
Absence of deep 
bluish green colour  
Absence of 
phenolic 
compounds 
 
8. 
 
 
 
 
Test for Glycosides:An aqueous 
plant extract of 2 ml is added with 1 
ml of concentrated Hcl and boiled in 
a water bath for about 2 hours. The 
filtrate is separated and 3 ml of 
chloroform is added, then 10% of 
1ml Ammonium solution is added.  
Pink colour formed. Presence of 
glycosides 
 
4.2.4. Chemical analysis 
Proximate Chemical Analysis of Panai poo chooranam 
Methodology For Chemcial Analysis 
Preparation of Extract  
Add 5 gm of the sample to 50ml of distilled water. Boil the solution for 20 
minutes, cool and then filter. The Extract was used for the following tests. 
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Table No: 4.2.4 
S.No Experiment Observation Inference 
1. Test for reducing Sugar : 
To 5ml of Benedicts qualitative 
reagent, add 10 drops of extract, then 
boil for two minutes 
 
Green colour PPT 
Presence of 
Reducing 
Sugar 
2. Test for Starch : 
To 5 ml of extract add 2ml of acetic 
acid and then add few drops of N/50 
Iodine Solution. 
 
Blue Colour 
Presence of 
Starch 
3. Test for Proteins : 
To 2 ml of extract, add 2ml of 5% 
Sodium Hydroxide mix and add 2 
drops of Copper Sulphate Solution. 
 
Violet  Colour 
Presence of 
Proteins 
4. Test for amino Acid : 
Place  2 drops of extract on a filter 
paper and allow to dry well. Then 
spray 1% ninhydrin over the same and 
allow to dry. 
 
Violet Colour 
Presence of 
Amino Acid 
5. Test for Albumin : 
To 2 ml of extract, add 2ml of 
Esboch’s reagent. 
 
Yellow PPT 
Presence of 
Albumin 
6. Test for Phosphate : 
To 2ml of extract, add 2ml of 
ammonium Molybdate solution and 
2ml of concentrated Nitric Acid. 
 
Absence of yellow 
PPT 
Absence of 
Phosphate 
7. Test for Sulphate : 
To 2 ml of extract add 2ml of 4% 
ammonium oxalate solution. 
 
Absence of  white 
PPT 
Absence of 
Sulphate 
8. Test for Chloride :  
Add 2ml of extract to dilute nitric acid 
till the effervescence ceases. Then add 
2 ml of Silver Nitrate Solution. 
 
Cloudy White PPT 
Presence of 
Chloride 
9. Test for Iron : 
To 2ml of extract, add 2ml of 
ammonium thio cynate solution and 
add 2ml of concentrated Nitric Acid. 
 
Red Colour 
 
Presence of 
Iron 
10. Test for Calcium : 
To 2 ml of extract, add 2 ml of 4% 
ammonium Oxalate Solution. 
Absence of white 
PPT 
Absence of 
Calcium 
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S.No Experiment Observation Inference 
11. Test for Sodium : 
Make a paste with 2 pinches of the 
sample with Hcl and Introduce it into 
the blue flame.  
Absence of yellow 
Flame 
Absence of 
Sodium 
12. Test for Potassium : 
Add a pinch of the sample to 2 ml of 
Sodium Nitrate Solution. Then add 
2ml of Cobal Nitrate in 20% acetic 
acid. 
Absence of yellow 
PPT 
Absence of 
Potassium 
13. Test for Zinc : 
To 2ml of extract, add few drops of 
Sodium Hydroxide. 
Absence of white 
PPT 
Absence of 
Zinc 
14. Test for Magnesium : 
To 2ml of extract, add few drops of 
Sodium Hydroxide Solution 
Absence of white 
PPT 
Absence of 
Magnesium 
15. Test for Alkaloids : 
a. To 2ml of extract, add 2ml of 
Potassium Iodide Solution 
b. To 2ml of extract add 2ml of Picric 
Acid. 
c. To 2 ml of extract add 2ml of 
Phosphotunqstic Acid. 
 
Absence of red 
Colour 
Absence of yellow 
Colour 
Absence of  white 
PPT 
 
Absence of 
Alkaloids 
Absense of 
Alkaloids 
Absence of 
Alkaloids 
16. Test for Tannic Acid : 
To 2ml of extract add 2 ml of Ferric 
Chloride Solution 
 
Black PPT 
Presence of 
Tannic Acid 
 
4.3.  TOXICOLOGICAL STUDY 
MATERIALS AND METHODS 
Chemicals and reference drug: All chemicals used in the present study were 
analytical grade and purchased from SD fine chemicals Ltd (Mumbai, India). Aspirin 
was obtained from BD Pharmaceutical Works and Ranitidine (Reference drug) was 
obtained from Ranbaxy Laboratories. 
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Stock solution preparation 
 The powdered form of Panai Poo Chooranam was mixed uniformly in 2% 
CMC solution to achieve 100mg/ml as main stock solution and used in this study.  
Animals 
 Albino mice of either sex weighing 25-30g (For acute toxicity study) and 
Healthy Swiss Albino rats of the Wister strain weighing 150-200 g were used for the 
study. The animals were used with the approval of the Institute animal ethics 
committee and obtained from Vels University, Chennai. They were fed with a 
balanced standard pellet diet and maintained under standard laboratory conditions, 
providing 24-280C temperature, standard light cycle (12 h light, 12 h dark) and water 
ad libitum.  
 Animals were kept in cages with raised floors of wide mesh to prevent 
coprophagy. Animal welfare guidelines were observed during the maintenance period 
and experimentation. The rats were randomly assigned to control and different 
treatment groups, six animals per group.  
(Approval number: XIII/VELS/PCOL/11/2000/CPCSEA/IAEC/08.08.2012). 
The animals were acclimatized for one week under laboratory conditions.  
Acute toxicity study 
 Acute oral toxicity test for the Panai poo Chooranam was carried out as per 
OECD Guidelines 425. As with other sequential test designs, care was taken to ensure 
that animals are available in the appropriate size and age range for the entire study. 
The test substance is administered in a single dose by gavage using a stomach tube or 
a suitable intubation cannula. The fasted body weight of each animal is determined 
and the dose is calculated according to the body weight. After the substance has been 
administered, food was withheld for a further 2 hours in mice. Single animals are 
dosed in sequence usually at 48 h intervals.  
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However, the time interval between dosing is determined by the onset, 
duration, and severity of toxic signs. Treatment of an animal at the next dose was 
delayed until one is confident of survival of the previously dosed animal. The time 
interval was adjusted as appropriately in case of inconclusive response. The test is 
simpler to implement when a single time interval is used for making sequential dosing 
decisions. Special attention was given during the first 4 hours and daily thereafter, for 
a total of 14 days, except where they need to be removed from the study and 
humanely killed for animal welfare reasons or are found dead.  
 All observations are systematically recorded and Observations include 
changes in skin and fur, eyes and mucous membranes, and also respiratory, 
circulatory, autonomic and central nervous systems, and somatomotor activity and 
behaviour pattern. Attention was directed to observations of tremors, convulsions, 
salivation, diarrhea, lethargy, sleep and coma. The principles and criteria summarized 
in the Humane Endpoints Guidance Document taken into consideration. Animals 
found in a moribund condition and animals showing severe pain or enduring signs of 
severe distress was humanely killed. When animals are killed for humane reasons or 
found dead, the time of death was recorded.  
4.4.  PHARMACOLOGICAL STUDY 
EVALUATION OF ANTIULCER  PROPERTY OF PANAI POO CHOORANAM 
 Gastric and duodenal ulcers are illnesses that affect a considerable number of 
people in the world. Some of the causes of these disorders are: stress, smoking, 
nutritional deficiencies and ingestion of non-steroidal anti-inflammatory drugs. The 
pathogenesis of gastro duodenal ulcers are influenced by various aggressive and 
defensive factors, such as acid-pepsin secretion, mucosal barrier, mucus secretion, 
blood flow, cellular regeneration and endogenous protective agents (prostaglandins 
and epidermal growth factor). 
 The genesis of peptic ulcer mechanism is related to the balance between the 
defensive and aggressive factors. Gastric mucosa is an active area of arachidonic acid 
metabolism the integrity of gastric mucosal barrier is influenced by mucus secretion, 
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acid secretion, and gastric blood flow. The gastric irritation of non-steroidal anti-
inflammatory drugs on the gastric mucosa is one of the major disadvantages of their 
using inflammatory. It is well established that NSAIDs causes inhibition of the 
synthesis of cytoprotective prostaglandin.  
 Recently, widespread effort has been launched to identify novel anti-ulcer 
drugs from natural resources. Ulcer is defined as the erosion in the lining of the 
stomach or duodenum and is caused by the disruptions of the gastric mucosal defense 
and repair systems. Ulcer in the stomach is called gastric ulcer and in the duodenum is 
called duodenal ulcer and together peptic ulcer. In clinical practice, peptic ulcer is one 
of the most prevalent gastrointestinal disorders, commonly occurs in developed 
countries.  
 Treatments available for ulcer is generally non-specific and is usually aimed at 
reducing the production of gastric acid and re-enforcing gastric mucosal protection 
such as regular food, adequate rest and avoidance of ulcerogenic agents such as 
coffee, alcohol and tobacco. The drugs used in the treatment of ulcer include receptor 
blockers, proton pump inhibitors, drugs affecting the mucosal barrier and act on the 
central nervous system. Even though a range of drugs are available for the treatment 
of ulcer, many of these do not fulfill all the requirements and have side effects. 
Recently, there has been much interest in natural medicines derived from the 
traditional knowledge of plant pharmacological properties. The present study was 
undertaken to evaluate the effect of Panai Poo Chooranam on Aspirin induced model 
of gastro intestinal ulceration. 
ANTI-ULCER EVALUATION 
Aspirin induced gastric ulcer: 
 Animals were divided into five groups (n = 6) Panai Poo Chooranam (250, 
500mg/kg) inter peritoneal and control vehicle were administered 30 min. before the 
administration of aspirin (400mg/kg) per orally. The animals were scarified, after 6 
hours following the administration of aspirin, stomachs were removed and 2% 
formalin was injected into the stomach. The stomach was open along with greater 
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curvature and immersed in 2% formalin solution. The length of each lesion was 
measured under the dissecting microscope. The sum of the length (mm) of all lesions 
for each rat was used in lesion index. 
 The ulcer score was determined by using a 10 × magnifying hand lens. The 
scoring of severity of ulceration was as follows:  
1 mm (pin point) = 1; 1-2 mm = 2; > 2 mm = 3; > 3 mm = 4. The mean ulcer 
score was determined by dividing the total ulcer indices in a group by the total 
number of animals in that group. Ulcer Score = Total ulcer index (UI) in a 
group/Total number of animals in that group.               
Statistical analysis 
 The statistical analysis was carried out using one-way ANOVA followed by 
Dunnett's multiple comparison test. All the results obtained in the study were 
compared with the vehicle control group. P values <0.05 were considered statistically 
significant. 
4.5.  CLINICAL ASSESSMENT 
I have selected the herbal drug which proved its anti – ulcer activity pre 
clinically. Panai poo chooranam, a herbal medicine was used for this clinical trial to 
prove its safety and efficacy against Peptic ulcer disease. 
Objectives 
The study was conducted on peptic ulcer patients to assess the “anti-ulcer” 
activity of “Panai poo chooranam” clinically, both in-patients and out-patients of 
both sex and varying age groups. 
Study centre    
 The clinical study for PEPTIC ULCER is carried out in outpatient 
department and in patient ward of Govt.Siddha medical college hospital and Arignar 
Anna Indian Hospital, Arumbakkam, Chennai-106. 
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Design of the study 
Open clinical trial, phase II B  
Selection 
 50 patients from both sexes of various age groups were selected for clinical 
trial. Among 50 patients 40 patients were treated as out-patients, 10 patients were 
treated as in-patients. The selection was based on the including and excluding criteria.  
They were clinically diagnosed on the basis of siddha principles with modern 
laboratory findings. 
Registration process 
To register a patient, the following documents have been proceeded. 
¾ Copy of required laboratory tests 
¾ Signed patient consent form 
Then I verified  eligibility and assigned  a patient study number, drug dose and 
registered the patient on the study. 
Criteria selection 
Including criteria 
 Epigastric pain 
 Heart burn 
 Regurgitation  
 Nausea/vomiting 
 Loss of appetite 
 Abdominal discomfort 
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Excluding criteria 
 Complication of peptic ulcer such as  
• Haemorrhage,  
• Perforation, 
• Gastric outlet obstruction 
 Radiating abdominal pain as in pancreatitis, appendicitis 
 Acute abdominal colic’s 
 Cancer of the stomach  
 Gall stone and hiatus hernia  
 Cirrhosis of liver and jaundice 
Criteria for withdrawal 
Patients were removed from study when any of the criteria listed below 
applies. In the absence of treatment delays due to adverse events, treatment may 
continue for 2 cycles or until one of the following criteria applies: 
♦ Disease progression, 
♦ Deterioration of vital signs with cardiac, respiratory, hepatic, renal and 
CNS changes. 
♦ Intercurrent illness that prevents further administration of treatment, 
♦ Unacceptable adverse event(s), 
♦ Patient decides to withdraw from the study, or  
♦ General or specific changes in the patient’s condition render the patient 
unacceptable for further treatment in the judgment of the investigator. 
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Investigation 
For all the cases full clinical data were recorded and they were diagnosed on 
the basis of siddha principles i.e.  Envagai thrvugal, Ezhu udal thathukkal etc. 
All the patients under study were subjected to blood investigations for TC, 
DC, ESR, and Hb. Blood urea, serum cholesterol and Blood sugar were also 
investigated. 
Urine test for albumin, sugar, deposits and motion test for ova, cysts were 
done. 
  The disease Peptic Ulcer was confirmed in the patients by means of 
Endoscope examination, Barium meal examination and clinically. 
Routine examination and assessment 
 The full details of history and physical examination of the patients were 
recorded as per the proforma. The clinical assessment was done initially at the end of 
7 days, 14 days and 21 days during treatment and at the end of the 21 days follow up 
were done. The laboratory investigation and the physiological parameters will be 
recorded initially and the end of the treatment and at follows up as per the Proforma. 
Administration of the drug: 
 Form of the medicine  : Chooranam 
  Route of Administration : Enteral 
 Dose    : 1gm 
 Anubanam (Vehicle)  : Warm water 
 Times of Administration : Two times a day; before food 
 Duration   : 7 weeks 
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Diet and medical advice 
Do’s 
o Timely food 
o Banana  
o Carrots and cabbage juice 
o Butter milk 
o Should chew every morsel thoroughly 
o Meals must be small and frequent 
 Dont’s 
o Fatty and tough meats 
o Fried foods, Sour foods  
o Unripe citrus fruits like oranges and sweet lime 
o Spicy foods, carbonated drinks 
o Strongly flavored veggies like cauliflower, turnip, radish, onion, etc 
o Strong tea and coffee 
o Alcoholic Beverages 
o Intake of steroids and NSAIDS. 
o  Above all avoid worrying. 
Trial conduct 
This study will be conducted in compliance with the protocol approved by the 
Institutional Review Board, and according to Good Clinical Practice standards. No 
deviation from the protocol will be implemented without the prior review and 
approval of the IRB except where it may be necessary to eliminate an immediate 
hazard to a research subject. In such case, the deviation will be reported to the IRB as 
soon as possible. 
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Criteria for assessment of response to therapy: 
1) Good Relief : 75% relief in the presenting signs and symptoms 
marked normality pathological investigation. 
2) Satisfactory : 60 – 75% relief signs and symptoms, moderate 
normality of pathological investigation. 
3) Moderate : 50% relief of signs and symptoms, mild changes in 
pathological investigations. 
4) Poor  :  less than 50% relief in symptoms and no 
significant improvement in laboratory parameters. 
Then clinical signs and symptoms like Epigastric pain, Heart burn, 
regurgitation and distension of abdomen were observed regularly under the 
supervision of HOD, Lecturers, and Asst.Lecturers.  
Follow up 
Assessment was taken for every three days before treatment and after 
treatment. During this period clinical assessment and laboratory investigation was 
carried out. 
Statistical analysis 
The data will be tabulated and analyzed by student‘t’ test.  
Ethical review 
The protocol and amendments were submitted to the Govt siddha medical 
college, Institutional Ethical Committee (IEC) and got formal approval for conducting 
the study. The decision of the IEC concerning the conduct of the study was made in 
writing to the investigator. 
All subjects for this study was provided a consent form describing this study 
and provided sufficient information for subjects to make an informed decision about 
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their participation in this study. This consent form was submitted with the protocol for 
review and approval by the IEC. The formal consent of a subject, using the IEC-
approved consent form, was obtained before that subject is submitted to any study 
procedure. This consent form was signed by the subject or legally acceptable 
surrogate, and the investigator-designated research professional obtaining the consent.  
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Table No: 4.5.1 
CLINICAL STUDY ON PANAI POO CHOORANAM  IN OUT PATIENTS DEPT. IN THE MANAGEMENT OF PEPTIC ULCER 
SI 
NO 
Op. 
No 
Name/ Age/ 
Sex Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD    
Blood 
CL 
Urine X ray bms/ 
Endoscopy TC 
cells/cumm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/dl 
Ur 
mg/dl 
  
Sgr 
  
Alb 
   
Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
1. 2823 Theivanayagi 
60/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
3.6.12 
To 
15.7.12 
BT 8700 53 40 7 30 71 9.6 88 23 159 NIL NIL PCS  
 Good 
 AT 8700 54 39 7 30 71 9.6 88 20 152 NIL NIL NIL  
2. 7268 Ajith 
23/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
4.6.12 
To 
28.7.12 
BT 10000 64 32 4 2 4 14.4 89 21 159 NIL NIL FPC  
- 
Good 
 
AT 10000 65 32 4 2 4 14.4 89 19 160 NIL NIL NIL 
3. 7276 Saraswathy 
25/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
4.6.12 
To 
28.7.12 
BT 8800 60 37 3 8 12 10 90 20 173 NIL NIL FPC  
- 
Good 
 
AT 8800 61 37 2 8 12 10 90 18 170 NIL NIL NIL 
4. 4271 Rangasamy 
45/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
5.6.12 
To 
10.8.12 
BT 9800 62 34 4 3 6 13 92 24 165 NIL NIL FPC  
- 
 
Satisfactory 
 AT 9800 61 35 4 3 6 13 92 22 163 NIL NIL NIL 
5. 5167 Chandra 
32/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
6.6.12 
To 
25.7.12 
BT 9000 58 38 4 26 44 12 94 22 162 NIL NIL NIL  
- 
 
  Good 
                   AT 9000 58 38 3 27 43 12 94 22 160 NIL NIL NIL 
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Table No: 4.5.2 
CLINICAL STUDY ON PANAI POO CHOORANAM  IN OUT PATIENTS DEPT. IN THE MANAGEMENT OF PEPTIC ULCER 
SI 
NO 
Op. 
No Name/ Age/ Sex Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD    
Blood 
CL 
Urine                 
X ray bms/ 
Endoscopy 
TC 
cells/cumm 
DC (%) ESR(mm) Hb 
Gm 
Sgr 
mg/dl 
Ur 
mg/dl 
  
Sgr 
  
Alb 
   
Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
6. 1919 Sumathy 
29/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
7.6.12 
To 
15.7.12 
BT 9600 55 41 4 12 20 11.5 94 20 150 NIL NIL PCS  
- 
Good 
 
AT 9600 54 42 4 12 20 11.5 94 21 148 NIL NIL NIL 
7. 1575 Kiruba rani 
35/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
8.6.12 
To 
18.7.12 
 
BT 9300 54 40 6 15 22 12 85 23 164 NIL NIL NIL  
- 
Good 
 
AT 9300 56 39 5 15 22 12 86 20 163 NIL NIL NIL 
8. 1781 Sakthivel 
47/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
9.6.12 
To 
10.7.12 
BT 9800 59 39 2 4 6 14 95 21 159 NIL NIL FPC  
- 
Good 
 
AT 9800 58 40 2 4 6 14 95 19 162 NIL NIL NIL 
9. 9410 Prabhu 
30/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
12.6.12 
To 
29.7.12 
BT 9900 57 39 4 6 10 13 99 19 161 NIL NIL NIL  
- 
Good 
 
AT 9900 57 39 4 6 10 13 98 18 157 NIL NIL NIL 
10. 302 Palaniyammal 
36/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
14.6.12 
To 
10.8.12 
BT 8800 53 42 5 15 24 11 89 19 190 NIL NIL FPC  
- 
Good 
 
 
                  
AT 8800 54 41 5 15 20 11.5 89 20 188 NIL NIL NIL 
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Table No: 4.5.3 
CLINICAL STUDY ON PANAI POO CHOORANAM  IN OUT PATIENTS DEPT. IN THE MANAGEMENT OF PEPTIC ULCER 
SI 
NO 
Op. 
No Name/ Age/ Sex Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD       
Blood 
CL 
Urine                 
X ray bms/ 
Endoscopy 
TC 
cells/cumm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/dl 
Ur 
mg/dl 
  
Sgr 
  
Alb 
  
 
Dep 
     
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
11. 126 Madhaiyan 
41/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
16.6.12 
To 
10.8.12 
BT 9700 60 37 3 4 8 13 90 17 170 NIL NIL PCS  
- 
Moderate 
 
AT 9700 60 37 3 4 8 13 90 19 173 NIL NIL NIL 
12. 7657 Ayisha 
60/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
19.6.12 
To 
4.8.12 
BT 8700 57 38 5 20 45 8 150 21 168 NIL NIL NIL  
- 
 
Good 
 AT 8700 56 40 4 18 40 9 150 19 162 NIL NIL NIL 
13. 9039 Tarus 
47/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
21.6.12 
To 
30.7.12 
BT 9000 58 36 6 10 16 10 85 23 171 NIL NIL FPC  
- 
 
   Good 
 AT 9000 57 38 5 10 16 10 84 20 168 NIL NIL NIL 
14. 4216 Manonmani 
29/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
23.6.12 
To 
29.7.12 
BT 8900 59 37 4 8 12 12 82 18 162 NIL NIL NIL  
- 
     
   Good 
AT 8900 58 38 4 10 12 12 84 20 166 NIL NIL NIL 
15. 783 Sofiya 
32/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
27.6.12 
To 
12.8.12 
BT 9300 61 35 4 10 14 11 98 26 158 NIL NIL FPC  
- 
 
 
Good 
 
                  
AT 9300 61 35 4 10 14 11 100 28 160 NIL NIL NIL 
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Table No: 4.5.4 
            CLINICAL STUDY ON PANAI POO CHOORANAM  IN OUT PATIENTS DEPT. IN THE MANAGEMENT OF PEPTIC ULCER 
SI 
NO 
Op. 
No Name/ Age/ Sex Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD   
Blood 
CL 
Urine                 
X ray bms/ 
Endoscopy 
TC 
cells/cumm 
DC (%) ESR(mm) Hb 
Gm 
Sgr 
mg/dl 
Ur 
mg/dl 
  
Sgr 
  
Alb 
   
Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
16. 784 Shanthi 
51/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
27.6.12 
To 
23.8.12 
BT 9000 54 41 5 11 20 10.8 100 21 155 NIL NIL PCS  
- 
      
   Good       
AT 9000 55 42 3 12 20 11 100 19 160 NIL NIL FPC 
17. 1048 Rajendran 
50/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
28.6.12 
To 
2.8.12 
BT 9700 60 37 3 8 12 13 94 21 158 NIL NIL NIL  
- 
 
   
Moderate 
 
AT 9700 60 36 4 8 12 13 92 20 156 NIL NIL NIL 
18. 3255 Suresh 
32/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
2.7.12 
To 
25.8.12 
BT 9800 61 35 4 4 8 14 90 19 160 NIL NIL FPC  
- 
 
   Good 
AT 9800 62 34 4 4 8 14 90 20 162 NIL NIL NIL 
19. 4027 Ganapathy 
29/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
4.7.12 
To 
29.8.12 
BT 9500 60 38 2 8 10 13.5 89 26 165 NIL NIL NIL  
- 
 
Good 
 AT 9500 61 37 2 8 10 13.5 90 26 158 NIL NIL NIL 
20. 3043 Selvalakshmi 
35/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
7.7.12 
To 
31.8.12 
BT 8600 55 40 5 22 52 12 89 19 159 NIL NIL PCS  
- 
 
   Good 
 
                 
AT 8600 55 39 6 10 20 13 86 22 160 NIL NIL FPC 
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Table No: 4.5.5 
CLINICAL STUDY ON PANAI POO CHOORANAM  IN OUT PATIENTS DEPT. IN THE MANAGEMENT OF PEPTIC ULCER 
SI 
NO 
Op. 
No 
Name/ Age/ 
Sex Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD   
Blood 
CL 
Urine                 
X ray bms/ 
Endoscopy 
TC 
cells/cumm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/dl 
Ur 
mg/dl 
  
Sgr 
  
Alb 
  
 
Dep 
     
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
21. 3046 Amaravathi 
46/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
9.7.12 
To 
28.8.12 
BT 10000 60 36 4 8 14 11.5 105 20 162 NIL NIL PCS  
- 
Good 
 
AT 10000 60 37 3 8 14 11.5 106 19 160 NIL NIL FPC 
22. 3017 Srinivasan 
30/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
10.7.12 
To 
5.9.12 
BT 9800 62 34 4 4 8 13 101 18 157 NIL NIL PCS  
- 
Moderate 
 
AT 9800 63 34 3 4 8 13 98 20 160 NIL NIL NIL 
23. 4581 Sumathy 
31/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
12.7.12 
To 
21.8.12 
BT 8000 55 41 4 45 80 9 93 21 162 NIL NIL FPC  
- 
Good 
 
AT 8200 56 40 4 40 70 10 90 20 160 NIL NIL NIL 
24. 4032 Chitra 
37/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
14.7.12 
To 
25.8.12 
BT 8500 58 37 5 20 30 10 89 22 168 NIL NIL PCS  
- 
    Good 
AT 8500 58 37 5 20 30 10 91 20 161 NIL NIL FPC 
25. 5967 Visalakshi 
53/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
18.7.12 
To 
28.8.12 
BT 7600 53 41 6 30 56 8 100 20 153 NIL NIL NIL  
- 
 
Good 
 
 
                 
AT 8000 53 42 5 20 40 10 96 18 155 NIL NIL NIL 
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Table No: 4.5.6 
CLINICAL STUDY ON PANAI POO CHOORANAM  IN OUT PATIENTS DEPT. IN THE MANAGEMENT OF PEPTIC ULCER 
SI 
NO 
Op. 
No 
Name/ Age/ 
Sex Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD   
Blood 
CL 
Urine                 
X ray bms/ 
Endoscopy 
TC 
cells/cumm 
DC (%) ESR(mm) Hb 
Gm 
Sgr 
mg/dl 
Ur 
mg/dl 
  
Sgr 
  
Alb 
   
Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
26. 5811 Sinthamani 
39/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
20.7.12 
To 
30.8.12 
BT 9600 58 38 4 10 14 12 90 24 159 NIL NIL FPC  
- 
 
 
Satisfactory AT 9600 59 38 3 10 14 12 88 22 160 NIL NIL NIL 
27. 4741 Mariappan 
40/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
21.7.12 
To 
7.9.12 
BT 9800 60 35 5 14 20 13 98 20 162 NIL NIL PCS  
- 
 
Good 
 AT 9800 61 35 4 14 20 13.5 96 18 161 NIL NIL NIL 
28. 8263 Saraswathy 
40/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
26.7.12 
To 
12.12.11 
BT 9200 58 37 5 8 12 12 85 20 170 NIL NIL NIL 
 
- 
 
Good 
 AT 9200 59 36 5 8 12 12 88 18 168 NIL NIL NIL 
29. 8606 Kumar 
51/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
28.7.12 
To 
10.9.12 
BT 10600 64 31 5 10 18 12.6 96 19 167 NIL NIL PCS  
- 
 
         
   Good          AT 10600 65 31 4 10 14 13 98 20 168 NIL NIL FPC 
30. 361 Balakrishnan 
45/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
3.8.12 
To 
28.9.12 
 
BT 9400 62 35 3 4 8 14 108 20 158 NIL NIL FPC  
- 
 
 
   Good 
                   
AT 9400 64 34 2 4 8 14 106 20 160 NIL NIL NIL 
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Table No: 4.5.7 
CLINICAL STUDY ON PANAI POO CHOORANAM  IN OUT PATIENTS DEPT. IN THE MANAGEMENT OF PEPTIC ULCER 
SI 
NO 
Op. 
No 
Name/ Age/ 
Sex Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD   
Blood 
CL 
Urine                 
X ray bms/ 
Endoscopy 
TC 
cells/cumm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/dl 
Ur 
mg/dl 
  
Sgr 
  
Alb 
  
 
Dep 
     
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
31. 3278 Mamitha banu 
44/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
16.8.12 
To 
29.9.12 
BT 9400 60 36 4 20 36 11 98 19 157 NIL NIL NIL  
- 
 
    Good         
AT 9400 59 38 3 20 36 11 100 16 155 NIL NIL NIL 
32. 5548 Kumar 
28/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
27.8.12 
To 
20.9.12 
BT 10100 62 35 3 6 12 14 90 22 167 NIL NIL PCS  
- 
 
 
    Poor AT 10100 62 36 2 6 12 14 90 20 163 NIL NIL NIL 
33. 5549 Shanthi 
35/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
27.8.12 
To 
6.10.12 
BT 9600 57 40 3 18 25 9 100 23 157 NIL NIL PCS  
- 
   
    Good         
AT 9600 56 41 3 18 25 9 97 22 162 NIL NIL FPC 
34. 7443 Rani 
44/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
4.9.12 
To 
14.10.12 
BT 9800 59 37 4 10 26 10.8 100 16 150 NIL NIL NIL  
- 
 
 
Satisfactory 
 
AT 9800 59 38 3 10 24 11 98 17 154 NIL NIL NIL 
35. 2107 Balamurali 
36/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
 
24.9.12 
To 
27.10.12 
BT 10000 60 35 5 10 16 13 118 22 159 NIL NIL PCS  
- 
 
     
    Good 
 
 
                   
AT 10000 60 36 4 10 16 13 114 20 158 NIL NIL FPC 
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Table No: 4.5.8 
CLINICAL STUDY ON PANAI POO CHOORANAM  IN OUT PATIENTS DEPT. IN THE MANAGEMENT OF PEPTIC ULCER 
SI 
NO 
Op. 
No Name/ Age/ Sex Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD   
Blood 
CL 
Urine                 
X ray bms/ 
Endoscopy 
TC 
cells/cumm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/dl 
Ur 
mg/dl 
  
Sgr 
  
Alb 
  
Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
36. 2639 Shajahan 
50/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
26.9.12 
To 
29.10.12 
BT 10700 66 29 5 7 12 14 108 23 158 NIL NIL NIL  
- 
 
Good 
 AT 10700 66 31 3 7 12 14 104 20 155 NIL NIL NIL 
37. 6363 Shakilabegam 
26/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
11.10.12 
To 
18.11.12 
BT 9600 62 34 4 12 20 12 92 19 158 NIL NIL PCS  
- 
 
Moderate 
 AT 9600 62 35 3 12 20 12 92 20 160 NIL NIL FPC 
38. 319 Meenakshi 
sundaram 
50/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
31.10.12 
To 
29.11.12 
BT 10500 64 32 4 6 10 14 120 21 162 NIL NIL PCS  
- 
 
   Good 
AT 10500 64 34 2 6 10 14 118 18 163 NIL NIL FPC 
39. 2543 Prabhavathi 
37/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
10.11.12 
To 
12.12.12 
BT 9300 60 34 6 10 24 11 88 22 157 NIL NIL FPC  
- 
Good 
 
AT 9300 62 33 5 10 24 11 87 20 160 NIL NIL NIL 
40. 1925 Ganthamani 
35/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
7.11.12 
To 
15.12.12 
BT 8700 60 36 4 25 40 9 98 22 159 NIL NIL NIL  
- 
 
Good 
 
                  
AT 8500 60 37 3 20 35 10 95 20 158 NIL NIL NIL 
 
Anti Ulcer Activity of Panai poo Chooranam 
 
 
P.G. Gunapadam Department  61
Table No: 4.5.9 
 
CLINICAL STUDY ON PANAI POO CHOORANAM  IN, IN-PATIENTS DEPT.IN THE MANAGEMENT OF PEPTIC ULCER 
SI 
NO IP. No Name/ Age/ Sex Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD    
Blood 
CL 
Urine X ray bms/ 
Endoscopy TC 
cells/cumm 
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/dl 
Ur 
mg/dl 
  
Sgr 
  
Alb 
   
Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
1. 663/ 
6046 
Thaiyal nayagi 
55/Female 
Epigastric pain, Heart burn, 
Regurgitation, vomiting, 
Abdominal Distension 
12.6.12 
To 
28.6.12 
BT 8700 53 40 7 30 71 9.6 88 23 156 NIL NIL  PCS  
- 
 
 
 
Good 
AT 8700 54 41 5 25 40 11 90 22 154 NIL NIL NIL 
2. 1052/ 
6013 
Sinnaponnu 
50/Female 
Epigastric pain, Heart burn, 
Regurgitation, vomiting, 
Abdominal Distension 
18.7.12 
To 
4.8.12 
BT 9200 57 40 3 15 28 12 108 23 159 NIL NIL  PCS  
- 
 
Poor 
 
AT 9200 57 41 2 15 25 12 104 20 152 NIL NIL NIL 
3. 1059/ 
7509 
Krishnaprasanth 
62/Male 
Epigastric pain, Heart burn, 
Regurgitation, vomiting, 
Abdominal Distension 
24.7.12 
To 
11.9.12 
BT 10200 62 35 3 18 26 11.5 106 20 171 NIL NIL FPC  
- 
 
   Good 
 AT 10000 63 34 3 15 23 12 102 19 169 NIL NIL NIL 
4. 1115/ 
7963 
Lakshmi 
45/Female 
Epigastric pain, Heart burn, 
Regurgitation, vomiting, 
Abdominal Distension 
25.7.12 
To 
5.8.12 
BT 9000 52 43 5 18 28 11 100 23 164 NIL NIL  FPC  
- 
 
Good 
 
AT 9100 60 36 4 18 28 11 102 20 162 NIL NIL NIL 
5. 1132/ 
8234 
Aarumugathammal 
60/Female 
Epigastric pain, Heart burn, 
Regurgitation, vomiting, 
Abdominal Distension 
26.7.12 
To 
8.8.12 
BT 8800 54 40 6 20 35 10 106 21 163 NIL NIL NIL  
- 
 
Satisfactory    
AT 8900 55 40 5 20 35 10 106 23 160 NIL NIL NIL 
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Table No: 4.5.10 
CLINICAL STUDY ON PANAI POO CHOORANAM  IN, IN-PATIENTS DEPT.IN THE MANAGEMENT OF PEPTIC ULCER 
 
SI 
NO 
IP. 
No Name/ Age/ Sex Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD    
Blood 
CL 
Urine X ray bms/ 
Endoscopy TC 
cells/cumm 
DC (%) ESR(mm) Hb 
Gm 
Sgr 
mg/dl 
Ur 
mg/dl 
  
Sgr 
  
Alb 
   
Dep      
P 
     
L 
   
E 
½ 
hr 
 1 
hr 
6. 1170/ 
9601  
Krishnaveni 
45/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
1.8.12 
To 
18.9.12 
BT 8100 56 38 6 18 24 10 96 22 160 NIL NIL PCS  
- 
 
 
Good 
 
AT 8200 56 39 5 16 22 11 92 20 158 NIL NIL NIL 
7. 1287/ 
3252 
Aarumugam 
36/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
16.8.12 
To 
30.8.12 
BT 10200 63 34 3 10 20 12 106 21 159 NIL NIL FPC  
- 
Good 
 
AT 10200 63 33 4 10 14 12 102 20 154 NIL NIL NIL 
8. 1376/ 
6161 
Parvin 
54/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
29.8.12 
To 
7.9.12 
BT 9700 59 36 5 15 28 11 89 20 168 NIL NIL FPC  
- 
Moderate 
AT 9700 60 37 3 15 25 11.5 90 18 164 NIL NIL NIL 
9. 1403/ 
6882 
Irsan 
47/Male 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
1.9.12 
To 
19.9.12 
BT 9800 62 35 3 6 12 13 102 23 165 NIL NIL FPC  
- 
Good 
 
AT 9900 62 36 2 6 12 13 98 20 159 NIL NIL NIL 
10. 63/ 
1884 
Gowri 
47/Female 
Epigastric pain, Heart 
burn, Regurgitation, 
vomiting, Abdominal 
Distension 
24.9.12 
To 
3.10.12 
BT 8600 56 38 6 16 22 10.5 94 21 163 NIL NIL NIL  
- 
 
   Poor        
AT 8500 57 38 5 14 20 11 92 19 158 NIL NIL NIL 
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4.5.   CLINICAL ASSESSMENT 
Age wise distribution 
Table No: 4.5.11 
SL. NO AGE IN YEARS NO. OF 
PATIENTS 
PERCENTAGE (%) 
1 20-30 9 18 
2 31-40 16 32 
3 41-50 14 28 
4 51-60 10 20 
5 61-70 1 2 
TOTAL 50 100 
 
9
16 14
10
1
18
32
28
20
2
0
10
20
30
40
50
20‐30 31‐40 41‐50 51‐60 61‐70
Age wise distribution
NO.OF PATIENTS PERCENTAGE
Inference 
Among 50 patients, 
 9 patients belongs to the age group of  20-30 years 
 16 patients belongs to the age group of 31-40 years 
 14 patients belongs to the age group of 41-50 years 
 10 patients belongs to the age group of 51-60 years 
 1 patient belongs to the age group of 61-70 years 
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Sex distribution 
Table No: 4.5.12 
SL. NO SEX NO. OF 
PATIENTS 
PERCENTAGE 
1 Male 20 40 
2 Female 30 60 
TOTAL 50 100 
 
 
40%
60%
Percentage
MALE
FEMALE
 
Inference: 
Among 50 patients, 
• 20 patients were male 
• 30 patients were female 
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Socio-economic status 
Table No: 4.5.13 
SL. NO SOCIO – ECONOMIC STATUS 
NO. OF 
PATIENTS 
PERCENTAGE 
(%) 
1 Poor 21 42 
2 Lower middle 18 36 
3 Upper middle 7 14 
4 Rich 4 8 
TOTAL 50 100 
 
0
10
20
30
40
50
POOR LOWER MIDDLE UPPER MIDDLE RICH
Socio- economic status
NO. OF PATIENTS PERCENTAGE  (%)
 
Inference: 
 Among 50 patients, 
• 21 patients were poor. 
• 18 patients were lower-middle. 
• 7 patients were upper middle. 
• 4 patients were rich. 
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Occupational status 
Table No: 4.5.14 
SL. NO OCCUPATION NO. OF PATIENTS 
PERCENTAGE 
(%) 
1 Students 3 6 
2 Home makers 13 26 
3 Retired persons 1 2 
4 Drivers 6 12 
5 Workers 27 54 
TOTAL 50 100 
 
3
13
1
6
27
6
26
2
12
54
0
10
20
30
40
50
60
Students Home Maker Retd.Persons Drivers Workers
Occupational status
No of Patients Percentage
 
Inference 
 Among 50 patients, 
• 3 (6%) patients were Students. 
• 13 (26%) patients were Home makers. 
• 1 (2%) patients were Retired persons. 
• 6 (12%) patients were Drivers. 
• 27 (54%) patients were Workers. 
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Personal habits 
Table No: 4.5.15 
SL. NO PERSONAL HABITS NO. OF PATIENTS 
PERCENTAGE 
(%) 
1 Vegetarian 11 22 
2 Non-vegetarian 39 78 
3 Smoking 15 30 
4 Alcohol 13 26 
 
13
37
15 13
26
74
30
26
0
15
30
45
60
75
Vegetarian Non‐Vegetarian Smoking  Alcohol
Personal habits
NO. OF PATIENTS PERCENTAGE  (%)
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5. RESULTS AND DISCUSSION 
Panai poo chooranam was taken for the treatment of Peptic ulcer disease in 
reference with Agathiyar gunavagdam.  
There are various studies done in the trial drug Panai poo chooranam. The 
study includes literary collections, Pharmacognostic study, physico and Phyto 
chemical analysis, toxicological study, pharmacological study and clinical study. 
Literature collections about the drug indicate the efficiency of the drug in the 
treatment of Peptic ulcer.  
Botanical aspect deals with the identification, description, cultivation and 
ethno medicinal importance of the plant. 
Gunapadam aspect expressed strongly that the drug possess good Anti ulcer 
property. 
4.2.1.  PHARMACOGNOSTIC ASPECT OF Borassus flabellifer Linn.    
Structure of the Perianth 
 The perianth is thick and woody. The central part is thick and the marginal 
part becomes thin. In cross sectional view the perianth exhibits outer epidermis, 
middle ground tissue with numerous scattered vascular bundles and inner epidermis( 
Fig4.2.1.2 ). The outer epidermis is stomatiferous with deeply sunken stomata. ( 
Fig4.2.1.2 and 4.2.1.3). The outer epidermal cells are radially rectangular, thin walled 
with prominent article.(Fig 4.2.1.3). The epitermal cells are 20µm thick. The inner 
epidermis is comparatively thin and the cells are spindle shaped and the article is 
prominent. The ground tissue of the perianth is parenchymatous and most of the cells 
posses dense accumulation of darkly stained tannin. Diffusely distributed in the 
ground tissue there are numerous vascular strands. The vascular strands are of 2 types 
some of the strands consists of only fibers and no vessels and phloem elements are 
seen within bundle sheath fibers. Fibers sheath may enclose entirely, the vascular 
elements or the fibers may occur as caps on the outer and inner parts of the strands. 
(Fig 4.2.1.1and 4.2.1.5).   
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 The vascular strands having both phloem and xylem are collateral with outer 
phloem and inner xylem. The phloem occurs as thick, semi circular strand and the 
phloem elements are narrow and angular. The inner xylem strand diffusely distributed 
wide and thick walled vessels. No xylem parenchyma is evident. The fiber strands are 
mostly distributed along the outer and inner zones. The vascular strands are located in 
the middle portion of the perianth (Fig 4.2.1.2 and 4.2.1.3). 
Structure of the Ovary 
 The ovary is tricarpellary syncarpous and 3 chambered (Fig 3.1). The carpels 
are elliptical and have their walled vesicles, attached all along the carpel wall. The 
ground tissue is aerenchymatous with several wide airspace distributed diffusely, 
within the tissue of the ovary. The ovary tissue also contains large number of fiber 
bundles and vascular bundles  (Fig 4.2.1.6, 4.2.1.8 & 4.2.1.10). The epidermal layer 
of the ovary consists of radially elongated thick walled cylindrical cells with thick 
cuticle. The fiber bundles occurs throughout the ovary (pericarp) they are circular 
comprising thick walled, lignified fibers. The fiber bundles are 70µm in diameter . 
The vascular bundles are either circular , elliptical or ovate in outline. The bundles 
have central core of collateral, xylem and phloem elements. The fibers occur either 
entirely enclosing the vascular elements or the fibers may occur as thick arcs on 
phloem side and xylem side.(Fig 4.2.1.8, 4.2.1.7). The xylem elements of the vascular 
bundles occur in cluster. They are wide, regular and thick walled. Phloem elements 
are seen in shallow arc. The phloem elements are wide, regular and thick walled.  ( 
Fig 4.2.1.11 ) The xylem elements are upto 30µm in dia meter. 
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T.S. of  Perianth 
Figure No: 4.2.1.1 Perianth outer part and inner part 
                   
                    Perianth outer part:                                Perianth outer ep 
                   Figure No: 4.2.1.2                                  Figure No: 4.2.1.3                                   
 
                         
Perianth inner part                                 Ovary central part showing  
three carpels 
                     Figure No: 4.2.1.4                                Figure No: 4.2.1.5                                     
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      Ovary air chambers                               Ovary VB and central portion 
      Figure No: 4.2.1.6                                 Figure No: 4.2.1.7                                   
             
        
    Ovule Sec 1 and 2                                       Ovule VB outer portion 
    Figure No: 4.2.1.8                                       Figure No: 4.2.1.9                                  
                     
         
    Ovule  VB                                                      Ovule single VB enlarged 
    Figure No: 4.2.1.10                                        Figure No: 4.2.1.11                                 
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4.2.2.  PHYSICO-CHEMICAL ANALYSIS 
Table No: 4.2.2.1 
S.No Parameter Mean Value 
1. Loss on Drying at 105°C 5.975 % 
2. Total Ash  6.048 % 
3. Acid insoluble Ash   0.473 % 
4. Water Soluble Extractive 10.0 % 
5. Alcohol Soluble Extractive 10.15% 
6. pH 6.6 
 
                              TLC RESULT OF PANAI POO CHOORANAM 
                             Table No: 4.2.2.2 
Sl.No After Dipping in Vanillin-Sulphuric acid 
 
Rf value Colour of the spot 
 
1 0.26 Grey 
2 0.36 Grey 
3 0.47 Purple 
4 0.51 Purple 
5 0.67 Purple 
6 0.74 Grey 
7 0.81 Blue 
                                      After spray with visualizing agent 
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Figure No: 4.2.2.2 TLC result of Borassus flabellifer 
                                                             
Physico chemical analysis, The analytical parameters like total Ash value, 
Acid insoluble ash value, Loss on drying values are helping us to interpret the 
digestion and solubility capacity of the crude extract. As per the result the tested 
sample contains good percentage of solubility as well as digestive capacity. Gastric 
juice is highly acidic with pH of 0.9 to 1.2. It is due to the presence of hydrochloric 
acid. The pH of Panai poo chooranam is 6.6. So it neutralizes the acidic pH of 
gastric juice.   
4.2.2.3 FTIR result of Panai poo chooranam: 
   PEAK                                     FUNCTIONAL GROUP 
3403cm-1   Amine N-H stretch, Alcohol/ phenol O-H stretch 
2924 cm-1   Carboxylic acid O-H stretch 
2128 cm-1   Alkynyl C=C stretch 
1617 cm-1   C-C with C=O 
1521 cm-1   Aromatic C=C bending 
1376 cm-1   Alkyl methyl 
1062 cm-1   Primary alcohol 
612 cm-1   Bromo alkanes 
Anti Ulcer Activity of Panai poo Chooranam 
 
 
P.G. Gunapadam Department  74
4.2.2.4  SEM result of Panai poo chooranam 
Figure No: 4.2.4 
 
 
             Result showed particle sizes are:  micro particles and nano particles. 
Hence Panai poo chooranam is biologically produced micro and nano particles 
to enhance fast pharmacological action in target site. They are readily absorbable, 
adaptable and assimilate in the body without producing any adverse effects at 
therapeutic doses.  
Anti Ulcer Activity of Panai poo Chooranam 
 
 
P.G. Gunapadam Department  75
4.2.5 Qualitative phytochemical analysis: 
                    Results:  Phytochemical analysis of Borassus flabellifer  
Table no: 4.2.5 
Qualitative Phytochemical Tests 
1. Alkaloids      Negative 
2. Triterpenes      Positive 
3. Tannin       Positive 
4. Flavonoids      Negative 
5. Steroids       Positive 
6. Glycoside       Positive 
7. Saponin       Positive 
8. Phenol       Positive 
 
From the test results Triterpenes, Tannins, Steroids, Glycosides, Saponins, and 
Phenol were revealed to be present.  
  Alkaloids and Flavonoids were reported to be absent. 
Recent reports and extensive literature review indicated that tannins showed 
cytoprotective action by increasing mucosal content of prostaglandis and mucous in 
gastric mucosa                                                                                                                 
(Dandagi 2008 )                         
   Tannins inhibit gastric mucosal injury by scavenging the stress generated 
oxygen metabolites.                                                                
 (Shetty et al – 2008) 
Tannin may prevent ulcer development due to their protein precipitating and 
vasoconstricting effects. Their astringent action can helps precipitating micro proteins 
on the ulcer site, there by forming an imperious layer over the lining that hinders gut 
secretions and protects the underlying mucosa from toxins and other irritants.  
( Aguwa et al 1988  and Nwafor et al 1996 ) 
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Disscussion: 
Tannin which is present in Panai poo chooranam may be responsible for its 
anti ulcer activity. 
4.2.3. Chemical analysis of panai poo chooranam: 
Results 
The Chemical analysis of Panai poo Chooranam showed the following 
chemicals, 
         Presence of reducing sugar, starch, proteins, amino acid, albumin, and chloride. 
4.3. Toxicity study 
Table No: 4.3 Dose finding experiment and its behavioral Signs of Toxicity 
No Dose mg/kg 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1 2000 + + - + + + - - - - - - - - - - - - - - 
2 5000 + + - + + + - - - - - - - + - - - - - - 
 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. Touch 
Response 7. Decreased Motor Activity 8. Tremors 9. Convulsions 10. Muscle Spasm 
11. Catatonia 12. Muscle relaxant 13. Hypnosis 14. Analgesia 15.Lacrimation 16. 
Exophthalmos 17. Diarrhoea 18. Writhing 19. Respiration 20. Mortality 
4.4.  PHARMACOLOGICAL STUDY 
Antiulcer property of panai poo chooranam 
Results and discussion 
The examination of acute toxicity carried out on mice indicated that Panai poo 
chooranam has no toxicity when administered orally (up to 5g/kg). Administration of 
aspirin to fasted rats resulted in severe gastric damage visible from the outside of the 
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stomach as thick reddish-black lines. After opening, the gastric lesions were found in 
the mucosa and consisted of elongated bands, 1–8mm long, usually parallel to the 
long axis of the stomach. They were located mostly in the corpus.  
 The pathophysiology of ulcers is due to an imbalance between aggressive 
factors and local mucosal defensive factors (mucus bicarbonate, blood flow and 
prostaglandins). Prostaglandins are known to play an important role in maintaining 
mucosal integrity. An Increase in certain endogenous prostaglandins can enhance 
gastric mucosal resistance to ulcerogenic agents. The mechanisms involved in 
prostaglandin action are multiple, including stimulation of mucus and bicarbonate 
output, gastric mucosal blood flow, decreasing gastric motility, increasing the release 
of endogenous mediators of gastric injury vasoactive amines and leucotrienes and 
stimulation of cellular growth and repair. The integrity of the gastroduodenal mucosa 
is maintained through a hemostatic balance between these aggressive and defensive 
factors. The major cause of gastric ulcer is the chronic use of NSAIDs. Therapeutic 
and adverse effects of NSAIDs have been attributed to the ability of these drugs to 
inhibit the action of cyclooxygenase (COX). COX is responsible for the synthesis of 
prostaglandins that normally inhibit acid secretion, as well as having a protective 
effect on the gastric mucosa.  
 In conclusion, Panai Poo Chooranam significantly inhibits the occurrence of 
lesions in stomach but exact mechanisms are not clearly understood. Further studies 
using more specific methods are required to explore the compounds responsible for 
the protective effect, and the mechanism of this activity. Ulcer has long been 
recognized as one of the most important gastrointestinal problem. From this study, it 
is clear that Panai Poo Chooranam have significant anti-ulcer activity in animal 
models when compared with that of reference drug. The Panai Poo Chooranam is 
non-toxic even at relatively high concentrations. The anti-ulcer activity is probably 
due to the presence of active principles like tannin. 
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Effect of Panai Poo Chooranam on ulcer index 
Table No: 4.4 
Groups Ulcer index 
Normal 1.22±0.05** 
CMC control  22.56 ± 0.28 
PPC (250mg/kg) 17.14 ± 0.21** 
PPC (500mg/kg) 12.36 ± 0.25** 
Ranitidine (60mg/kg) 10.12 ± 0.14** 
*P values <0.05 as compared to control;  
Values are the mean ± S.E.M. of six rats/treatment. 
Significance *p <0.05, **p<0.01 Vs Control. 
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Anti ulcer activity of panai poo chooranam 
Figure No: 4.4 
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Clinical assessment- Improvements in signs and symptoms 
Table No: 4.5.16 
SL. 
NO SIGNS AND SYMPTOMS 
NO. OF PATIENTS 
BT AT IMP. IMPROVEMENT 
(%) 
1 Epigastric pain 50 4 46 92 
2 Heart burn 48 5 43 89.5 
3 Regurgitation 40 4 36 90 
4 Nausea 24 7 17 71 
6 Vomiting 15 6 9 60 
7 Abdominal distension 38 7 31 81.5 
8 Constipation 40 5 35 87.5 
 
50 48
40
24
15
38 40
4 5 4 7 6 7 5
46 43
36
17
9
31
35
Epigastric 
pain
Heart burn Regurgitation Nausea Vomiting Abdominal 
distension
Constipation
Improvements in signs and symptoms
BT AT IMPROVEMENT
Inference: 
Among 50 patients, 
• 46 out of 50 patients were relieved from Epigastric pain. 
• 43 out of 48 patients were relieved from heart burn. 
• 36 out of 40 patients were relieved from regurgitation. 
• 17 out of 24 patients were relieved from nausea. 
• 9 out of 15 patients were relieved from vomiting. 
• 31 out of 38 patients were relieved from abdominal distension.  
• 35 out of 40 patients were relieved from Constipation 
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Gradation result 
Table No: 4.5.17 
SL. 
NO 
LEVEL OF 
IMPROVEMENT 
NO.OF 
PATIENTS 
PERCENTAGE 
(%) 
1 Good 38 76 
2 Satisfactory 4 8 
3 Moderate 5 10 
4 Poor 3 6 
TOTAL 50 100 
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0
20
40
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GOOD SATISFACTORY MODERATE POOR
Gradation result
NO.OF PATIENTS PERCENTAGE  (%)
 
Clinical study 
 50 patients of both sexes were selected. Among the 50 patients, 40 patients 
were treated as out- patients in the Post graduate department of Gunapadam, 
Govt.Siddha medical college hospital and Govt. Arignar Anna hospital, 
Arumbakkam, Chennai- 106.  10 patients were treated as in - patients. 
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 The patients were observed regularly. 
 The trial drug Panai poo chooranam was given to the patients at the dose of 1 
gm twice a day with warm water before meals. On administration of Panai poo 
chooranam 1 gm twice a day for 7 weeks should significant anti ulcer activity. Warm 
water which was used as vehicle also has ulcer healing property as per classical 
siddha literature.   
Among 50 patients, 46 out of 50 patients were relieved from Epigastric pain. 
43 out of 48 patients were relieved from heart burn.  36 out of 40 patients were 
relieved from regurgitation. 17 out of 24 patients were relieved from nausea. 9 out of 
15 patients were relieved from vomiting. 31 out of 38 patients were relieved from 
abdominal distension. 35 out of 40 patients were relieved from constipation. 
 The results revealed that the drug possess 76% good relief, 8% satisfactory 
relief, 10% moderate relief mild relief, 6% cases there was no improvement. 
STATISTICAL ANALYSIS 
Descriptive statistical for improvement of signs & symptoms in “Peptic ulcer” 
Paired t test results: 
P value and statistical significance 
   The two-tailed P value is less than 0.0001 
   By conventional criteria, this difference is considered to be extremely 
statistically significant.  
 
Confidence interval 
  The mean of Group One minus Group Two equals 5.43 
   95% confidence interval of this difference: From 4.25 to 6.61  
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Intermediate values used in calculations 
   t = 11.2877 
   df = 6 
   standard error of difference = 0.481  
Result 
Table No: 5 
 Mean S.D S.E.M 
Before treatment 36.43 12.65 4.78 
After treatment 31.00 13.48 5.09 
 
 Discussion: 
 Improvements of signs and symptoms by statistical analysis shows the two 
tailed “p” value equals 0.0001, by conventional criteria, this difference is considered 
to be extremely statistically significant. From the above results p < 0.05, it shows the 
improvement in the subjective parameters produced by Panai poo chooranam 
statistically significant. 
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CONCLUSION 
The trial drug Panai poo chooranam ( Borassus flabellifer Linn ) was selected 
from the classical siddha text Gunapadam-Mooligai vagupu, Agathiyar 
gunavaakadam, for the evaluation of safety and efficacy in the management of Peptic 
ulcer disease. 
The trial drug was  identified and authenticated by the botanist and 
Gunapadam experts. 
The physico chemical analysis result showed the pH of Panai poo chooranam 
is 6.6. So it neutralizes the acidic pH of gastric juice.   
The phyto chemical analysis result showed the presence of Tannins, 
triterpenes, steroids, glycosides, saponin and phenol. 
Previous studies about tannin proved that, it had the anti ulcer property. Hence 
the author concluded that Panai poo chooranam has anti ulcer property. 
The examination of acute toxicity carried out on mice indicated that Panai 
poochooranam has no toxicity when administered orally (up to 5g/kg). Toxicity study 
revealed the safety of the drug. 
Clinical trial results showed that 76% of patients were having improvement in 
the clinical features. The drug is easily available and preparation is very simple. The 
trial medicine is cost effective. No adverse effects were produced during the entire 
course of treatment. From these results the author has concluded that the drug “Panai 
poo chooranam”( Borassus flabellifer Linn ) gives a new hope in the treatment of 
Peptic ulcer disease. 
Anti Ulcer Activity of Panai poo Chooranam 
 
 
P.G. Gunapadam Department  85
SUMMARY 
The herb Panai poo was collected from Soorapalli, Salem (Dt) and purified 
then powered and stored. This drug was subjected to various studies by the author. 
Panai poo Chooranam was selected for this study to evaluate the Anti – ulcer 
activity, and to prove its efficacy and safety in peptic ulcer disease.  
To collect the information about the drug, various text books, Literature were 
referred. From them, the author came to an idea about the drug and its efficacy on 
Peptic ulcer. 
A brief description about botanical aspect of the herb Panai poo and its 
identifying characters and Phyto chemical data’s were given. 
The pharmacological analysis showed that the drug has got significant Anti 
ulcer activity. 
In clinical study, the drug has showed marked improvement in 76% of cases. 
The patients were responding well from the beginning of the treatment and no 
adverse effects were reported. 
This present study suggests that Panai poo Chooranam has the remarkable 
medicinal value against the disease Peptic ulcer without any adverse effect. 
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INTRODUCTION 
Siddha system of medicine being highly systematized medicine which has 
been founded by siddhars. This system of medicine is a gift to the mankind.  
According to Siddha System the human body is the replica of the universe. 
Siddha system believes that all objects in the universe including human body are 
composed of five basic primordial elements, namely earth, water, fire, air and space. 
The human body is a conglomeration of three humors (Vatham, Pitham, and 
Kapam) and seven physical components (Saaram, Senneer, Oon, Kozhuppu, Enbu, 
Moolai, and Sukkilam). The Food is considered to be the basic building material of 
human body, which gets processed into humors, tissues and wastes. The equilibrium 
of humors, body tissues and waste products is considered as health and its disturbance 
or imbalance leads to disease or pathologic state. 
According to the humoral pathology, Liver diseases occur due to the 
derangement of Pitha humor. 
Liver is the largest solid organ in the body. The liver plays astonishing vital 
functions in the maintenance, performance and regulating homeostasis of the body.  It 
carries out a large number of critical functions, including manufacture of essential 
proteins, and metabolism of fats and carbohydrates.  It also serves to eliminate 
harmful biochemical waste products and detoxify alcohol, certain drugs, and 
environmental toxins.  
Maintenance of a healthy liver is essential for the overall well being of an 
individual. 
Liver diseases are becoming one of the significant worldwide health problems, 
with high endemicity in developing countries. 
Liver disease is a term for a collection of conditions, diseases, and infections 
that affect the cells, tissues, structures, or functions of the liver.  
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Liver is continuously exposed to lots of toxins, carcinogenic agents, 
infections, alcohol, and many other harmful substances. This will lead to liver 
diseases. Jaundice is often seen in liver disease such as hepatitis or liver cancer. 
Types of liver disease are, 
♦ Liver disorders due to impaired metabolic function. Generally the disorders 
associated with fat (liposis) and bilirubin (Jaundice) metabolisms are very 
commonly seen. 
♦ Disorders associated with fat metabolism - Fatty Liver 
♦ Classification of Jaundice 
• Hepatocellular jaundice 
• Hemolytic  
• Obstructive  
♦ Hepatitis – may be viral, toxic or deficiency type. 
♦ Chemical / Drug induced Hepatotoxicity:  
♦ Cirrhosis. 
♦ Necrosis. 
♦ Hepatic failure. 
Jaundice is one of the important signs of liver disease. 
Long-term effects of liver disease include: 
Cirrhosis of the liver, Liver failure, Illnesses in other parts of the body, such as 
kidney damage or low blood counts, Gastrointestinal bleeding, Encephalopathy, 
Peptic ulcers, Liver cancer.(Text book of medicine- K V Krishna doss). 
According to the latest WHO data published in April 2011 Liver Disease 
Deaths in India reached 208,185 or 2.31% of total deaths. The age adjusted Death 
Rate is 23.59 per 100,000 of population ranks India #27 in the world. 
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Study estimated the annual incidence of jaundice cases as 244 (95% CI201-
287) per 100,000 population. Almost 95% jaundice cases occurred in summer and 
monsoon months. People from all socio-economic strata were affected.  (WHO 2011) 
Jaundice cases were reported to be 1361 persons per 100,000 populations. 
(WHO 2011) 
Treatment options for common liver diseases are challenging. The 
effectiveness of treatments such as interferon, colchicine, penicillamine, and 
corticosteroids are inconsistent.  Treating hepatitis B, hepatitis C, and hepatitis D may 
involve the use of medications such as the antiviral medication alpha interferon. Side 
effects of interferon include a flu-like illness with fever, and body aches. Other 
medications used to treat liver disease may include ribavirin, lamivudine, steroids, and 
antibiotics.  Antibiotics may cause stomach upset or allergic reactions. (Bowman 
W.G, Rand M.J., Text book of Pharmacology) 
A liver transplant can cause many complications, including failure or rejection 
of the new liver. After a liver transplant, a person will need to take powerful anti-
rejection medications for the rest of his or her life. Because these medications 
interfere with normal immunes system functioning, they increase the person's risk for 
infections and certain types of cancer.  
Hence, there is an ever increasing need for safe hepatoprotective agent. 
A drug having beneficial effect on the liver is known as hepatoprotective drug.  
Hepato protection is the ability to prevent damage to the liver. 
Despite the significant popularity of several herbal medicines for liver diseases  
they are still unacceptable treatment modalities for liver diseases. The limiting factors 
include Lack of standardization of the herbal drugs, identification of active principles, 
clinical trials, toxicological evaluation. 
Siddha medicines offer cure to varied spectrum of ailments. They are 
mysterious of curing and healing as well as preventing diseases.  
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Herbal drugs are significant source of hepatoprotective drugs. Mono and poly-
herbal preparations have been used in various liver disorders. 
In siddha literature Sarabendra Vaithiya rathnaavali the herbo mineral 
preparation Arithiraadhi Chooranam is indicated for Jaundice. Arithiraadhi 
chooranam contains Curcuma longa, Terminalia chebula, Terminalia bellerica, 
Phyllanthus emblica, Picrorhiza kurrao, Sodium chloride impure (Rock salt).  
Hence the author is very much interested to conduct a detailed scientific study 
including toxicological profile, pre clinical and clinical trial to explore the value of 
siddha system of medicine. 
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2. AIM AND OBJECTIVES 
Aim 
In the modern world Liver diseases are the most serious ailment. Plant drugs 
are known to play a vital role in the management of liver diseases. There are 
numerous plants and polyherbal formulation claimed to have hepatoprotective 
activities. The ultimate aim of this study is to evaluate the scientific validity of 
Arithiraadhi chooranam (AC) for hepatoprotective activity.  
Objectives 
 In this dissertation work, the “Arithiraadhi chooranam” is analyzed to assess 
the following aspects: 
K Collecting the literature evidences related to the trail drug 
K Getting the proper authentication of Raw drugs 
K Preparation of the trial drug, according to the text in a sasthric manner 
K Physico-chemical, Chemical Analysis for the trial drug to identify the 
active components.  
K Toxicological studies to prove the safety of the drug.  
K Pharmacological study to evaluate the hepatoprotective efficacy of the 
drug 
K  Clinical studies Evaluating the therapeutic efficacy of Arithiraadhi 
chooranam  through open clinical trial on kamalai patients 
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3. REVIEW OF LITERATURE 
The literature support for my trial drug were collected from the classical 
literatures of Siddha, Siddha text books, Wealth of India,  Materia medica, 
Compendium of Medicinal Flora, and MAPA. 
3.1.Botanical aspect 
Manjal  - Curcuma longa 
Scientific classification 
 Kingdom : Plantae 
 Division : Magnoliophyta 
 Class  : Liliopsida 
 Order  : Zingiberales 
 Family  : Zingiberaceae 
 Genus  : Curcuma 
 Species : C.longa 
3.2 Gunapadam aspect 
Vernacular  names 
 Eng  : Turmeric 
 Tamil  : Arisanam, kansani, Nisi, Peedham 
 San  : Haridra 
 Tel  : Pasupu 
 Mal  : Mannal 
 Kan  : Arisina 
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Part used   : Rhizome 
Taste    : Acrid, bitter 
Thanmai   : vepam 
Pirivu    : karpu 
Actions 
 Hepato tonic 
 Stimulant 
 Carminative 
 Aromatic 
ெபா¢ண 
 ெபா}னறமா ேமன ©லானாற «ேபா 
 ம}§ ©¯ட வசியமா – ப}னெய¸  
 வா|திப{த ேதாடைமய வாதேபா| தபனமா 
 |தமxச ள}கிழut. 
 தைலவலிந ேரறx சைளயாத ேமக  
 உைலºத¯ பனச{தி ¨ேட - வலிர~© 
 வx கவட« வ ²வர ணuக¶ேபா 
 மxச கிழut மா. 
அக{திய ணவாகட 
Medicinal uses 
 Turmeric used by externally gives golden colour to the body. 
 It removes bad odour. 
 Stimulates appetite. 
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 It cures vomiting, vadha, pitha disorders, headache, Leucorrhoea, running 
nose, 5  types of vali, oedema, insect bite, wounds. 
 The powdered form of turmeric used as externally cures wounds. 
 The burnt form of turmeric, when inhaled relives sinusitis. 
 It is grounded with neem leaves, and applied externally for chicken pox. 
 It is grounded with adadhoda leaves and cow’s urine, it cures scabies, itching. 
 Fresh turmeric juice cures leech bite, and wounds. 
 520-650mg of turmeric powder gives internally, it will cure stomach disorders. 
It also strengthens the intestine. 
 Water mixed with turmeric and consumed, it cures jaundice. 
Phyto chemical constituents 
¾ Rhizome has phenolic compound called curcumin, and a volatile oil with 
turmerone and zingiberene, cineole and other monoterpenes; starch; protein; 
and high amounts of vitamin A and other vitamins. 
¾ The essential oil stimulates the gallbladder and also stimulates the liver to 
produce more bile and regulate its viscosity.  
¾ Antioxidants including vitamins C and E, several carotenoids, curcumin, and 
related compounds called curcuminoids. 
¾ Turmeric also has anti-inflammatory and strong liver-protecting properties. 
¾ Cineole which stimulates the central nervous system. It is also an antiseptic 
and expectorant. 
Wealth of India Volume- 3 
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Nelli mulli - Phyllanthus emblica 
3.1 Botanical aspect 
Scientific classification 
 Kingdom : Plantae 
 Division : Angiosperm 
 Class  : Eudicots 
 Order  : Malpighiales 
 Family  : Phyllanthaceae 
 Genus  : Phyllanthus 
 Species : P.emblica 
3.2 Gunapadam aspect 
Vernacular names 
 Eng  - Indian gooseberry 
 Tam  - Nellikai  
 Sans  - Amaraphalam, Amalaki 
 Tel  - Nelli 
 Hind  - Amla 
Part used : Dried fruit 
Actions 
 Refrigerant 
 Diuretic 
 Laxative 
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Taste     : Pulipu, thuvarpu, inipu 
Thanmai : Thatpam 
Pirivu  : Inipu 
ெநலி«ளய} ண 
ஆகவன லxசசிஅ சிtெக}© ¯tகிகzேணா 
தாக «திரவ{த| தா¢ நட- ேமகன{தி} 
இலி«ள ேபால¯க எzகா மியவயuக 
ெநலி«ள யாேபா நிைன. 
ேதைரய ணவாகட 
நலெநலி «ளய¢ நாtt ¯சித¯ 
அலவ¾ ப{த அக²மைத - ெமல{ 
தைல «¸கt கzள¯| தாºப{த வா|தி 
இைலயழிேம கuக¶ ேபா எz. 
ேதைரய ணவாகட 
ெநலி«ளயா உy, எ´©¯tகி, ¯தியழ, ெப¯பா, 
ெவறி ேநா, நர¯க, வா|தி, ெவைள, ஆzறி ெகா~©ள, ஆகியைவ 
வல. 
Medicinal uses 
 Nellikai legiyam and nelli mulli legiyam cures jaundice. 
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Kadugurohini - Picrorrhiza kurroa 
3.1 Botanical aspect 
Scientific Classification 
 Kingdom :  Plantae 
 Division :  Magnoliphyta 
 Class  :  Magnoliopsida 
 Order  :  Solamaceae 
 Family  :  Scrophulariaceae 
 Genus  :  Pirorhiza 
Species : P. kurrao 
3.2 Gunapadam aspect 
Vernacular names 
 Eng : Picrorhiza 
 Tam : Kadugurohini 
 Sans : Katurohini 
 Hind : Katuka 
 Tel : Katki 
Part used : Dried rhizome 
Taste  : kaipu, karpu 
Thanmai : vepam 
Pirivu  : karpu 
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Actions 
 Antiperiodic 
 Cathartic 
 Stomachic 
 Anthelmintic 
ெபா¢ண 
 மா|த ரைமய வா­கர~ பானாமx 
 ேச|தமலt கy தி¾ேதாட - ேபா|தெபாy~ 
 ©zவய² ேநாயைவேபா ெபாெகாேய ேபதி­zடா 
 திzக ேராகணt{ ேத. 
அக{திய ணவாகட 
மா|த, ர, ஐய, கர~பா}, சீதகழிvச, வய²வலி, ©zக, 
வள ேநாக த¯. 
Phyto chemical Constituents 
Root contains iridoid glycosides, glucoside called Picrorhizin, picroside I, 
picrosideII, kutkoside, picroside III, veronicoside, minecoside, phenol, cucurbitacin 
glycosides, glucose, wax, Cathartic acid etc. 
Picrorhiza prevented damage caused to the liver by intraperitoneal 
administration of carbon tetra chloride.  
Kokate Text book of Pharmacognosy 
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Kadukkai - Terminalia chebula 
3.1 Botanical aspect 
Scientific classification 
 Kingdom : Plantae 
 Division : Magnoliophyta 
 Class  : Magnoliopsida 
 Order  : Myrtales 
 Family  : Combretaceae 
 Genus  : Terminalia 
 Species : T. chebula 
3.2 Gunapadam aspect 
Vernacular names  
 Eng  : Chubulic myrobalan 
 Tam  : kadukai 
 Sans  : Pathya 
 Hind  : Pile hara 
Actions 
 Astringent 
 Alterative 
 Laxative 
ெபா¢ண 
 தாைட க¸{தtகி தா´ றியவட~ 
 பைட சிலிபத« ேபதி«ட – ஆைடெயyடா{ 
 £லமி ©zவாத ேசாணகா மாைலயரz 
 டாலமி ேபாவ¾tகா யா. 
அக{திய ணவாகட 
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க}ன, க¸{¢, நா, ஆzறி ேநாக, கால~©², அதி£ல, 
இ~©z, வாத ேசாணத வாத, காமாைல, தாவர சuகம வடuக 
ேபா. 
Phytochemical Constituents 
Tannin, gallic acid, Chebulinic acid, mucilage 
Thanrikkai - Terminalia bellerica 
3.1 Botanical aspect 
Scientific classification 
Kingdom : Plantae 
 Division : Magnoliophyta 
 Class  : Magnoliopsida 
 Order  : Myrtales 
 Family  : Combretaceae 
 Genus  : Terminalia 
 Species : T. bellerica 
3.2 Gunapadam aspect 
Vernacular names 
 Eng : Belleric myrobalan 
 Tam : Thanrikai 
 Sans : Vebeethaki 
 Hind : Bhairah 
Hepatoprotective Activity of Arithiraadhi Chooranam 
 
  
  P.G. Gunapadam Department  100
Actions  
 Astringent 
 Expectorant 
 Laxative 
 Tonic 
Part used  : Fruit 
Taste  : Thuvarpu 
Thanmai : Vepam 
Pirivu  : Inipu 
ெபா¢ண 
 சில|திவட காமிய~©z சீழான ேமகu 
 கல|¢வ¯ வாதப{தu காேலா – டல|¢டலி 
 ஊ}றிtகா ெவ~ப «திரப{ ¢uகரt| 
 தா}றிtகா ைகயெல{ தா. 
ஆண~ெபா} ேமனt கழ ஒள­மி 
ேகாணtெகா வாதப{தtெகாைகேபா – தானtகா 
ெகாzடவt ேமகம² றா அனறண­ 
கzடவt வாதேபா காz. 
அக{திய ணவாகட. 
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தா}றிtகாயா சில|தி நx, ஆzறி~©z, ெவைள, 
¯தியழ, வள த றuகளா வ¯  ேநாக ேபா. உட 
அழைக­ ஒளைய­ ெகா{¢ «tறuகைள­ 
த}னைல~ப{¢. 
Phytochemical Constituents 
Gallotanic acid, resins, colouring matter, greenish yellow oil 
Wealth of India Vol-7  
Indhuppu - Sodium chloride impura 
3.2 Modern aspect 
Chemical Name: Sodium chloride – NaCl 
Source 
 Found in nature in extensive beds mostly associated with clay and calcium 
sulphate. To obtain it, holes are dug into these rocks which soon become filled up 
with salt water, the water is evaporated and the salt is left ready for use. 
Characters 
 It is found in small white crystalline grains or transparent cubes. It is brownish 
white externally and white internally. It has a pure saline taste and burns with a 
yellow flame. 
Action 
 Carminative, Stomachic, and digestive. 
 It promotes the appetite. 
 Cathartic and Emetic (in large doses) 
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Uses 
 It is given in dyspepsia and other abdominal disorders. 
 A powder containing pancha lavana 5 parts impure oxide of iron 10 
grains in dyspepsia, congested liver. 
 Medicated oil named Salpa Masha Taila is used as an application in 
rheumatism, contracted knee joint, stiff shoulder joint. 
Indian material medica Vol - 7  
3.1 Gunapadam aspect 
Vernacular names 
 Eng : Rock salt 
 Tam : Indu uppu 
 Sans : Saindhava 
 Hind : Sendhalon 
 Tel : Saindhalavanam 
 Mal : Intu uppu 
 Guj : Sindhaluna 
ெபா¢ண 
 அyட}ம ம|த அசிtகரx சீதப{த| 
 ¢yடைவய நா~©z ேடாடuக – ெகyடமலt 
 கyவட வ|ைதயt காமியேனா வ}கர~பா} 
 வyவட வ|¢~ைப வ. 
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ெச}னtகzணா ப³ ெசவகºகz டபகேநா 
 ச|நியா சuகாச| தாகமிைர~ – ©}னர{த 
 ¬லx சில|திநள ¬கநx ைத வலி 
 லx சிைத­மி|தா ெசா.                   
ணபாட தா¢ வ~© 
இ|¢~பனா எzவத }ம, அலச, அசிtகர, கபப{த, 
கபாதிtக, நர©கிர|தி, தி¾ேதாட, மலப|த, வட, tகில, கப 
உபதச, கவ}, தைல, வழி, நா, த|த¬ல, தா¢, க}ன, கzட, 
ேயான ேநாக, ச|நியாச,  ேந{திர காச, தாக, வாச, ர{த 
¬ல «தலிய பணக, சில|தி, ேத, எலி இவறி} வடuக, வாதt 
க~©, ைல «தலியன நu. 
Other Tamil names 
Saindhavam, Sindhooram, chandhiranuppu, Madhikoormai, Madhiyuppu, 
Mindhasol 
Actions 
Carminative, Stomachic, digestive, cathartic and emetic  
Occurrence 
In sindhu desam and North West part of Punjab rock salt is mined from under 
ground salt deposits. The weight of this salt bar is about 2 to 10 pounds. Outer surface 
is kabila niram and inner surface is white in colour. Salt in taste. 
Vaipu murai 
 Sea water -200 lit 
 Pottasium nitrate (vediuppu) -175 g 
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Alumen (seenakaram) -175g, 
Fullers earth (pooneru) -105g  
by evaporation of sea water, we get salt crystals. Take this salt 3800kg and heat it. 
When the salt is melting, add powder of last 3 drugs. Then cool it. Now this structure 
of salt is look like diamond, when broken. It ruins Borneo camphor (pachai 
karpooram). It can convert calomel (pooram) into muppoo. 
Rock salt is one of the earth bootha elements. 
Purification 
 Soak in vinegar for 3 days and dry it in sun light. 
 Soak in vinegar or goat urine and dry it in sun light. 
Medicinal uses 
External 
Rock salt paste is applied externally for sprain. Fomentation for painful 
oedema. 
Internal 
Rock salt is used for emetic action give it with warm water. 
Pitha kasayam 
Cassia senna 
 Pimpinella anisum each  -6gm 
 Dried ginger 
 Coriander seeds   
break these drugs into few pieces. Add 325 ml water and boil it till reduce into 162.5 
ml. Add 8.4g to 21g rock salt with this kasayam for purgative action. This is called 
Pitha kasayam. Dr. Mohedeen shareep said that it is specially used to cure indigestion 
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(akni mantham), eye diseases(nethira rogam), kiranthi, thaabanum, kaba pitham, and 
rat poison. 
i. Indhuppu chooranam 
Rock salt  -1 part 
Cuminum cyminum - 1 part 
Carum copticum  - 4 Parts 
Piper longum  -8 times  
Dried ginger  -16 times 
Terminalia chebula -32 times  
Make these into fine powder 
Dosage - 12 g 
Curable diseases: Indigestion (akni mantham), vomiting, ascitis (magotharam). 
ii. Cassia senna - 1 part  
Dried ginger, Piper nigram, Embelia ribes, Carum copticum, Rock salt  take 
each one as 1/4 part and  make it into powder.  
Sugar  - 2 1/4 times 
Mix the above drugs together. 
Dosage:  4.2g to 8.4g 
Curable diseases: Ascitis, abdominal pain, constipation (mala bantham). 
Indhuppu is also an ingredient in uppu mandooram, sanga thravagam which 
cure anemia & ascitis. 
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Other Preparations containing Indu uppu curing jaundice are, 
1. Sarabaraasa mathirai  
Adjuvent:  Mixture of Vizhudhi saaru, honey, ghee 
Anuboga vaithiya navaneedham, 7th part, Pg no- 136 
2. Gowri Sinthaamani rasa Chendooram 
Anuboga vaithiya navaneedham, 7th part, Pg no- 112 
3. Navarasa mezhugu 
Adjuvent:  Mixture of  kumatikkai uppu, Castor oil, honey 
Anuboga vaithiya navaneedham, 7th part, Pg no- 62 
4. Kowsikar Kuzhamb - Adjuvent: Castor oil 
Siddha Vaithiya thiratu, Pg no- 209 
Other preparations of Indu uppu 
1.   Vengara mathirai    - Siddha vaithiya thiratu  - Pg no 45 
2. Pancha lavana parpam   - Siddha vaithiya thiratu  - Pg no 116 
3. Nayuruvi uppathi kuzhambu  - Siddha vaithiya thiratu  - Pg no 193 
4. Sanga thiravagam    - Siddha vaithiya thiratu -  Pg no 298 
3.3 Siddha aspect of the disease 
 Manjal noi 
Other names of the disease 
Pithu noi, manjal kaamalai, kaamalaa, kaamila 
Essential features of the disease 
 In this disease, the urine, eyes, tongue and the whole body will appear yellow 
in colour. 
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Genesis of the disease 
 If one who perform the acts which aggravate pitha dosha, 
 If one eats foods which are too much excess in quantity, the blood will 
be adversely affected; this causes accumulation of bilious fluid in the 
blood, muscles, skin, eyes and tongue producing the disease. 
மxச ேநாய} «றி ணuக  
ப¯கேவ உளuகா ´ளu ைகக 
  பக«கuகz  ட©மிக ெவ¶~© கா u 
 க¯கேவ காைகக ேளாvச லாu 
  கனமாக நtகிேய இைள~©z டாtx 
 ¯கேவ மல|தா§ வறz கy| 
  £ய«க மxசள  நிறம தா 
 ெவ¯கேவ வ tகமாt கைள~©z டா 
  மிகtகா¢ ம|த|தைல கன~©z டா. 
®கி «ன 
Prodromal symptoms 
 Excessive salivation, vomiting, bitterness of tongue, dislike to food 
 Indigestion if food is taken 
 Dryness of body and shrinkage of skin appearing like frog’s skin 
 Yellow colouration of eyes, nail, face and skin of the body 
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In addition to the above, the following signs and symptoms may also be seen: 
 Paleness of sole of foot, hand, face and eyes 
 Fatigue of upper and lower limbs 
 Tremors of the body, frequent attack of tiredness 
 The bowel may be constipated and the stool comes out as a 
darkened mass 
 Excessive sleep and heaviness of head and yellow colouration 
of the body. 
Types of disease 
 Kaamalai disease has been classified into thirteen types as follows 
1.   Vali manjal noi  
 The essential features of the disease are, flatulence, hiccough, 
constipation, swelling of the body, edema of face and feet.  
 In addition to the above, the patient may not be in a position to perform 
to any job due to body fatigue. 
 Body pain, swelling of upper and lower limps, lean body mass, 
diminision of vision with swelling of eyes, anorexia and insomnia are 
other features of the disease. 
2.    Azhal manjal noi  
 In this disease, the skin will appear dry and patient will suffer from 
insomnia, will lie    down on the bed lazily. 
 Indigestion of food taken, pain all over the body, frequent dyspnoea, 
frequent diarrhea, excessive bowel sounds, loss of strength in upper 
and lower limbs. 
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3. Iya manjal noi  
 The disease develops due to kapha.  
 The essential features of the disease are, yellow colouration of whole 
body, uncontrolled cough, sweating of face and head, difficulty in 
walking and dyspnoea during walking, excessive congestion of eyes, 
tremors of the body, heaviness of chest. 
 If patients take areca nut may develop giddiness. 
4.  Vali iya manjal noi  
 The food taken may not be digested, sweating over the body, face, 
nose and  eyes, excessive bowel sounds with flatulence, tongue will 
have bitter taste. 
 The tongue and eyes will appear pale, dyspnoea on fast walking, 
swelling of nail bed and excessive cough. 
5.  Azhal iya manjal noi  
 The body will become yellow in colour. The patient will develop 
vomiting and headache.  
 There may be also loose motion appearing white like milk.  
 Excessive thirst, indigestion, giddiness, swelling of whole body, 
paleness of face and limbs. 
6.  Tri-dosha jaundice 
 In this disease, a few or more signs and symptoms of the three diseases 
mentioned above may be seen.  
 The body will be severely inflamed and produce burning sensation.  
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 The body will appear weak; there may be also cough, excessive thirst, 
hiccup, burning sensation of the body and dyspepsia. 
7.  Oodhu manjal noi 
 Discharge from the eyes, sweating in face, generalized swelling of the 
body with pain, loss of sensation over the body.  
 The body will become hot and this causes excessive activity of the 
kapha, giddiness, tiredness, numbness and generalized anasarca. 
8.  Varattumanjal noi 
 Dryness of upper and lower limbs, unsteady gait,  passing blue 
coloured stool and red coloured urine, burning pain during micturation,  
pain while eating and ageusia, night blindness and darkening of body. 
 The whole body will be inflamed with burning sensation. There may 
be also frequent occurrence of tiredness and cough.  
 Excessive thirst, throbbing pain of the whole body, flatulence, sour 
taste of tongue, frequent occurrence of pseudo appetite, hypothermia, 
distention of lower abdomen and swelling of the body. 
9. Perumanjal noi 
 Passing of yellow coloured urine, swelling of the body with loss of 
strength, yellow discolouration of face upper and lower limps, eyes and 
uvula. 
 Patient may develop dyspnoea and mental depression on noticing the 
severity of the disease and impotence and constipation. 
10. Azhagu manjal noi 
 In this disease, there will be weakness of upper and lower limbs. The 
eyes and eyebrows will become green in colour.  
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 Excessive thirst, burning micturition with yellow coloured urine. 
 In addition, there may be abdominal distention with indigestion and the 
body will appear hot like that of fire. 
11. Sengamala manjal noi 
 In this disease, due to renal insufficiency the body will be inflamed and 
patient will develop fatigue.  
 The urine will be concentrated and appear reddish yellow in colour, the 
body and nail will appear pale; the body may become dry and there 
may be fever.  
 There may be also yellow discolouration of uvula, tongue and saliva. 
12. Kumbamanjal noi 
 In this disease, the body will become heavy and patient may develop 
tiredness frequently. 
 The urine will appear yellow in colour; there may be sweating of the 
body during evening; there may be also congestion of the eyes. 
 Due to illness, the body will also shrink as if a flower garland shrinks.  
 Due to severity of the illness, the patient may sleep while standing 
similar to that of a peacock sleeps while standing.  
 Patient may also passing motion frequently similar to that of dysentery. 
13. Gunma manjal noi 
 In this disease, the mouth will appear pale and the eyes will appear 
greenish in colour. The urine becomes yellow in colour and will be 
passed like colloid.  
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 During digestion pain may develop in the lower abdomen along with 
vomiting; patient may also develop loss of smell, frequent cough 
dyspnoea.  
 He may also lie down without any movement like a dead body or he 
may also roll down in the bed due to severe abdominal pain. 
Curable and incurable disease 
Of the thirteen  disease mentioned above , the following seven diseases are 
curable, 
Azhal Kaamaalai, manjal Kaamaalai, Kaamaalai, Oothu kaamaalai, Varattu 
kaamaalai, Vali iya kaamaalai and vali azhal kaamaalai. 
Not easily curable diseases are 
 Kumba kaamaalai, Gunma kaamaalai, Tri-dosha kaamaalai, vali kaamaalai, 
Sengamala kaamaalai and Azhaghu kaamaalai. 
General features of the disease 
 As soon as the disease develops, the sclera of the eye will become yellow 
in colour. After that face, neck and body will become yellow in colour. As 
the disease progresses, the upper portion of the mouth, lips and urine will 
also become yellow in colour. Finally, the skin will appear yellowish green 
in colour. 
 When the severity of the disease increases there may be bleeding from the 
nose, gums and mouth.  
 The urine will appear dark yellow in colour as if haematuria has occurred. 
If the urine has fallen on the cloth, it will cause stain. 
 Even the sweat will appear yellow in colour.  
 The stool will appear pale and will be passed like a gum. 
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 In some patients, even the saliva, tears and teeth will also appear yellow in 
colour. 
 In addition to the above, when the disease develops, the body will become 
dry and the skin will appear as if frog’s skin.  
 There may be also itching, the gait will be unsteady and also suffer from 
insomnia and all the objects will appear to him yellow in colour. 
Tri-dosha factors 
The pitha dosha becomes excessive in activity due to certain diets which 
aggravate pitha dosha, walking under the sun rays and awakening at night. 
This pitha dosha in association with kapha dosha adversely affects the 
function of directional factors and impairs the potency of the blood and causes the 
disease . 
There may be also excessive secretion of bilious fluid which will not be 
metabolized naturally, the excess bilious fluid in the blood produce a lot of adverse 
effects. 
 Due to association of pitha and kapha, the eyes, ears and stool will attain 
yellow colour. 
3.4 Modern aspect of the disease 
Jaundice 
Jaundice is the yellow discolouration of sclera, mucous membranes, and skin 
caused by accumulation of bilirubin. Jaundice results from either excessive 
production or defective elimination of bilirubin. The level of serum bilirubin  has to 
reach approximately 3 mg/dl before such a change is noted clinically. 
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There are classically three types of jaundice. These are: 
1. Obstructive (post hepatic) jaundice  
In this condition there is obstruction either in the common bile-duct, both 
hepatic ducts, or in the biliary ductules or canalicu inside the liver. It can therefore be 
classified as either intra-or extra hepatic. 
2. Liver cell (Hepato cellular) jaundice 
There is a failure of the liver cell to take up and conjugate bilirubin and to 
deliver it to the biliary canaliculi for excretion. 
3. Haemolytic (Pre hepatic) jaundice 
In this situation which is accompanied by haemolytic anaemia the amount of 
bilirubin delivered to the liver is in excess of its excretory capacity. It therefore 
collects in the serum in the unconjugated form. 
JAUNDICE 
 
  
Unconjugated Hyperbilirubinaemia                           Conjucated Hyperbilirubinaemia 
 
 
 
1. Increased bilirubin production                  1. Isolated abnormality 
2. Hepatic removal     2. Hepatitis ( Virus, drug, toxin)
                            3.Cirrhosis 
                                                                  4. Infiltrative disorder 
      5. Cholestasis 
 
      Intrahepatic          Extrahepatic 
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The main causes of unconjugated hyperbilirubinaemia are, 
1. Gilbert’s syndrome 
2. Crigler-Najjar type I 
3. Crigler-Najjar type II 
4. Physiological jaundice of the newborn 
5. Transient familial neonatal hyperbilirubinaemia 
6. Breast milk jaundice 
Causes for conjucated hyperbilirubinaemia are,  
1. Dubin-johnson syndrome 
2. Rotor syndrome  
Pathophysiology of jaundice:  
 Hyperbilirubinaemia with jaundice may result from excessive bilirubin 
production, reduced hepatic uptake of bilirubin, reduced hepatic conjugation of 
bilirubin, or reduced excretion of conjugated bilirubin. 
Excessive production of bilirubin 
 Excessive production of bilirubin occurs in the haemolytic anaemias. It also 
may occur in patients with a marked degree of ineffective erythropoiesis and 
intramedullary destruction of red cell precursors, as occurs, for example, 
inthalassaemia and pernicious anaemia. 
Reduced uptake of bilirubin 
 A defect in the transfer of bilirubin to the hepatocyte may explain the 
cnconjugated hyperbilirubinaemia associated with Gilbert’s syndrome, severe 
congestive heart failure, portocaval shunts, and the action of certain drugs. 
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Obstructive Jaundice 
Clinical picture 
 Patients with obstructive jaundice have usually experienced a gradual onset of 
the condition, as serum bilirubin levels take some days, or longer, to reach a 
maximum. The jaundice is of variable intensity, but with complete obstruction serum 
bilirubin levels may be 30 mg/dl or more. 
The jaundice is usually accompanied by persistent itching, though this is not 
invariable, and this phenomenon is thought to be due to the deposition of irritant bile 
salts in the skin. The patient may complain of pain, particularly if the cause lies in the 
obstruction of the common bile-duct by gallstones or by a growth at the head of the 
pancreas. 
 In a similar way there may be gross weight loss in patients with neoplastic 
disease. Pale stools and dark urine are universal accompaniments of this form of 
jaundice. 
The intrahepatic causes of obstructive jaundice include various drugs, one 
form of viral hepatitis (Obstructive hepatitis) and wide intrahepatic spread of 
malignant tissue as is sometimes seen in patients with carcinomatosis or Hodgkin’s 
disease.  
The physical signs of obstructive jaundice include icterus and hepatomegaly. 
In chronic cases the spleen may become enlarged, and in patients with neoplastic 
disease enlargement of supraclavicular glands on either side of the neck may be a 
feature.  
Rectal examination may reveal secondary deposits in the pouch of Douglas, 
and this is an important part of the physical examination of the jaundiced patient. 
It is also important in patients with chronic obstruction to look for deposits of 
cholesterol, particularly around the eyelids (xanthelasma) and on bony points or sites 
of pressure. An important physical sign is occasionally seen in patients with 
neoplastic obstruction of the common bile-duct below the cystic duct and this is the 
presence of a spherical tumour felt under the hepatic free margin, which is an 
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enlarged gall-bladder. This is called courvoisier’s sign and is not seen in patients with 
obstructive jaundice due to biliary calculi. 
Masses may be found in the abdomen suggesting a primary neoplasm in the 
stomach, colon or elsewhere, and in such patients’ examination of the stools for occult 
blood and precise localization by radiology are important. 
Diagnosis 
 Characteristically, in obstructive jaundice the liver function tests show a raised 
serum bilirubin of variable extent, a high percentage of conjugated bilirubin in the 
serum, Negative flocculation tests, raised α2 and β globulins, and moderately raised 
transaminases, though these may be more elevated in patients with chronic 
obstruction due to accompanying liver-cell dysfunction. 
Most important of all, there is a raised serum alkaline phosphatase usually in 
excess of 30KA units/dl. 
The urine contains bile and in cases of complete obstruction is free of 
urobilinogen. The stools are pale because of lack biliary pigment and accompanying 
steatorrhoea. 
The serum cholesterol is raised and a specific lipoprotein, LPX, can be 
demonstrated in the serum. 
The differentiation of intra-from extra –hepatic biliary obstruction very much 
depends on the demonstration in the first of the patency and non-dilation of the biliary 
tree by ERCP or transhepatic cholangiography. 
Drugs which cause obstructive jaundice include the phenothiazines. Rare 
examples are due to the contraceptive pill, anticoagulant drugs, butazolidine, 
chlorpropamide, and amitriptyline. 
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Liver Cell Jaundice 
Aetiology 
 The usual causes of this disease are virus hepatitis and action of certain 
poisons and drugs. Ccl4 which is used in fire extinguishers and dry cleaning causes 
severe fatty infiltration of the liver and other organs.  
 Other examples of drugs causing liver cell injury include the monoamine 
oxidase inhibitors used in the treatment of depression and the anaesthetic agent 
halothane. 
Clinical picture 
 The onset of this type of jaundice is usually rapid, the degree of jaundice 
increasing to a maximum within a day or two of the onset of the disorder.  
The patient often feels unwell; there is not usually persistent itching. On 
examination the liver may be enlarged or decreased in size and there may be 
splenomegaly. 
Signs like, spider naevi, palmar erythema, gynaecomastia, and clubbing are 
important. If liver cell jaundice is severe, the patient may show evidence of a bleeding 
tendency and there may be evidence of hepatic encephalopathy and oedema 
formation, the later due to fall in the serum albumin levels. 
Diagnosis 
  The liver function tests apart from showing high serum bilirubin show 
abnormal flocculation tests, a rise in the β and γ globulins, normal or raised alkaline 
phosphatase, and most important of all, considerable elevation of the transaminases. 
In patients with acute liver cell disease associated with necrosis there may be a 
polymorphonuclear leucocytosis in the peripheral blood. The urine contains bile 
pigment and an excess of urobilin or urobilinogen may be demonstrated. 
Haemolytic Jaundice 
 The patient with haemolytic jaundice shows only mild icterus and the urine 
does not contain bile pigment. It does, however, contain excessive urobiligen, and 
may be darker than normal, as may the stools. 
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The liver function tests are normal unless the patient has developed biliary 
calculi associated with chronic haemolysis and these may then cause a picture of 
biliary obstruction with raised alkaline phosphatase. The patient may show 
splenomegaly and there may, on occasions, be hepatomegaly. 
Diagnosis 
 Examination of the blood will show other features suggestive of haemolysis, 
such as macrocytes and reticulocytes in the peripheral film.  
Examination of the bone marrow in patients with haemolysis shows evidence 
of erythroid hyperplasia. 
Important tests to determine the nature of the haemolytic process include a 
history of taking of drugs, examination of the red cells for the detection of antibody 
coating, an L.E. cell preparation, an electrophoresis of the haemoglobin, and a blood 
culture. 
Table No:3.4 
Laboratory features of jaundice 
Laboratory Studies Hemolytic Obstructive Hepatocellular 
Serum bilirubin Indirect Direct Biphasic 
Urine bilirubin Negative Positive Positive 
Urine urobilinogen Increased Low or absent High 
Stools Dark Clay-coloured Pale 
Flocclation and turbidity tests Negative Negative ( early) Positive 
Serum alkaline phosphatase Normal Increased Normal 
Total serum cholesterol Normal Increased Decreased 
[ Ref:  Oxford Text book of Medicine,  Ronald’s  text book of Medicine, Robbins patholoy] 
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4. MATERIALS & METHODS 
Materials 
 Arithiraadhi chooranam has been selected from the classical siddha 
literature, “Sarabendhira vaithiya rathnaavali”. Ingredients of the test drug are as 
follows: 
1. Curcuma longa 
2. Terminalia chebula 
3. Terminalia bellerica 
4. Phyllanthus emblica 
5. Picrorhiza kurao 
6. Sodium chloride 
4.1 Preparation of chooranam 
4.1.1 Collection of drugs 
Curcuma longa 
 250 gram of the raw drug was collected from the Tampcol raw drug store at 
Chennai. The adulteration particles were cleaned well.  
Terminalia chebula 
 250 gram of the raw drug was collected from the Tampcol raw drug store at 
Chennai. The adulteration particles were cleaned well. 
Terminalia bellerica 
 250 gram of the raw drug was collected from the Tampcol raw drug store at 
Chennai. The adulteration particles were cleaned well. 
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Phyllanthus emblica 
 250 gram of the raw drug was collected from the Tampcol raw drug store at 
Chennai. The adulteration particles were cleaned well. 
Picrorhiza kurao 
 250 gram of the raw drug was collected from the Tampcol raw drug store at 
Chennai. The adulteration particles were cleaned well. 
Sodium chloride 
 250 gram of the raw drug was collected from the Tampcol raw drug store at 
Chennai. 
All materials were identified and confirmed by the Head of the Gunapadam 
department, GSMC, Chennai. 
4.1.2 Purification of the raw materials 
Curcuma longa 
 Skin was removed, and used. 
Terminalia chebula 
  Seeds were removed, and rinds part only used. 
Terminalia bellerica 
 Seeds were removed, and rinds part only used. 
Phyllanthus emblica 
 Seeds were removed, and rinds part only used. 
Picrorhiza kurao 
 Its root was soaked in neem leaf juice, kept in sunlight, and then dried. 
Indu uppu: 
 Soaked in vinegar for 3 days, and dried in sunlight. 
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4.1.3 Method of Preparation of Arithiraadhi chooranam 
After purification process, each material should be complete dried and was 
powdered separately by grinding method. Those powders were sieved by white cloth 
(Vasthirakayam). 
Preservation 
               The purified Chooranam was stored in a clean, air tight glass container. 
Life span 
                3 Months. 
Administration of the drug: 
            Form of the medicine             : Chooranam 
  Route of Administration : Enteral 
 Dose    :  500 mg 
 Anubanam (Vehicle)             : Warm water 
 Times of Administration : Two times a day; before food 
 
Figure No: 4.1.1 
Curcuma longa 
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Figure No: 4.1.2 
Terminalia bellerica 
 
 
Figure No: 4.1.3 
Picrorhiza kurao 
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Figure No: 4.1.4 
Terminalia chebula 
 
 
Figure No: 4.1.5 
Phyllanthus emblica 
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Figure No:4.1.6 
Indhuppu 
 
Figure No: 4.1.7 
Arithiraadhi chooranam 
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4.2 Standardization of Arithiraadhi chooranam 
4.2.1 Physico‐chemical  Investagations  
Physico‐chemical studies like total ash, water soluble ash, acid insoluble ash, 
water and alcohol soluble extract, loss on drying  at 105°C and  PH  as per the WHO 
guide lines  in Central Research Institute For Siddha. 
Determination of Total Ash 
Incinerate about 2 to 3 g accurately weighed, of the ground drug in a tared 
platinum or silica dish at a temperature not exceeding 450º until free from carbon, 
cool and weigh. Calculate the percentage of ash with reference to the air-dried drug. 
Determination of Acid Insoluble Ash 
Boil the ash obtained for 5 minutes with 25 ml of dilute hydrochloric acid; 
collect the insoluble matter in a Gooch crucible or on an ash less filter paper, wash 
with hot water and ignite to constant weight. Calculate the percentage of acid-
insoluble ash with reference to the air dried drug. 
Determination of Alcohol Soluble Extractive 
Macerate 5 g of the air dried drug, coarsely powdered, with 100 ml of Alcohol 
of the specified strength in a closed flask for twenty-four hours, shaking frequently 
during six hours and allowing to stand for eighteen hours. Filter rapidly, taking 
precautions against loss of solvent, evaporate 25 ml of the filtrate to dryness in a 
tarred flat bottomed shallow dish, and dry at 105º, to constant weight and weigh. 
Calculate the percentage of alcohol-soluble extractive with reference to the air-dried 
drug. 
Determination of Water Soluble Extractive 
Proceed as directed for the determination of Alcohol-soluble extractive, using 
chloroform water instead of ethanol. 
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Determination of Moisture Content (Loss on Drying) 
Procedure set forth here determines the amount of volatile matter (i.e., water 
drying off from the drug). For substances appearing to contain water as the only 
volatile constituent, the procedure given below, is appropriately used. Place about 10 
g of drug (without preliminary drying) after accurately weighing (accurately weighed 
to within 0.01 g) it in a tared evaporating dish. For example, for underground or 
unpowderdd drug, prepare about 10 g of the sample by cutting shredding so that the 
parts are about 3 mm in thickness. 
After placing the above said amount of the drug in the tared evaporating dish 
dry at 105º for 5 hours, and weigh. Continue the drying and weighing at one hour 
interval until difference between two successive weighings corresponds to not more 
than 0.25 per cent. Constant weight is reached when two consecutive weighings after 
drying for 30 minutes and cooling for 30 minutes in a desiccator, show not more than 
0.01 g difference. 
Determination of pH 
1% solution of the drug was prepared in distilled  water and pH was 
determined using pH meter systronics digital ph meter. 
TLC estimation of  Arithiraadhi Chooranam 
Thin-layer chromatography is a technique in which a solute undergoes 
distribution between two phases, stationary phase acting through adsorption and a 
mobile phase in the form of a liquid. The adsorbent is a relatively thin, uniform layer 
of dry finely powdered material applied to a glass, plastic or metal sheet or plate. 
Glass plates are most commonly used. 
Identification can be effected by observation of spots of identical Rf value and 
about equal magnitude obtained, respectively, with an unknown and a reference 
sample chromatographed on the same plate. A visual comparison of the size and 
intensity of  the spots usually serves for semi-quantitative estimation. 
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Solvent system 
            Toluene: Ethyl acetate (6:1.5). 
TLC plate 
Aluminium plate precoated with silica gel 60F254 of 0.2 mm thickness 
(Merck). 
Developing chamber 
Camag’s twin trough chamber. 
Visualizing reagent 
Vanillin-sulphuric acid agent. 
Extract Preparation  
4 g of the chooranam was soaked overnight in chloroform. Boiled on a water 
bath  for 10 mins, filtered and concentrated to 10 ml.  
Procedure 
The extract was applied on the TLC using capillary and developed in the 
solvent system.  The developed TLC plate was air dried, dipped in vanillin-sulphuric 
acid reagent and heated in an oven at 105°C until the development of coloured spots 
and photograph taken. 
4.2.1.3 Fourier transform infrared spectroscopy  (FTIR) 
Instrument details 
Model   :  Spectrum one: FT-IR Spectrometer  
Scan Range   :  MIR 450-4000 cm-1  
Resolution   :  1.0 cm-1  
Sample required :  50 mg, solid  
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 Fourier Transform Infrared Spectroscopy (FTIR) is an analytical technique 
used to identify mainly organic materials. FTIR analysis results in absorption spectra 
which provide information about the chemical bonds and molecular structure of a 
material.  
Infrared spectrum is useful in identifying the functional groups like -OH, -CN, 
-CO, -CH, -NH2, etc.  
 
Figure No: 4.4.1.3 Showing FTIR results. 
The drug sample was analyzed by the FTIR to identify the chemical bonds and 
molecular structure of a material. 
4.2.1.4. Scanning electron microscope (SEM) 
The Scanning Electron Microscope (SEM) is a microscope that was electrons 
rather than light to form an image. There are many advantages to using the SEM 
instead of a light microscope. 
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Resolution : 1.2 nm gold particle separation on a carbon substrate 
Magnification : From a min of 12 x to greater than 1, 00,000 X 
The SEM has a large depth of field, which allows a large amount of the 
sample to be in focus at one time. The SEM also produces images of high resolution, 
which means that closely spaced features can be examined at a high magnification. 
Preparation of the samples is relatively easy since most SEM one require the sample 
to be conductive. 
The combination of higher magnification, larger depth of focus, greater 
resolution, and easy of sample observation marks the SEM one of the most heavily 
used instruments in research areas today. 
4.2.2 Phyto chemical analysis of test drug  
Table No: 4.2.2 
Sl.No Experiment Observation Inference 
1. Test for Alkaloids: Alkaloids 
are identified by precipitate 
method 
Dragendroff’s reagent: 
An aqueous plant extract of 2 
ml is mixed with 2 ml of 
Dragendroff’s reagent. 
Absence of reddish 
brown precipitate 
Absence of 
alkaloids 
2. Test for Triterpenoids 
(Noller’s Test) 
To few mg of extract, add tin 
and thionyl chloride and heat 
in water bath. 
Presence of purple 
colour 
 
Presence of  
Triterpenes 
3. Test for Tannins:A plant 
sample dried powder 0.5 gm 
is boiled in 20 ml of water 
and filtered. The filterate 2 ml 
is taken and 3-5 drops of 
Fecl2  (0.1%) is slowly added 
to it. 
Forms a brownish-
green or bluish- black 
colour. 
Presence of 
Tannins 
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Sl.No Experiment Observation Inference 
4. Test for Flavonoids: An 
aqueous filterate of plant 
sample is mixed with 5 ml of 
dilute Ammonium solution 
and few drops of concentrated 
H2SO4  is slowly added 
through the sides of the test 
tube. 
Yellow colour formed Presence of 
flavonoids 
7. Test for Phenolic 
compounds: 
About 2 ml of aqueous plant 
extract is mixed with 2 ml of 
Fecl3 solution.  
Presence of deep 
bluish green colour  
Presence of 
phenolic 
compounds 
 
4.2.3 Chemical analysis  
Proximate Chemical Analysis of a Drug 
Methodology For Chemcial Analysis 
Preparation of Extract 
Add 5 gm of the sample to 50ml of distilled water. Boil the solution for 20 
minutes, cool and then filter. The Extract was used  for the following tests. 
Table No: 4.2.3 
S.No Experiment Observation Inference 
1. Test for reducing Sugar : 
To 5ml of Benedicts qualitative 
reagent, add 10 drops of extract, 
then boil for two minutes 
Green colour PPT Presence of 
Reducing Sugar 
2. Test for Starch : 
To 5 ml of extract add 2ml of 
acetic acid and then add few drops 
of N/50 Iodine Solution. 
Blue Colour Presence of 
Starch 
3. Test for Proteins : 
To 2 ml of extract, add 2ml of 5% 
Sodium Hydroxide mix and add 2 
drops of Copper Sulphate Solution.
Violet  Colour Presence of 
Proteins 
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S.No Experiment Observation Inference 
4. Test for amino Acid : 
Place  2 drops of extract on a filter 
paper and allow to dry well. Then 
spray 1% ninhydrin over the same 
and allow to dry. 
Violet Colour Presence of 
Amino Acid 
5. Test for Albumin : 
To 2 ml of extract, add 2ml of 
Esboch’s reagent. 
Yellow PPT Presence of 
Albumin 
6. Test for Phosphate : 
To 2ml of extract, add 2ml of 
ammonium Molybdate solution 
and 2ml of concentrated Nitric 
Acid. 
Absence of yellow 
PPT 
Absence of 
Phosphate 
7. Test for Sulphate : 
To 2 ml of extract add 2ml of 4% 
ammonium oxalate solution. 
White PPT Presence of 
Sulphate 
8. Test for Chloride :  
Add 2ml of extract to dilute nitric 
acid till the effervescence ceases. 
Then add 2 ml of Silver Nitrate 
Solution. 
Cloudy White PPT Presence of 
Chloride 
9. Test for Iron : 
To 2ml of extract, add 2ml of 
ammonium thio cynate solution 
and add 2ml of concentrated Nitric 
Acid. 
Red Colour Presence of Iron 
10. Test for Calcium : 
To 2 ml of extract, add 2 ml of 4% 
ammonium Oxalate Solution. 
Absence of white 
PPT 
Absence of 
Calcium 
11. Test for Sodium : 
Make a paste with 2 pinches of the 
sample with Hcl and Introduce it 
into the blue flame.  
Absence of yellow 
Flame 
Absence of 
Sodium 
12. Test for Potassium : 
Add a pinch of the sample to 2 ml 
of Sodium Nitrate Solution. Then 
add 2ml of Cobal Nitrate in 20% 
acetic acid. 
Absence of yellow 
PPT 
Absence of 
Potassium 
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S.No Experiment Observation Inference 
13. Test for Zinc : 
To 2ml of extract, add few drops 
of Sodium Hydroxide. 
Absence of white 
PPT 
Absence of Zinc 
14. Test for Magnesium : 
To 2ml of extract, add few drops 
of Sodium Hydroxide Solution 
Absence of white 
PPT 
Absence of 
Magnesium 
15. Test for Alkaloids : 
a. To 2ml of extract, add 2ml 
of Potassium Iodide 
Solution 
b. To 2ml of extract add 2ml 
of Picric Acid. 
c. To 2 ml of extract add 2ml 
of Phosphotunqstic Acid. 
 
Absence of red 
Colour 
 
Absence of yellow 
Colour 
Absence of  white 
PPT 
 
Absence of 
Alkaloids       
Absence of 
Alkaloids             
Absence of 
Alkaloids 
16. Test for Tannic Acid : 
To 2ml of extract add 2 ml of 
Ferric Chloride Solution 
Black PPT Presence of 
Tannic Acid 
 
4.3 Toxicological studies 
Animals  
 Mice of either sex weighing 25-30g and rats weighing 210-240g were 
obtained from the animal house of Vels University. The animals were used with the 
approval of the Institute animal ethics committee and obtained from Vels University, 
Chennai. They were fed with a balanced standard pellet diet and maintained under 
standard laboratory conditions, providing 24-280C temperature, standard light cycle 
(12 h light, 12 h dark) and water ad libitum. Animals were kept in cages with raised 
floors of wide mesh to prevent coprophagy. Animal welfare guidelines were observed 
during the maintenance period and experimentation. The rats were randomly assigned 
to control and different treatment groups, six animals per group.  
Acute toxicity study-OECD 425 guidelines 
 Acute oral toxicity test for the Arithirathi Chooranam was carried out as per 
OECD Guidelines 425. As with other sequential test designs, care was taken to ensure 
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that animals are available in the appropriate size and age range for the entire study. 
The test substance is administered in a single dose by gavage using a stomach tube or 
a suitable intubation cannula. The fasted body weight of each animal is determined 
and the dose is calculated according to the body weight. After the substance has been 
administered, food was withheld for a further 2 hours in mice. The animals were 
observed continuously for the first 4 h and then each hour for the next 24 h and at 6 
hourly intervals for the following 48 h after administering of the test drug, to observe 
any death or changes in general behaviour and other physiological activities. Single 
animals are dosed in sequence usually at 48 h intervals. However, the time interval 
between dosing is determined by the onset, duration, and severity of toxic signs. 
Treatment of an animal at the next dose was delayed until one is confident of survival 
of the previously dosed animal. 
Acute toxicity study 
 Acute oral toxicity test for the Arithirathi Chooranam was carried out as per 
OECD Guidelines 425. As with other sequential test designs, care was taken to ensure 
that animals are available in the appropriate size and age range for the entire study. 
The test substance is administered in a single dose by gavage using a stomach tube or 
a suitable intubation cannula. The fasted body weight of each animal is determined 
and the dose is calculated according to the body weight. After the substance has been 
administered, food was withheld for a further 2 hours in mice.  
 Single animals are dosed in sequence usually at 48 h intervals. However, the 
time interval between dosing is determined by the onset, duration, and severity of 
toxic signs. Treatment of an animal at the next dose was delayed until one is confident 
of survival of the previously dosed animal. The time interval was adjusted as 
appropriately in case of inconclusive response. The test is simpler to implement when 
a single time interval is used for making sequential dosing decisions. Special attention 
was given during the first 4 hours and daily thereafter, for a total of 14 days, except 
where they need to be removed from the study and humanely killed for animal 
welfare reasons or are found dead.  
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 All observations are systematically recorded and Observations include 
changes in skin and fur, eyes and mucous membranes, and also respiratory, 
circulatory, autonomic and central nervous systems, and somatomotor activity and 
behaviour pattern. Attention was directed to observations of tremors, convulsions, 
salivation, diarrhea, lethargy, sleep and coma. The principles and criteria summarized 
in the Humane Endpoints Guidance Document taken into consideration.  
 Animals found in a moribund condition and animals showing severe pain or 
enduring signs of severe distress was humanely killed. When animals are killed for 
humane reasons or found dead, the time of death was recorded. Mortality was not 
noticed up to 5000 mg/kg. One-tenth and one twentieth of this dose was selected as 
the therapeutic dose for the hepatoprotective evaluation.  
Observation of toxicity signs: General behavior, respiratory pattern, 
cardiovascular signs, motor activities, reflexes, change in skin and fur, mortality and 
the body weight changes were monitored daily. The time of onset, intensity, and 
duration of these signs, if any, was recorded.  
Sub-acute toxicity  
 In a 28-days sub acute toxicity study, twenty four either sex (3+3) rats were 
divided into four groups of 6 rats each. Group I that served as normal control was 
administered with distilled water (p.o.) while groups II, III and IV were administered 
daily with the Arithirathi Chooranam (p.o.) for 28 days at a dose of 100, 250 and 
500mg/kg respectively. The animals were then observed daily for gross behavioural 
changes and any other signs of subacute toxicity. The weight of each rat was recorded 
on day 0 and weekly throughout the course of the study, food and water consumption 
per rat was calculated. At the end of the 28 days they were fasted overnight, each 
animal was anaesthetized with diethylether, following which they were then dissected 
and blood samples were obtained by cardiac puncture into heparinised tubes. The 
blood sample collected from each rat was centrifuged with 3000 X g at 4oC for 10 min 
to separate the serum and used for the biochemical assays.  
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Hematological and blood biochemical analyses  
At the end of the study, all animals were kept fasted for 16-18 h and then 
anesthetized with anesthetic ether on the 28th day. Blood samples for hematological 
and blood chemical analyses were taken from retro orbital vein. Heparinized blood 
samples were taken for determining complete blood count (white blood cell count, 
differential white blood cell count, platelet count, red blood cell count, hematocrit, 
and hemoglobin) by semiautomated hematology analyzer. The serum from non-
heparinized blood was carefully collected for blood chemistry and enzyme analysis 
glucose, creatinine, total protein, albumin, total and direct bilirubins, serum 
glutamate-oxaloacetate transaminase (SGOT), serum glutamate pyruvate 
transaminase (SGPT), and alkaline phosphatase (ALP) were automatically determined 
using autoanalyzer. 
Necropsy  
All rats were sacrificed after the blood collection. The positions, shapes, sizes 
and colors of internal organs were evaluated. The Spleen, Testes, Pancrea, Lung, 
Liver, Brain, Heart, Stomach, Intestine, Bone, Ovary, and Kidney tissues were 
excised from all rats to visually detect gross lesions, and weighed to determine 
relative organs’ weights and preserved in 10% neutral formalin for histopathological 
assessment. The tissues were embedded in paraffin, and then sectioned, stained with 
haematoxylin and eosin and were examined microscopically. 
Statistical analysis 
Values were represented as mean ± SEM. Data were analysed using one-way 
analysis of variance (ANOVA) and group means were compared using the Tukey-
Kramer Multiple Comparison test using GraphPad Instat-V3 software. P values < 0.05 
were considered significant. 
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4.4 Pharmacological activity 
Hepatoprotective activity of Arithiraadhi chooranam 
 The disorders associated with the liver are numerous and no effective 
treatment for these numerous disorders. In spite of tremendous advances in modern 
medicine, there are no effective drugs available that stimulate liver function, offer 
protection to the liver from damage or help to regenerate hepatic cells. Liver plays a 
major role in detoxification and excretion of many endogenous and exogenous 
compounds, any injury or impairment of its function may lead to several implications 
on one's health. Management of liver diseases is still a challenge to modern medicine. 
Conventional drugs used in the treatment of liver diseases are often inadequate. It is 
therefore necessary to search for alternative drugs for the treatment of liver diseases to 
replace the currently used drugs of doubtful efficacy and safety.  
 Liver is the key organ regulating homeostasis in the body. It is involved with 
almost all the biochemical pathways related to growth, fight against disease, nutrient 
supply, energy production and reproduction. Because of its unique metabolism and 
relationship to the gastrointestinal tract, the liver is an important target for toxicity 
produced by drugs, xenobiotics and oxidative stress. In view of severely undesirable 
side effects of synthetic agents and the absence of reliable liver-protective drugs in 
modern medicine, Siddha system of Indian medicine recommended for the treatment 
of liver disorders.  
 The liver regulates many important metabolic functions. Hepatic injury is 
associated with distortion of these metabolic functions. Additionally, it is the key 
organ of metabolism and excretion, thus it is continuously and variedly exposed to 
xenobiotics because of its strategic placement in the body .The toxins absorbed from 
the intestinal tract go first to the liver resulting in a variety of liver ailments. Thus 
liver ailments remain one of the serious heath problems. Modern medicines have little 
to offer for alleviation of hepatic diseases and it is chiefly the plant based preparations 
which are employed for their treatment of liver disorders. But there are not much 
drugs available for the treatment of liver disorders. Hence the present study was 
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undertaken to investigate the hepatoprotective activity of Arithirathi Chooranam 
against CCL4 induced liver damage in rats. 
Materials and methods 
Drugs and chemicals 
 Analytical Laboratory grade chemicals, solvents were used for the studies, 
which were procured from S.D. fine and span diagnostic Ltd. 
Animals 
 Swiss albino mice (25-30g) and male Wistar rats (150-200 g) were procured 
from an in-house animal facility of School of Pharmaceutical Sciences, Vels 
University, Chennai. The animals were housed under standard conditions of 
temperature (22 ± 3°C) and relative humidity (30-70%) with a 12:12 light: dark cycle. 
The animals were fed with standard pellet diet (Sai meera  Feeds Ltd. Bangalore.) and 
water ad libitum. The Institutional Animal Ethics Committee  (IAEC)Approved the 
protocol (Approval number) XIII/ VELS/ PCOL/ 12/2000/ CPCSEA/ IAEC/ 
08.08.2012).  
Hepatoprotective activity  
 Four groups of animals containing six each were used for the study. The 
animals from Group I served as the normal control and received the vehicle 2% CMC 
at a dose of 2ml kg/d of p.o. Group II served as the control received CCl4 i.p. (3ml/kg) 
only. Groups III & IV received the CCl4 i.p. + Arithirathi Chooranam 250 and 
500mg/kg orally. The standard drug silymarin was administered to Group V animals 
in the dose 100 mg/kg/day p.o. The treatment was continued for all the 14days. The 
silymarin and the Arithirathi Chooranam were administered concomitantly to the 
respective groups of animals.  
 All the animals were killed on day 14 under light ether anesthesia. The blood 
sample were collected separately by retro orbital bleeding into sterilized dry 
centrifuge tube and allowed to coagulate for 30 min at 37°C. The clear serum was 
separated at 2500G for 10 min and biochemical investigations were carried out assess 
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liver function viz., total bilirubin, total protein, serum transaminases and serum 
alkaline phosphates. The activities of serum aspartate aminotransferase (AST), 
alanine aminotransferase (ALT), alkaline phosphatase (ALP), and total proteins (TP) 
were analyzed using commercial kits, to assess the acute hepatic damage caused by 
CCl4.  
Histopathological studies  
 After draining the blood liver samples were excised, and immediately fixed in 
10% formalin, dehydrated in gradual ethanol (50-100%), cleared in xylene and 
embedded in paraffin. Sections (4-5 µm) were prepared and then stained with 
hematoxylin and eosin dye for photomicroscopic observations. Initially, the materials 
were fixed in 10% buffered neutral formalin for 48h and then bovine solution for 6 h. 
Paraffin sections were taken at 5mm thickness. The sections were examined 
microscopically for histopathological changes.  
Statistical analysis  
 The data was represented as mean ± S.E.M. Results were analyzed statistically 
by one-way ANOVA followed by Dunnet's multiple comparison test using Prism 
software (Version 4). The minimum level of significance was set at P < 0.05. 
4.5 Clinical assessment 
 The pre clinical study of this drug has been showed the marked 
hepatoprotective efficacy. The clinical study was conducted to establish the efficacy 
and safety of the Arithiraadhi chooranam for Kamalai. 
Objectives 
• To evaluate the hepatoprotective effect of Arithiraadhi chooranam. 
• To explore the efficacy and safety of Arithiraadhi chooranam in patients with 
liver disorder. 
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Design of the study 
Open clinical trial Phase II B 
Study centre 
Arignar Anna Government Hospital of Indian Medicine and Homeopathy, 
Arumbakkam, Chennai – 106. 
Study participants 
Both men and women and members of all races and ethnic groups are eligible 
for this trial. Treatment was administered on an inpatient/outpatient basis. The 
patients were selected from the In-patient and Out-patient department of Arignar 
Anna Government Hospital of Indian Medicine and Homeopathy, Chennai – 106. 
Number of subjects 
Number of participants will be 50. 
Selection 
 50 patients from both sexes of various age groups were selected for clinical 
trial. Among 50 patients 40 patients were treated as out-patients, 10 patients were 
treated as  in – patients. The selection was based on the including and excluding 
criteria.  They were clinically diagnosed on the basis of siddha principles with modern 
laboratory findings. 
Registration process 
To register a patient, the following documents have been produced. 
• Copy of required laboratory tests 
• Signed patient consent form 
Then I verified the eligibility and assigned a patient study number, drug dose 
and registered the patient on the study. 
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Criteria for inclusion 
Patients with liver disease are eligible for entry to the trial if the following 
criteria are satisfied. 
9 Co operative patients 
9 The previous drug regimen if any have been with held for 24 hours before the 
clinical trial. 
Criteria for exclusion 
9 AIDS 
9 Malignancy 
9 Pregnant and lactating women 
9 TB 
9 Renal diseases 
9 Cardio vascular disorder 
9 Age below 10 year 
9 Syphilis 
9 The patient requires systemic steroid for the control of symptoms 
Withdrawal criteria 
Patients were removed from study when any of the criteria listed below 
applies. In the absence of treatment delays due to adverse events, treatment may 
continue for 2 cycles or until one of the following criteria applies: 
9 Disease progression, 
9 Deterioration of vital signs with cardiac, respiratory, hepatic, renal and 
CNS changes. 
9 Intercurrent illness that prevents further administration of treatment, 
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9 Unacceptable adverse event(s), 
9 Patient decides to withdraw from the study, or  
9 General or specific changes in the patient’s condition render the patient 
unacceptable for further treatment in the judgment of the investigator. 
Routine examination and assessment 
The full details of history and physical examination of the patients were 
recorded as per the proforma .The clinical assessment was done initially at the end of 
7 days, 14 days and 21 days during treatment and at the end of the 21 days follow up 
was done. The laboratory investigation and the physiological parameters were 
recorded initially at the end of the treatment and at the end of follow up as per the 
proforma. 
Dosage 
The trial drug Arithiraadhi chooranam was given in the dose of 500mg. 
Administration of the drug 
 Form of the medicine  : Chooranam 
  Route of Administration : Enteral 
 Dose    : 500mg  
 Anubanam (Vehicle)  : Warm water 
 Times of Administration : Two times a day; after food 
 Duration   : 7 weeks 
Diet restriction and medical advice 
9 The patients were instructed to follow fat free, salt free easily digestible foods. 
9 They were advised to take tender coconut, sugar cane juice and vegetables like 
radish, juice of plantain stem. 
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9 The patient was advised to take rest. But prolonged immobilization should be 
avoided. 
9 The clinical improvement was observed and recorded  in the proforma of case 
sheet. 
Trial conduct 
The study was conducted in compliance with the protocol approved by the 
Institutional Review Board, and according to Good Clinical Practice standards. No 
deviation from the protocol was implemented without the prior review and approval 
of the IRB except. 
Classification of results 
1. Good Response 
a. Relief of Symptoms above 75% 
b. Laboratory parameter findings towards normalcy. 
2. Fair Response 
a. 50% to 75% relief in symptoms. 
b. Significant improvement in laboratory parameter. 
3. Poor Response 
25% to 49% relief in symptoms and minimal improvement in laboratory 
parameters. 
4. No Response 
No relief in symptoms and no significant improvement in laboratory 
parameters. 
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Follow up 
Assessment will take for every three days before treatment and after treatment. 
During this period clinical assessment and laboratory investigation was carried out. 
Statistical analysis 
The data will be tabulated and analyzed by students ‘t’ test. 
Ethical review 
The protocol and any amendments were submitted to Govt siddha medical 
college, Chennai – 106 (IEC) and got formal approval to conduct the study. The 
decision of the IEC concerning the conduct of the study was made in writing to the 
investigator. All subjects for this study was provided a consent form describing this 
study and provided sufficient information for subjects to make an informed decision 
about their participation in this study. This consent form was submitted with the 
protocol for review and approval by the IEC. The formal consent of a subject, using 
the IEC-approved consent form, was obtained before that subject was submitted to 
any study procedure. This consent form was signed by the subject or legally 
acceptable surrogate, and the investigator-designated research professional obtaining 
the consent. 
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Table No: 4.5.1 
 
CLINICAL STUDY ON ARITHIRAADHI CHOORANAM, OUT – PATIENTS DEPT.IN THE MANAGEMENT OF KAMALAI 
Sl 
No 
Op. 
No 
Name/ Age/ 
Sex Complaints 
Duration 
of Days 
BT 
& 
AT
INVESTIGATION 
 
 
Results 
BLOOD 
Blood 
CL 
Urine 
 TC 
cells/cumm
DC (%) ESR(mm) Hb
gm
Sgr 
mg/dl
Ur 
mg/dl Sgr Alb
 
Dep      P 
     
L 
   
E 
½ hr  1 hr 
1. 5735 Chandran 
50/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera. 
17.7.12 
To 
20.8.12 
BT 9800 61 35 4 4 8 14 100 20 173 NIL NIL PCS 
Good 
 AT 9800 62 35 3 4 8 14 98 18 168 NIL NIL NIL 
2. 2355 Vishwanathan 
36/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera. 
18.7.12 
To 
15.8.12 
BT 9900 60 36 4 3 6 15 94 22 158 NIL NIL FPC  
Good 
 AT 9900 60 37 3 3 6 15 96 20 155 NIL NIL NIL 
3. 3875 Sangeetha 
40/Female 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera. 
21.7.12 
To 
25.8.12 
BT 9000 55 39 6 26 40 10.5 112 19 165 NIL NIL FPC  
Poor 
 AT 9000 56 39 5 23 38 11 110 29 160 NIL NIL NIL 
4. 9768 Meganathan 
39/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera. 
25.7.12 
To 
30.8.12 
BT 10100 63 34 3 8 12 13 104 19 175 NIL NIL FPC  
 
Satisfactory
 
AT 10100 63 33 4 8 12 13 100 18 165 NIL NIL NIL 
5. 3674 Janani 
37/Female 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera. 
28.7.12 
To 
28.8.12 
BT 9100 54 39 7 15 30 10 88 21 158 NIL NIL NIL  
  Good  
 
                   
AT 9100 55 40 5 15 30 10 86 19 144 NIL NIL NIL 
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Table No: 4.5.2 
CLINICAL STUDY ON ARITHIRAADHI CHOORANAM, OUT – PATIENTS DEPT.IN THE MANAGEMENT OF KAMALAI 
Sl No Op. No Name/ Age/ Sex Complaints Duration of Days 
BT 
& 
AT 
INVESTIGATION 
 
 
Results 
BLOOD 
Blood 
CL 
Urine 
 TC 
cells/cumm
DC (%) ESR(mm) Hb 
Gm 
Sgr 
mg/dl
Ur 
mg/dl Sgr Alb 
 
Dep      P 
     
L 
   E ½ 
hr 
 1 hr 
6. 5174 Ramakrishnan 
36/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera. 
30.7.12 
To 
5.9.12 
BT 10200 62 34 4 6 10 14 82 21 164 NIL NIL PCS  
Good 
 
 
AT 10200 62 36 2 6 10 14 82 19 160 NIL NIL NIL 
7. 9531 Visalatchi 
53/Female 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera. 
31.7.12 
To 
3.9.12 
 
BT 8800 56 38 6 15 25 12 88 19 190 NIL NIL NIL  
Good 
AT 8800 56 37 5 14 24 12.5 86 20 185 NIL NIL NIL 
8. 7105 Vijaya 
41/Female 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera 
2.8.12 
To 
30.8.12 
BT 9000 53 40 7 18 28 11 100 20 150 NIL NIL FPC  
Good 
 AT 9100 57 38 5 16 26 12 98 20 148 NIL NIL NIL 
9. 7219 Siraj 
37/Female 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored  sclera 
4.8.12 
To 
10.9.12 
BT 9500 58 37 5 20 35 10 90 19 155 NIL NIL NIL  
Satisfactory
 AT 9500 58 38 4 18 32 11 89 19 160 NIL NIL NIL 
10. 8593 Devi ammal 
39/Female 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera 
5.8.12 
To 
9.9.12 
BT 8900 55 40 5 8 14 13 95 20 161 NIL NIL FPC  
Good 
 
 
                   
AT 8900 56 39 5 8 14 13 94 18 157 NIL NIL NIL 
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Table No: 4.5.3 
CLINICAL STUDY ON ARITHIRAADHI CHOORANAM, OUT – PATIENTS DEPT.IN THE MANAGEMENT OF KAMALAI 
Sl 
No Op. No Name/ Age/ Sex Complaints 
Duration 
of Days 
BT 
& 
AT
INVESTIGATION Results 
BLOOD 
Blood 
CL 
Urine 
 TC 
cells/cumm
DC (%) ESR(mm) Hb
gm
Sgr 
mg/dl
Ur 
mg/dl Sgr Alb 
 
Dep P L E ½ hr 1 hr
11. 6897 Kamaraj 
41/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored  sclera 
7.8.12 
To 
14.9.12 
BT 9900 60 35 5 4 8 14 98 21 168 NIL NIL PCS  
Good 
 AT 9900 60 36 4 4 8 14 97 20 164 NIL NIL NIL 
12. 2309 Jayaprasath 
37/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera 
10.8.12 
To 
18.9.12 
BT 10000 63 33 4 6 12 13.5 118 21 158 NIL NIL NIL  
Good 
 AT 10000 63 35 2 5 10 14 110 19 160 NIL NIL NIL 
13. 8909 Arokiya raj 
39/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored  sclera 
11.8.12 
To 
19.9.12 
BT 10100 59 36 5 8 14 13 98 18 172 NIL NIL FPC  
Moderate
 AT 10100 58 37 5 8 14 13 100 20 170 NIL NIL NIL 
14. 214 Jeevanandham 
34/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera 
13.8.12 
To 
14.9.12 
BT 9500 62 32 6 10 16 13 89 22 159 NIL NIL NIL  
  Good 
AT 9700 63 32 5 10 16 13 88 20 165 NIL NIL NIL 
15. 136 Puhpa 
36/Female 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera 
16.8.12 
To 
20.9.12 
BT 8900 54 40 6 15 30 10 95 16 162 NIL NIL FPC  
 
Good 
 
                  
AT 8900 53 42 5 13 26 11 92 19 160 NIL NIL NIL 
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Table No: 4.5.4 
CLINICAL STUDY ON ARITHIRAADHI CHOORANAM, OUT – PATIENTS DEPT.IN THE MANAGEMENT OF KAMALAI 
Sl No Op. No Name/ Age/ Sex Complaints Duration of Days 
BT 
& 
AT 
INVESTIGATION Results 
BLOOD 
Blood 
CL 
Urine 
 TC 
cells/cumm
DC (%) ESR(mm) Hb 
Gm 
Sgr 
mg/dl
Ur 
mg/dl Sgr Alb 
 
Dep P L E ½ hr 1 hr
16. 391 Valarmathi 
42/Female 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored  sclera 
20.8.12 
To 
21.9.12 
BT 9200 57 37 6 20 43 12 85 19 160 NIL NIL PCS  
Satisfactory
                   AT 9200 58 37 5 19 40 12.5 85 20 159 NIL NIL FPC 
17. 1469 Prithiviraj 
39/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored  sclera 
22.8.12 
To 
26.9.12 
BT 10100 62 34 4 6 12 14 95 20 158 NIL NIL NIL  
Good 
 AT 10100 62 33 5 6 10 14 90 21 160 NIL NIL NIL 
18. 1503 Krishnaveni 
34/Female 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera 
24.8.12 
To 
30.8.12 
BT 9500 55 40 5 15 25 11 86 20 159 NIL NIL FPC  
    Good 
 AT 9600 58 39 3 15 25 11 85 19 160 NIL NIL NIL 
19. 205 Rejina mary 
26/Female 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored  sclera 
26.8.12 
To 
29.9.12 
BT 8400 55 38 7 20 35 12 96 18 155 NIL NIL NIL  
Poor 
 AT 8400 58 37 5 20 35 12 94 18 158 NIL NIL NIL 
20. 7542 Aarumugam 
51/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored  sclera 
29.8.12 
To 
5.10.12 
BT 9500 62 33 5 10 16 13 108 21 165 NIL NIL PCS  
Moderate 
 
                   
AT 9500 61 35 4 10 15 13.5 104 20 160 NIL NIL FPC 
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Table No: 4.5.5 
CLINICAL STUDY ON ARITHIRAADHI CHOORANAM, OUT – PATIENTS DEPT.IN THE MANAGEMENT OF KAMALAI 
SI 
NO Op. No Name/ Age/ Sex Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION Results 
BLOOD 
Blood 
CL 
Urine 
 TC 
cells/cumm
DC (%) ESR(mm)
Hb 
Gm 
Sgr 
mg/dl
Ur 
mg/dl
Sgr Alb 
 
Dep P L E ½ hr 1 hr
21. 3841 Kalaiselvi 
36/Female 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored  sclera 
8.9.12 
To 
15.10.12 
BT 9300 54 39 7 18 30 12 99 21 162 NIL NIL PCS  
Good 
 AT 9300 54 40 6 16 26 12.5 98 19 158 NIL NIL FPC 
22. 8444 Jothimani 
44/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored  sclera 
15.9.12 
To 
25.10.12 
BT 10200 63 34 3 6 8 14 112 21 153 NIL NIL PCS  
Good 
 AT 10200 59 36 5 6 8 14 116 20 155 NIL NIL NIL 
23. 5870 Siva Arvinth 
40/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored  sclera 
26.9.12 
To 
26.10.12 
BT 10100 63 34 3 3 6 15 105 21 162 NIL NIL  FPC  
Moderate 
 AT 10100 63 34 3 3 6 15 102 18 164 NIL NIL NIL 
24. 5086 Kanagavalli 
50/Female 
  Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera 
16.10.12 
To 
15.11.12 
BT 10000 64 29 5 15 40 10.8 101 20 199 NIL NIL PCS  
Good 
 AT 10100 63 33 4 15 40 11 99 19 188 NIL NIL FPC 
25. 8010 Meenakshi 
30/Female 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera 
18.10.12 
To 
30.12.12 
BT 9200 58 36 6 35 60 10.5 82 18 179 NIL NIL NIL  
Good 
 
 
 
AT 9300 61 33 6 30 55 11 80 21 181 NIL NIL NIL 
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Table No: 4.5.6 
CLINICAL STUDY ON ARITHIRAADHI CHOORANAM, OUT – PATIENTS DEPT.IN THE MANAGEMENT OF KAMALAI 
SI 
NO Op. No Name/ Age/ Sex Complaints 
Duration 
of Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD   
Blood 
CL 
Urine  
TC 
cells/cumm
DC (%) ESR(mm) Hb 
Gm 
Sgr 
mg/dl
Ur 
mg/dl
  Sgr   Alb    
Dep      
P 
     
L 
   E ½ 
hr 
 1 hr 
26. 225 Munusamy 
50/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored  sclera 
30.10.12 
To 
18.12.12 
BT 9200 61 36 3 4 10 15 108 21 163 NIL NIL FPC Good 
 
AT 9300 62 34 4 4 10 15 104 20 161 NIL NIL NIL 
27. 318 Mallika 
38/Female 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored  sclera 
31.10.12 
To 
04.12.12 
BT 9500 58 38 4 18 28 11 85 19 163 NIL NIL PCS Good 
 
AT 9300 59 38 3 18 28 11 84 20 161 NIL NIL NIL 
28. 947 Naveen kumar 
35/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored  sclera 
3.11.12 
To 
6.12.12 
BT 1000 64 32 4 8 14 14 104 20 175 NIL NIL NIL Poor 
 
AT 9800 65 31 4 8 14 14 102 18 169 NIL NIL NIL 
29. 948 Murugan 
38/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored  sclera 
3.11.2012 
To 
10.12.12 
BT 9900 62 35 3 10 15 14 105 20 167 NIL NIL PCS  
      Good 
             AT 9900 61 35 4 10 15 14 110 21 168 NIL NIL FPC 
30. 1379 Vasanthi 
30/Female 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored  sclera 
05.11.12 
To 
6.12.12 
 
BT 8800 56 39 5 14 22 12 97 18 159 NIL NIL FPC  
 
Satisfactory
                   
AT 8800 57 37 6 14 22 12 98 19 160 NIL NIL NIL 
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Table No: 4.5.7 
CLINICAL STUDY ON ARITHIRAADHI CHOORANAM, OUT – PATIENTS DEPT.IN THE MANAGEMENT OF KAMALAI 
SI 
NO 
Op. 
No Name/ Age/ Sex Complaints 
Duration of 
Days 
BT 
& 
AT
INVESTIGATION  
 
Results 
BLOOD   
Blood 
CL 
Urine  
TC 
cells/cumm
DC (%) ESR(mm) Hb 
Gm
Sgr 
mg/dl
Ur 
mg/dl
  Sgr   Alb   Dep 
     
P 
     
L 
   E ½ 
hr 
 1 hr
31. 1973 Daisy 
30/Female 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored  sclera 
5.11.12 
To 
15.12.12 
BT 8600 62 34 4 17 25 9 98 22 163 NIL NIL NIL Good 
 
AT 8400 63 32 5 17 25 10 98 20 162 NIL NIL NIL 
32. 1388 Rajeshwari 
38/Female 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored  sclera 
5.11.12 
To 
12.12.12 
BT 8800 58 37 5 12 20 11 100 22 159 NIL NIL PCS Moderate 
 
AT 8500 60 36 4 12 20 11 98 18 158 NIL NIL FPC 
33. 3550 Suseela 
64/Female 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera 
6.11.12 
To 
8.12.12 
BT 8600 61 34 5 10 24 12 110 19 180 NIL NIL PCS Good 
AT 8800 57 36 7 10 24 12 108 20 175 NIL NIL FPC 
34. 1664 Kalavathy 
38/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera 
6.11.12 
To 
13.12.12 
BT 8800 58 37 5 9 18 13 100 21 190 NIL NIL FPC Good 
 
AT 8700 55 39 6 9 19 13 97 20 190 NIL NIL NIL 
35. 1661 Murugesan 
30/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored  sclera 
6.11.12 
To 
15.12.12 
BT 10100 66 30 4 4 9 15 89 21 158 NIL NIL NIL  
Good 
 
                  
AT 10200 67 29 4 4 9 15 91 18 164 NIL NIL NIL 
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Table No: 4.5.8 
CLINICAL STUDY ON ARITHIRAADHI CHOORANAM, OUT – PATIENTS DEPT.IN THE MANAGEMENT OF KAMALAI 
SI 
NO Op. No 
Name/ Age/ 
Sex Complaints 
Duration of 
Days 
BT 
& 
AT 
INVESTIGATION  
 
Results 
BLOOD   
Blood 
CL 
Urine  
TC 
cells/cumm
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/dl
Ur 
mg/dl 
  Sgr   Alb   
 Dep      
P 
     
L 
   E ½ 
hr 
 1 hr 
36. 1834 Balu 
40/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow colored 
sclera 
7.11.12 
To 
14.12.12 
BT 10900 64 31 5 4 26 13 108 20 163 NIL NIL NIL Satisfactory
 
AT 10800 65 31 4 4 26 13 98 19 160 NIL NIL NIL 
37. 1923 Vaithilingam 
40/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow colored 
sclera 
7.11.12 
To 
15.12.12 
BT 10500 62 34 4 6 18 12 100 16 158 NIL NIL PCS Good 
 
AT 10400 61 35 4 6 18 12 100 17 155 NIL NIL NIL 
38. 2542 Sanmugam 
47/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow colored 
sclera 
10.11.12 
To 
16.12.12 
BT 9800 57 38 5 10 20 11 98 19 157 NIL NIL PCS  
Good 
 
AT 9800 56 39 5 10 20 11 96 16 162 NIL NIL FPC 
39. 3551 Ranga 
48/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow colored 
sclera 
16.11.12 
To 
27.12.12 
BT 9900 59 37 4 9 16 13 115 21 167 NIL NIL NIL  
Satisfactory
 AT 10000 59 38 3 9 16 13 105 20 163 NIL NIL NIL 
40. 3559 Sumathi 
45/Female 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow colored 
sclera 
16.11.12 
To 
25.12.12 
BT 
 
AT 
9500 
 
9500 
58 
 
58 
36 
 
38 
6 
 
4 
15 
 
15 
30 
 
30 
10 
 
10 
96 
 
94 
19 
 
20 
180 
 
178 
NIL 
 
NIL 
NIL 
 
NIL 
NIL 
 
NIL 
Good 
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Table No: 4.5.9 
CLINICAL STUDY ON ARITHIRAADHI CHOORANAM, IN – PATIENTS DEPT.IN THE MANAGEMENT  
OF KAMALAI 
SI 
NO 
IP. 
No 
Name/ Age/ 
Sex Complaints 
Duration 
of Days 
BT 
& 
AT
INVESTIGATION  
 
Results 
BLOOD    
Blood 
CL 
Urine X ray bms/ 
EndoscopyTC 
cells/cumm
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/dl
Ur 
mg/dl
  Sgr   
Alb 
   
Dep      
P 
     
L 
   E ½ 
hr 
 1 
hr 
1. 908/ 
2732 
Elumalai 
40/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera 
5.7.12 
To 
18.7.12 
BT 9900 61 36 3 15 23 12 106 18 178 NIL NIL PCS  
- 
 
 
Good 
AT 9900 60 37 3 15 23 12 102 20 174 NIL NIL NIL 
2. 1076/ 
7058 
Moorthy 
51/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera 
23.7.12 
To 
22.8.12 
BT 10000 59 38 3 16 25 11.5 114 21 186 NIL NIL PCS  
- 
Poor 
 
AT 10000 58 40 2 16 23 12 108 20 183 NIL NIL NIL 
3. 1146/ 
8782 
Kolnchi 
31/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera 
28.7.12 
To 
5.8.12 
BT 10200 62 34 4 12 21 10 106 19 170 NIL NIL FPC  
- 
 
Satisfactory
 AT 10100 60 35 5 10 18 11 102 20 173 NIL NIL NIL 
4. 1156/ 
9029 
Premkumar 
36/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera 
30.7.12 
To 
5.8.12 
BT 9900 63 34 3 6 13 13 108 18 169 NIL NIL FPC  
- 
 
Satisfactory
 AT 9800 62 34 4 8  15 13 102 21 163 NIL NIL NIL 
5. 1274/ 
2712 
Venkatesan 
50/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera 
14.8.12 
To 
27.8.12 
BT 9600 64 33 3 13 25 10 110 20 166 NIL NIL NIL  
- 
 
 Good       
AT 9600 63 34 3 13 25 10.5 106 20 160 NIL NIL NIL 
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Table No: 4.5.10 
CLINICAL STUDY ON ARITHIRAADHI CHOORANAM, IN – PATIENTS DEPT.IN THE MANAGEMENT  
OF KAMALAI 
SI 
NO 
IP. 
No 
Name/ Age/ 
Sex Complaints 
Duration of 
Days 
BT 
& 
AT
INVESTIGATION  
 
Results 
BLOOD    
Blood 
CL 
Urine X ray bms/ 
Endoscopy TC 
cells/cumm
DC (%) ESR(mm) Hb 
gm 
Sgr 
mg/dl
Ur 
mg/dl
  
Sgr 
  
Alb 
   
Dep     
P 
     
L 
   
E
½ 
hr 
 1 
hr 
6. 1416/ 
7108  
Sasikumar 
48/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera 
3.9.12 
To 
21.10.12 
BT 9100 60 34 6 9 16 11 95 20 188 NIL NIL PCS  
- 
 
 
Good 
AT 9000 58 37 5 4 8 11 90 19 186 NIL NIL NIL
7. 29/ 
742 
Gopal 
55/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera 
18.9.12 
TO 
13.10.12 
BT 9700 60 35 5 12 20 12 108 20 162 NIL NIL PCS  
- 
Poor 
 
AT 9700 56 40 4 12 22 12 102 17 155 NIL NIL NIL
8. 223/ 
6409 
John 
aabraham 
48/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera 
11.10.12To 
22.10.12 
BT 9900 58 35 7 5 15 13 110 20 170 NIL NIL FPC  
- 
 
Satisfactory
 AT 9600 56 38 6 5 15 13 105 18 162 NIL NIL NIL
9. 323/ 
9390 
Ganesh 
43/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera 
26.10.12 
To 
17.12.12 
BT 10100 64 32 4 4 9 14 96 21 190 NIL NIL FPC  
- 
 
Satisfactory
 AT 10100 62 34 4 4 9 14 96 20 185 NIL NIL NIL
10. 336/ 
299 
Kannan 
35/Male 
Anorexia, Nausea, 
Vomiting, Fatigue, 
Insomnia, Yellow 
colored sclera 
31.10.12 
To 
12.11.12 
BT 10000 62 33 5 6 12 13.5 125 18 178 NIL NIL NIL  
- 
 
 Good        
AT 10000 63 33 4 6 12 13.5 120 18 175 NIL NIL NIL
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        Table No: 4.5.11 
LIVER FUNCTION TEST 
S. 
No 
 
OP No 
 
Name/age/sex 
Duration of 
Treatment 
Duration LIVER FUNCTION TEST 
AST(SGOT) 
(IU/L) 
ALT(SGPT) 
(IU/L) 
ALP 
(IU/L) 
Total 
Bilirubin 
(mg/dl) 
Total protein 
g/dl 
Albumin 
g/dl 
1.  
5735 
 
Chandran 
50/ Male 
17.7.12 
To 
20.8.12 
BT  
95 
 
93 
 
130 
 
2.8 
 
5.7 
 
4.2 
AT  
45 
 
40 
 
116 
 
1.2 
 
6.4 
 
4.5 
2. 2355 Vishwanathan 
36/Male 
18.7.12 
To 
15.8.12 
BT  
50 
 
48 
 
72 
 
1.6 
 
4.6 
 
3.2 
AT  
40 
 
30 
 
68 
 
0.9 
 
4.6 
 
3.2 
3. 3875 Sangeetha 
40/Female 
21.7.12 
To 
25.8.12 
BT  
56 
 
62 
 
98 
 
2.4 
 
6.2 
 
3.8 
AT  
38 
 
30 
 
96 
 
1.2 
 
7.2 
 
4.1 
4. 9768 Meganathan 
39/Male 
25.7.12 
To 
30.8.12 
BT  
60 
 
52 
 
75 
 
2.0 
 
7.2 
 
5.3 
AT  
39 
 
32 
 
70 
 
1.0 
 
7.4 
 
5.4 
5. 3674 Janani 
37/Female 
28.7.12 
To 
28.8.12 
BT  
50 
 
52 
 
82 
 
2.5 
 
5.5 
 
2.8 
AT  
35 
 
47 
 
78 
 
1.4 
 
6.2 
 
3.4 
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Table No: 4.5.12 
LIVER FUNCTION TEST 
S. 
No 
OP No Name/age/sex Duration of Treatment Duration 
LIVER FUNCTION TEST 
AST(SGOT) 
(IU/L) 
ALT(SGPT) 
(IU/L) 
ALP 
(IU/L) 
Total 
Bilirubin 
(mg/dl) 
Total protein 
g/dl 
Albumin 
g/dl 
6. 
 
5174 
 
Ramkrishnan 
36/ Male 
30.7.12 
To 
5.9.12 
BT 
 
56 
 
50 
 
78 
 
2.8 
 
4.2 
 
2.3 
AT 
 
26 
 
25 
 
76 
 
1.0 
 
4.4 
 
2.6 
7. 9531 
Visalakshi 
53/Female 
31.7.12 
To 
3.9.12 
BT 
 
58 
 
56 
 
82 
 
2.1 
 
7.1 
 
4.3 
AT 
 
27 
 
28 
 
75 
 
0.9 
 
7.3 
 
4.5 
8. 7105 
Vijaya 
41/Female 
2.8.12 
To 
30.8.12 
BT 
 
80 
 
64 
 
98 
 
1.2 
 
6.2 
 
3.6 
AT 
 
25 
 
30 
 
92 
 
0.7 
 
6.4 
 
3.8 
9. 7219 
Siraj 
37/Female 
4.8.12 
To 
10.9.12 
BT 
 
57 
 
50 
 
76 
 
3.2 
 
5.5 
 
2.8 
AT 
 
42 
 
40 
 
74 
 
1.2 
 
6.8 
 
3.9 
10. 8593 
Devi ammal 
39/Female 
5.8.12 
To 
9.9.12 
BT 
 
56 
 
50 
 
90 
 
2.8 
 
7.2 
 
4.5 
AT 
 
38 
 
42 
 
88 
 
0.8 
 
7.4 
 
4.8 
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Table No: 4.5.13 
LIVER FUNCTION TEST 
S. 
No 
OP No Name/age/sex Duration of Treatment Duration 
LIVER FUNCTION TEST 
AST(SGOT) 
(IU/L) 
ALT(SGPT) 
(IU/L) 
ALP 
(IU/L) 
Total 
Bilirubin 
(mg/dl) 
Total protein 
g/dl 
Albumin 
g/dl 
11. 6897 Kamaraj 
41/Male 
7.8.12 
To 
14.9.12 
BT 57 66 128 2.0 5.8 3.8 
AT 31 38 112 1.1 5.8 4.8 
12. 2309 
Jayaprasath 
37/Male 
10.8.12 
To 
18.9.12 
BT 56 50 80 2.3 5.2 2.8 
AT 29 31 72 1.0 6.2 3.8 
13. 8909 
Arokiya raj 
39/Male 
11.8.12 
To 
19.9.12 
BT 58 44 98 2.6 6.2 3.2 
AT 46 42 96 1.2 6.3 3.3 
14. 214 Jeevanandham 
34/Male 
13.8.12 
To 
14.9.12 
BT 87 70 100 2.5 5.8 3.8 
AT 46 34 94 1.3 6.4 4.1 
15. 136 
Puhpa 
36/Female 
16.8.12 
To 
20.9.12 
BT 56 47 106 2.7 6.5 3.8 
AT 46 34 100 1.4 7.4 4.8 
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Table No: 4.5.14 
LIVER FUNCTION TEST 
S. 
No 
 
OP No 
 
Name/age/sex 
Duration of 
Treatment Duration 
LIVER FUNCTION TEST 
AST(SGOT) 
(IU/L) 
ALT(SGPT) 
(IU/L) 
ALP 
(IU/L) 
Total 
Bilirubin 
(mg/dl) 
Total protein 
g/dl 
Albumin 
g/dl 
16. 391 Valarmathi 
42/Female 
20.8.12 
To 
21.9.12 
BT 54 46 95 3.0 6.1 4.2 
AT 28 22 92 1.2 5.6 4.2 
17. 1469 
Prithiviraj 
39/Male 
22.8.12 
To 
26.9.12 
BT 160 143 109 2.8 7.4 4.8 
AT 68 73 97 1.0 7.4 5.1 
18. 1503 
Krishnaveni 
34/Female 
24.8.12 
To 
30.8.12 
BT 210 180 135 1.8 6.2 3.5 
AT 66 70 120 0.9 6.4 3.6 
19. 205 Rejina mary 
26/Female 
26.8.12 
To 
29.9.12 
BT 190 178 135 1.5 7.2 3.8 
AT 60 51 88 0.8 6.6 3.9 
20. 7542 
Aarumugam 
51/Male 
29.8.12 
To 
5.10.12 
BT 130 112 132 1.8 7.6 3.9 
AT 60 56 116 0.8 7.4 3.9 
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Table No: 4.5.15 
LIVER FUNCTION TEST 
S. 
No 
OP No Name/age/sex Duration of Treatment Duration 
LIVER FUNCTION TEST 
AST(SGOT) 
(IU/L) 
ALT(SGPT) 
(IU/L) 
ALP 
(IU/L) 
Total 
Bilirubin 
(mg/dl) 
Total protein 
g/dl 
Albumin 
g/dl 
21. 3841 
Kalaiselvi 
36/Female 
8.9.12 
To 
15.10.12 
BT 120 140 108 1.8 8.2 5.0 
AT 48 53 104 1.1 7.8 5.0 
22. 8444 
Jothimani 
44/Male 
15.9.12 
To 
25.10.12 
BT 166 152 106 2.0 5.4 4.1 
AT 52 50 118 1.0 5.8 4.4 
23. 5870 
Siva Arvinth 
40/Male 
26.9.12 
To 
26.10.12 
BT 120 158 135 2.6 6.0 4.3 
AT 30 36 117 0.9 6.7 4.5 
24. 5086 Kanagavalli 
50/Female 
16.10.12 
To 
15.11.12 
BT 147 93 127 1.5 5.4 3.2 
AT 41 44 112 0.9 6.3 4.1 
25. 8010 
Meenakshi 
30/Female 
18.10.12 
To 
30.12.12 
BT 95 50 140 1.7 5.8 3.5 
AT 34 22 106 1.3 5.1 3.4 
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Table No: 4.5.16 
LIVER FUNCTION TEST 
S. 
No 
OP No Name/age/sex Duration of Treatment Duration 
LIVER FUNCTION TEST 
AST(SGOT) 
(IU/L) 
ALT(SGPT) 
(IU/L) 
ALP 
(IU/L) 
Total 
Bilirubin 
(mg/dl) 
Total protein 
g/dl 
Albumin 
g/dl 
26. 225 
Munusamy 
50/Male 
30.10.12 
To 
18.12.12 
BT 145 85 130 3.5 6.8 4.6 
AT 48 38 94 0.9 7.4 4.3 
27. 318 
Mallika 
38/Female 
31.10.12 
To 
04.12.12 
BT 170 92 110 2.1 6.3 3.8 
AT 52 36 97 1.0 6.4 3.9 
28. 947 
Naveen kumar 
35/Male 
3.11.12 
To 
6.12.12 
BT 175 125 118 1.2 5.2 2.6 
AT 60 48 82 0.8 7.0 3.4 
29. 948 
Murugan 
38/Male 
3.11.2012 
To 
10.12.12 
BT 194 132 112 1.4 6.5 4.1 
AT 72 60 94 0.9 6.9 4.3 
30. 1379 
Vasanthi 
30/Female 
05.11.12 
To 
6.12.12 
 
BT 175 132 101 1.2 5.3 4.5 
AT 69 52 98 0.9 6.2 4.9 
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Table No: 4.5.17 
LIVER FUNCTION TEST 
S. 
No 
OP No Name/age/sex Duration of Treatment Duration 
LIVER FUNCTION TEST 
AST(SGOT) 
(IU/L) 
ALT(SGPT) 
(IU/L) 
ALP 
(IU/L) 
Total 
Bilirubin 
(mg/dl) 
Total protein 
g/dl 
Albumin 
g/dl 
31. 1973 Daisy 
30/Female 
5.11.12 
To 
15.12.12 
BT 170 92 110 2.1 6.3 3.8 
AT 62 36 97 1.0 6.4 3.9 
32. 1388 
Rajeshwari 
38/Female 
5.11.12 
To 
12.12.12 
BT 120 140 108 1.8 8.2 5.0 
AT 48 53 104 1.1 7.8 5.0 
33. 3550 
Suseela 
64/Female 
6.11.12 
To 
8.12.12 
BT 140 70 90.3 1.2 6.8 4.2 
AT 28 35 82 0.8 6.9 4.3 
34. 1664 Kalavathy 
38/Male 
6.11.12 
To 
13.12.12 
BT 110 88 126 1.3 6.5 4.7 
AT 52 40 116 0.7 6.5 4.7 
35. 1661 
Murugesan 
30/Male 
6.11.12 
To 
15.12.12 
BT 102 78 78 1.5 5.2 2.6 
AT 44 53 54 0.7 6.4 3.8 
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LIVER FUNCTION TEST 
Table No: 4.5.18 
S. 
No 
OP No Name/age/sex Duration of Treatment Duration 
LIVER FUNCTION TEST 
AST(SGOT) 
(IU/L) 
ALT(SGPT) 
(IU/L) 
ALP 
(IU/L) 
Total 
Bilirubin 
(mg/dl) 
Total protein 
g/dl 
Albumin 
g/dl 
36. 1834 
Balu 
40/Male 
7.11.12 
To 
14.12.12 
BT 95 93 130 2.8 5.7 4.2 
AT 45 40 116 1.2 6.4 4.5 
37. 1923 Vaithilingam 
40/Male 
7.11.12 
To 
15.12.12 
BT 210 180 135 1.8 6.2 3.5 
AT 66 70 120 0.9 6.4 3.6 
38. 2542 
Sanmugam 
47/Male 
10.11.12 
To 
16.12.12 
BT 190 177 135 1.5 7.2 3.8 
AT 60 54 89 0.8 6.6 3.9 
39. 3551 
Ranga 
48/Male 
16.11.12 
To 
27.12.12 
BT 112 112 139 1.8 7.6 3.9 
AT 59 56 116 0.9 7.4 4.2 
40. 3559 Sumathi 
45/Female 
16.11.12 
To 
25.12.12 
BT 124.8 84.8 152.6 1.67 7.2 5.2 
AT 43.2 32.7 112.6 0.9 7.4 5.3 
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                              5. RESULTS AND DISCUSSION 
                  4.2.1. Physico-chemical analysis: 
        Report of arithradi chooranam 
        Table No: 4.2.1.1 
S.No Parameter Mean Value 
1.  Loss on Drying at 105°C 7.355 % 
2.  Total Ash  17.584 % 
3.  Acid insoluble Ash   0.096 % 
4.  Water Soluble Extractive 45.40 % 
5.  Alcohol Soluble Extractive 39.30 % 
6.  pH 6.0 
 
TLC  result of arithiraadhi chooranam 
Figure No: 4.2.1.2 
   
                                After spray with visualizing agent 
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Table No: 4.2.1.2 
Sl.No After Dipping in Vanillin-Sulphuric acid 
 
Rf value Colour of the spot 
1 0.06 Purple 
2 0.11 Yellow 
3 0.17 Purple 
4 0.28 Pink 
5 0.34 Majenta 
6 0.39 Yellow 
7 0.44 Pink 
8 0.55 Pink 
11 0.66 Purple 
12 0.74 Purple 
13 0.82 Purple 
14 0.91 Purple 
 
                   4.2.4 Qualitative phytochemical analysis: 
                    Result of arithiraadhi chooranam 
                   Table No: 4.2.4 
Qualitative Phytochemical Tests 
1.  Alkaloids -  ve 
2.  Anthraquinones + ve 
3.  Triterpenes + ve 
4.  Flavonoids + ve 
5.  Steroids + ve 
6.  Phenol   + ve 
7.  Tannin   + ve 
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Phytochemical analysis of Arithiraadhi chooranam showed the following, 
Presence of Anthraquinone, Triterpenes, Flavonoids, Steroids, Phenol and 
Tannins.  
Curcuma longa which is one of the ingredients in the Arithiraadhi chooranam, 
protects the structural integrity of hepatocyte membrane. ( Somchit et al- 2005 ) 
Curcumin which is one of the phyto chemical constituents of Curcuma longa 
also has effect on the cellular oxidative metabolism, which may improve the 
hepatoprotective mechanism. (Donatus et al – 1998 )  
Tannins and flavanoids of Phyllanthus emblica contain anti oxidant and 
hepatoprotective properties. ( Kawala et al- 2002 ) 
Tannins, flavanoids and other phytochemicals which are present in 
Arithiraadhi chooranam may be responsible for its Hepatoprotective activity.  
4.2.1.3 Fourier transform infrared spectroscopy (FTIR) 
Ftir result of arithiraadhi chooranam 
Peak     Functional group 
3434 cm-1    Alcohol phenol O-H stretch 
2920 cm-1    Carboxylic acid O-H stretch 
2852 cm-1    Carboxylic acid O-H stretch 
2129 cm-1    Alkynyl C=C stretch 
1633 cm-1    Amide C=O stretch 
1379 cm-1    Alkyl methyl 
1233 cm-1    C-O ether aromatic 
1163 cm-1    Esters 
1036 cm-1    Aliphatic amines 
667 cm-1    Chloro alkanes 
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4.2.1.4 Scanning electron microscope (SEM): 
Figure No: 4.2.1.4 
 
Results:  
  SEM picture shows Nano particle (Micro level) size of the sample.  
 Physical properties of known elements and materials can change as their 
surface to area ratio is dramatically increased, i.e. when nanoscale sizes are achieved. 
These changes do not take place when going from macro to micro scale. Changes in 
physical properties such as colloidal properties, solubility and catalytic capacity have 
been found very useful in areas of bioremediation and drug delivery. The extremely 
small size of nanoparticles allows them to penetrate cells and interact with cellular 
molecules. Due to nanoparticle size a low dose of the drug can cure the diseases. 
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4.2.5.Chemical analysis of arithiraadhi chooranam: 
Results: 
The chemical analysis of Arithiraadhi chooranam showed the following 
chemicals, 
 Presence of Reducing sugar, Starch, Proteins, Amino acid, Sulphate, Chloride, 
Iron, and Tannin. 
4.3 .Toxicological study 
Results and discussion: 
 All the animals from control and all the treated dose groups up to 500 mg/kg 
survived throughout the dosing period of 28 days. No signs of major or significant 
intoxication were observed in animals from lower to higher dose groups during the 
dosing period of 28 days. Animals from all the treated dose groups exhibited 
comparable body weight gain with that of controls throughout the dosing period of 28 
days. Food consumption of control and treated animals was found to be comparable 
throughout the dosing period of 28days. Ophthalmoscopic examination, conducted 
prior to and at the end of dosing period on animals from control and all the treated 
dose groups did not reveal any abnormality.  
 Haematological analysis conducted at the end of the dosing period on day 28, 
revealed no significant abnormalities attributable to the treatment. Biochemical 
analysis conducted at the end of the dosing period on day 28, revealed no remarkable 
abnormalities attributable to the treatment. Functional observation tests conducted at 
termination revealed no abnormalities. Urine analysis, conducted at the end of the 
dosing period in week 4 and at the end of recovery period in week 6, revealed no 
abnormality attributable to the treatment. Organ weight data of animals sacrificed at 
the end of the dosing period was found to be comparable with that of respective 
controls. Gross pathological examination did not reveal any abnormality. 
Histopathological examination did not reveal any abnormality. 
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Table No: 4.3.1 Dose finding experiment and its behavioral Signs of Toxicity 
No Dose mg/kg 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
1 2000 + - - + - + - - - - - - - - - - - - - - 
2 5000 + - - + - + - - - - - - - - - - - - -  - 
 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. 
Touch Response    7.Decreased Motor Activity 8. Tremors  9. Convulsions  10. 
Muscle Spasm 11. Catatonia  12.Muscle relaxant 13. Hypnosis 14. Analgesia 
15.Lacrimation 16. Exophthalmos 17. Diarrhoea 18. Writhing 19. Respiration 20. 
Mortality 
Table No: 4.3.2  Body wt (g) of rats exposed to Arithirathi Chooranam for 28days. 
Dose 
(mg/kg/day) 
Days 
1 7 14 21 28 
Control 122.12±3.14 128.52±4.19 130.18±4.66 134.48±4.25 135.22±4.08
100 125.30±4.06 126.38±5.14 131.10±5.12 135.00±5.21 136.10±4.25
250 120.13±4.20 124.05±4.28 128.04±5.15 130.21±5.04 132.16±4.23
500 126.12±3.28 128.30±5.00 132.12±5.10 134.23±4.26 136.22±4.62
 Values are mean ± S.E.M. (Dunnett's test). nsP>0.05. N=6. 
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Table No: 4.3.3  Food (g/day) intake of rats exposed to Arithirathi Chooranam for 
28days. 
Dose 
(mg/kg/day) 
Days (gms/rats) 
1 7 14 21 28 
Control 40.25±2.13 42.11±2.27 44.57±2.42 42.18±2.52 45.64±2.58 
100 42.12±2.26 45.45±2.86 45.55±2.20 44.28±2.40 44.51±3.44 
250 47.20±2.28 46.41±2.94 46.34±2.14 45.53±2.11 45.46±3.51 
500 42.32±2.55 47.50±2.65 42.28±2.55 45.33±2.68 45.55±2.29 
Values are mean ± S.E.M. (Dunnet's test). nsP>0.05. N=6. 
Table No: 4.3.4 Water (ml/day) intake of rats exposed to Arithirathi Chooranam. 
 
Dose 
(mg/kg/day) 
Days(ml/rat) 
1 7 14 21 28 
Control 45.12±2.18 50.11±3.45 50.11±3.28 50.22±3.68 52.12±3.81 
100 45.18±2.26 52.21±3.00 52.18±3.45 56.14±3.20* 54.25±2.62 
250 50.22±2.28 50.10±3.55 54.24±3.60 54.14±2.46 54.42±3.42 
500 50.21±3.45 55.40±3.25 55.00±3.27 48.26±3.63 52.08±3.34 
Values are mean ± S.E.M. (Dunnet’t' test). *P<0.05. N=6. 
  
Hepatoprotective Activity of Arithiraadhi Chooranam 
 
  P.G. Gunapadam Department  175
Table No: 4.3.5 Hematological parameters after 28days treatment with 
Arithirathi Chooranam in rats. 
Parameter Control 100 mg/kg 250 mg/kg 500 mg/kg 
Red blood cell 
(mm3) 
5.00±0.42 4.80±0.50 5.18±0.48 5.21±0.44 
HB (%) 15.12±0.34 15.41±0.36 15.04±0.34 15.12±0.41 
Leukocyte 
(x103/Cu.mm) 
8.24±1.10 8.21±0.90 8.18±1.12 8.14±1.22 
Platelets(K/µl) 455±24.48 494±30.24 492±30.10 490±30.14 
MCV (gl) 52.56±4.18 50.22±4.45 52.11±4.26 51.42±4.31 
N 14.55±2.42 14.62±2.12 14.74±2.82 14.82±2.23 
L 80.30±4.28 82.13±4.11 81.62±3.84 82.02±3.92 
M 1.40±0.30 1.29±0.31 1.38±0.24 1.44±0.22 
E 1.04±0.11 1.07±0.28 1.00±0.14 1.00±0.16 
B 0±0.00 0±0.00 0±0.00 0±0.00 
ESR(mm) 1±00 1±00 1±00 1±00 
PCV 44.52±2.39 45.24±2.41 45.29±2.33 45.18±3.42 
Values are mean ± S.E.M. (Dunnet’t' test). nsP>0.01. N=6. 
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Table No:4.3.6  Effect of treatment with Arithirathi Chooranam ( biochemical 
parameters) 
Dose (mg/kg) Control 100 mg/kg 250 mg/kg 500 mg/kg 
Total Bilirubin 
(mg/dL) 
0.28±0.06 0.28±0.05 0.27±0.04 0.28±0.03 
Bilirubin direct 
(mg/dL) 
0.22±0.06 0.22±0.07 0.18±0.04 0.20±0.04
ALP (U/L) 102.26±8.02 106.10±10.00 105.10±7.55 106.1±8.02 
SGOT (U/L) 120.13±5.00 122.30±4.71 124.12±5.02 125.18±5.10 
SGPT(U/L) 35.11±2.10 35.54±2.04 35.10±2.15 36.00±2.00 
Total Protein(g/dl) 6.00±1.21 6.14±0.26 6.35±0.22 7.00±0.31 
Albumin(g/dl) 2.40±0.20 2.43±0.24 3.31±0.21 3.10±0.18 
Globulin(g/dl) 4.31±0.14 4.55±0.12 4.21±0.15 4.14±0.13 
 
Values are mean ± S.E.M. nsP>0.05 Vs Control N=6. 
 Table No: 4.3.7                     RFT 
Dose (mg/kg) Control 100 mg/kg 250 mg/kg 500 mg/kg 
Urea(mg/dL) 5.33±1.99 5.24±2.28 5.32±2.20 5.00±1.56 
Creatinine (mg/dL) 0.71±0.05 0.70±0.05 0.70±0.05 0.72±0.06 
Uric acid (mg/dL) 4.36±0.21 4.30±0.26 4.23±0.22 4.12±0.21 
Na m.mol 113.12±5.00 112.00±4.41 111.22±4.00 112.10±3.88 
K m.mol 5.00±2.04 5.14±1.76 5.32±1.62 5.11±2.21 
Cl m.mol 102.45±4.21 100.00±4.62 101.12±4.18 100.33±4.04 
 
Values are mean ± S.E.M. nsP>0.05. Vs. control group N=6. 
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Table No:4.3.8  Lipid Profile 
Dose (mg/kg) Control 100 mg/kg 250 mg/kg 500 mg/kg 
Total cholesterol 
(mg/dL) 
76.22±2.66 75.10±2.72 74.72±2.56 75.21±2.08 
HDL (mg/dL) 118.75±2.17 119.52±2.55 121.14±3.00 120.24±2.20
LDL (mg/dL) 42.00±2.44 42.74±2.85 41.55±2.18 42.00±3.00 
VLDL (mg/dl) 26.16±2.33 26.18±2.24 26.10±2.34 26.62±2.41 
Triglycerides (mg/dl) 26.10±2.14 25.86±2.52 26.00±3.00 28.12±2.53 
Blood glucose (mg/dl) 89.14±4.33 90.41±4.61 91.10±3.22 90.14±2.74 
Values are mean ± S.E.M. (Dunnet ’t' test). nsP>0.01 Vs Control N=6. 
       Table No: 4.3.9                                      Urine Analysis 
Parameters Control 100 mg/kg 250 mg/kg 500 mg/kg 
Colour Yellow Yellow Yellow Yellow 
Transparency Clear Slightly turbid Slightly 
cloudy 
Slightly turbid
Specific gravity 1.010 1.010 1.010 1.010 
PH >7.2 >8.0 >7.5 >7.5 
Protein Nil 1+ 1+ 2+ 
Glucose Nil Nil Nil Trace 
Bilirubin -ve -ve -ve -ve 
Ketones -ve -ve -ve -ve 
Blood Absent Absent Absent Absent 
Urobilinogen Normal Normal Normal Normal 
Pus cells 0-cells/HPF 1-cell/HPF 2-cells/HPF 1-cell/HPF 
RBCs Nil Nil 0-
1cells/HPF 
Nil 
Epithelial cells Nil 1-cell/HPF Nil 1-cell/HPF 
Crystals Nil Nil Nil Nil 
Casts Nil Nil Nil Nil 
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Table No:4.3.10 Effect of oral administration of Arithirathi Chooranam on organ 
weight 
Dose (mg/kg) Control 100 mg/kg 250 mg/kg 500 mg/kg 
Liver (g) 3.10±0.18 3.14±0.16 3.12±0.14 3.10±0.10 
Heart (g) 0.32±0.06 0.34±0.05 0.35±0.06 0.34±0.04 
Lung (g) 0.44±0.15 0.45±0.10 0.44±0.15 0.45±0.16 
Spleen (g) 0.42±0.06 0.44±0.05 0.45±0.05 0.46±0.05 
Ovary (g) 1.28±0.15 1.25±0.10 1.23±0.15 1.22±0.15 
Testes (g) 2.10±0.16 2.20±0.12 2.20±0.21 2.21±0.14 
Brain (g) 2.00±0.12 2.02±0.14 2.00±0.13 2.02±0.12 
Kidney (g) 0.85±0.04 0.84±0.05 0.85±0.05 0.86±0.05 
Stomach (g) 1.16±0.12 1.12±0.10 1.12±0.12 1.12±0.10 
Values are mean ± S.E.M. (Dunnet ’t' test). nsP>0.01 Vs Control N=6. 
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 SUB ACUTE TOXICITY STUDY 
Histopathological features  
        100mg                                           250mg                                             500mg 
                                 
Bone – Figure No: 4.3.1 
                               
Brain – Figure No: 4.3.2 
                                
Heart – Figure No: 4.3.3 
                               
Intestine – Figure No: 4.3.4 
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       100mg                                    250mg                                    500mg               
                                 
Kidney – Figure No: 4.3.5 
                                 
Liver – Figure No: 4.3.6 
                                
Lung – Figure No: 4.5.7 
                              
Ovary – Figure No: 4.3.8 
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          100mg                                     250mg                                500mg 
                                 
Pancreas – Figure No: 4.3.9 
                                
Spleen – Figure No: 4.3.10 
                                
Stomach – Figure No: 4.3.11 
                              
Testis – Figure No: 4.3.12 
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4.4 Pharmacology study 
Results of Arithiraadhi chooranam 
The acute toxicity study revealed the absence of lethality among the tested 
animals when the Arithirathi Chooranam was administered as a single dose upto 5000 
mg/kg). There were no signs of any gross behavioral changes except for mild tremors 
indicating the safe use of the Arithirathi Chooranam. The ability of a hepatoprotective 
drug to reduce the injurious effects or to preserve the normal hepatic physiological 
mechanisms, which have been disturbed by a hepatotoxin, is the index of its 
protective effects. Although serum enzyme levels and ascorbic acid in urine are not a 
direct measure of hepatic injury, they show the status of the liver. The lowering of 
enzymes level are definite indication of hepatoprotective action of the drug. 
 Liver possesses a unique metabolism and plays a pivotal role in the removal of 
substances from the portal circulation due to which it is susceptible to toxicity of 
drugs, xenobiotics, and oxidative stress. The two distinct pathways in liver 
metabolism occur via cytochrome p-450 and GSH-peroxidase. The current treatment 
for hepatotoxicity includes drugs which influence the p-450 enzyme mechanism either 
by inhibiting (amiodarone, cimetidine, ciprofloxacin, etc.) or inducing (rifampicin, 
carbamazepine, phenobarbital, phenytoin) the metabolic activity of enzymes. Necrosis 
or membrane damage releases the enzymes into circulation and hence it can be 
measured in the serum.  
 The reversal of increased serum enzymes in CCl4-induced liver damage by the 
Arithirathi Chooranam may be due to the prevention of the leakage of intracellular 
enzymes by its membrane stabilizing activity. Amino transferases contribute a group 
of enzymes that catalyze the interconversion of amino acids and a-keto acids by the 
transfer of amino groups. These are liver specific enzymes and are considered to be 
very sensitive and reliable indices for necessary hepatotoxic as well as 
hepatoprotective or curative effect of various compounds. Both AST and ALT levels 
increase due to toxic compounds affecting the integrity of the liver cells. Decreased 
levels of transaminases indicate stabilization of plasma membrane and protection of 
hepatocytes against damage caused by hepatotoxin.  
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 This is in agreement with the commonly accepted view that serum levels of 
transaminases return to normal with the healing of hepatic parenchyma and the 
regeneration of hepatocytes. Alkaline phosphatase is a membrane bound glycoprotein 
enzyme with a high concentration in sinusoids and endothelium. This enzyme reaches 
the liver mainly from the bone. It is excreted into the bile; therefore its elevation in 
serum occurs in hepatobiliary diseases. Serum alkaline phosphatase is related to the 
functioning of hepatocytes and increase in its activity is due to the increased synthesis 
in presence of biliary pressure. The results of the present study indicate that the test 
groups probably stabilize the hepatic plasma membrane from CCl4-induced damage. 
Reduction of alkaline phosphatase levels with concurrent depletion of raised bilirubin 
levels suggests the stability of the biliary function during injury with CCl4.  
 The liver is known to play a significant role in the serum protein synthesis, 
being the source of plasma albumin and fibrinogen and also the other important 
components like α and β-globulin. The liver is also concerned with the synthesis of g-
globulin. The metabolic biotransformation of amino acid in liver by synthesis, 
transamination, etc., may be impaired due to the escape of both non-proteins and 
protein nitrogenous substances from injured cells as mediated by a raise in the serum 
enzyme levels of ALP, AST and ALT. Normally, AST and ALP are present in high 
concentration in liver. Due to hepatocyte necrosis or abnormal membrane 
permeability, these enzymes are released from the cells and their levels in the blood 
increases. ALT is a sensitive indicator of acute liver damage and elevation of this 
enzyme in non hepatic diseases is unusual. ALT is more selectively a liver 
paranchymal enzyme than AST. Bilirubin is one of the most useful clinical clues to 
the severity of necrosis and its accumulation is a measure of binding, conjugation and 
excretory capacity of hypatocyte.  
 Decrease in serum bilirubin after treatment with the Arithirathi Chooranam in 
liver damage induced by CCL4, indicated the effectiveness of the test drug in normal 
functional status of the liver. The reduction in the total protein is attributed to the 
initial damage produced and localized in the endoplasmic reticulum which results in 
the loss of cytochrome P-450 enzymes leading to its functional failure with a decrease 
in protein synthesis and accumulation of triglycerides leading to fatty liver. Both the 
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test groups enhanced the synthesis of TP which accelerates the regeneration process 
and the protection of liver cells. Therefore, the increased level of total protein in 
serum indicates the hepatoprotective activity.  
 Inhibition of bile acids synthesis from cholesterol, which is synthesized in 
liver or derived from plasma lipids leading to increase in cholesterol levels, was also 
resulted due to CCl4 intoxication. Significant suppression of cholesterol levels by the 
test groups suggests that the bile acids synthesis inhibition was reversed. The extent of 
hepatic damage is assessed by histological evaluation along with the level of various 
biochemical parameters in circulation. The animals in the CCl4 group showed severe 
hepatotoxicity evidenced by profound steatosis, centrilobular necrosis, ballooning 
degeneration, nodal formation and fibrosis as compared to the normal hepatic 
architecture of the normal group animals. Test drug Arithirathi Chooranam showed 
the healing of damaged parenchyma which was comparable to that of the standard 
group treated with silymarin.  
 The efficacy of any hepatoprotective drug is dependent on its capacity of 
either reducing the harmful effect or restoring the normal hepatic physiology that has 
been disturbed by a hepatotoxin. The silymarin group and both the test groups 
decreased CCl4 induced elevated enzyme levels, indicating the protection of structural 
integrity of hepatocytic cell membrane or regeneration of damaged liver cells. 
Histopathological examinations of the liver tissues provided supporting evidence for 
the results obtained in the biochemical analysis.  
 Liver for rats treated with CCl4 alone showed multiple focal areas of 
hepatocellular necrosis, degeneration and fatty changes. But in the standard drug 
treated groups, few areas of necrosis only were observed. In the animals treated with 
extract at low dose along with CCl4, mild focal hepatocytes necrosis was observed. In 
the animals treated with extract at medium dose along with CCl4, mild hepatocytes 
swelling and sinusoidal dilation was observed. But in the animals treated with extract 
at high dose along with CCl4, Normal central vein and hepatocytes along with few 
areas of necrosis only were observed.  
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Table No: 4.4.1  Effect of Arithirathi Chooranam on serum constituents in CCl4 
induced hepatotoxic rats. 
Gro
up  
Treatm
ent  
Dose AST(i.u
/l)*** 
ALT(i.u
/l)*** 
ALP(i.u
/l)*** 
T.P(g/d
l)*** 
Albu
min 
(g/dl)
*** 
Biliru
bin 
(mg/dl
)*** 
Nor
mal  
---  49.50±0.9
9 
7.33±0.33 69.33±0.4
9 
5.23±0.0
2 
2.28±
0.54 
0.25±0.
02 
Cont
rol 
CCl4 (3ml/
kg) 
63.17±0.4
8 
13.0±0.73 86.33±0.9
7 
5.77±0.0
5 
4.33±
0.03 
0.80±0.
02 
Test 
I 
CCl4+Arit
hirathi 
Choorana
m 
250m
g/kg 
55.0±0.82 8.50±0.21 78.83±0.7
9 
5.40±0.0
4 
2.68±
0.05 
0.45±0.
04 
Test 
II 
CCl4+Arit
hirathi 
Choorana
m 
500m
g/kg 
53.83±0.4
8 
8.0 ± 0.37 76.50±0.7
3 
5.30±0.0
4 
2.58±
0.05 
0.42±0.
03 
Stan
dard 
CCl4+Sily
marin 
50mg
/kg 
50.17±0.7
0 
7.67±0.21 70.33±0.7
6 
5.25±0.0
3 
2.33±
0.03 
0.28±0.
03 
 
Values are as mean ± SEM (n=6)  
Values are statistically significant at ***P<0.001  
Comparison made between Group II Vs Group I  
Group III, IV, V Vs Group II. 
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Table No:4.4.2 Effect of Arithirathi Chooranam on hematological Parameters in 
CCl4 induced hepatotoxic rats. 
Group  Treatment  Dose RBC 
(106/mm)3
Hb (g/dl) PCV (%) MCV (%) MCHC 
(%) 
Normal  ---  6.30±0.32 13.29±0.45 54.05±2.23 60.13±1.44 25.29±0.17
Control CCl4 (3ml/kg) 6.24±0.25 12.40±0.28 49.44±2.20 57.04±0.60 25.76±0.22
Test I CCl4+Arithirathi 
Chooranam 
250mg/kg 6.52±0.23 15.33±0.33*** 55.30±2.13 62.62±0.52** 26.15±0.40
Test II CCl4+Arithirathi 
Chooranam 
500mg/kg 6.76±0.34 15.38±0.30*** 60.52±2.18* 63.24±0.36*** 26.34±0.21
Standard CCl4+Silymarin 50mg/kg 6.45±0.28 13.36±0.31 52.71±2.31 61.22±0.62** 26.28±0.40
 
Values are as mean ± SEM (n=6)  
Values are statistically significant at *P<0.05, **P<0.01, ***P<0.001  
Comparison made between Group II Vs Group I  
Group III, IV, V Vs Group II. 
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Inference: 
Among 50 patients, 
• 40 out of 44 patients were relieved from Anorexia. 
• 38 out of 43 patients were relieved from Nausea/ Vomiting. 
• 32 out of 38 patients were relieved from Fatigue. 
• 10 out of 15 patients were relieved from Insomnia. 
• 37 out of 46 patients were relieved from Yellow coloured eyes. 
• 38 out of 45 patients were relieved from Yellow coloured urine. 
• 6 out of 10 patients were relieved from pain in abdomen.  
• 2 out of 3 patients were relieved from Fever. 
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 STATISTICAL ANALYSIS 
Descriptive statistical for improvement Of liver function test In kamalai 
Paired t test results: 
AST in Jaundice Patients: 
P value and statistical significance:  
The two-tailed P value is less than 0.0001 
By conventional criteria, this difference is considered to be extremely statistically significant. 
Confidence interval: 
The mean of Group One minus Group Two equals 67.359 
95% confidence interval of this difference: From 53.440 to 81.278  
 
Intermediate values used in calculations: 
  t = 9.7969 
  df = 38 
  standard error of difference = 6.876  
Table No: 4.5.26 
Treatment No of 
Patients 
Mean S.D S.E.M N 
Before 
treatment 
40 113.920 52.024 8.226 40 
After treatment 40 46.282 13.533 2.167 39 
 
ALT (Alanine transaminase):  
The elevated ALT (Alanine transaminase) /serum glutamic pyruvic transaminase 
(SGPT) levels were also reduced significantly, when compared to the pre-treatment 
values, the two-tailed P value is less than 0.0001.By conventional criteria, and this 
difference is considered to be extremely statistically significant. 
Hepatoprotective Activity of Arithiraadhi Chooranam 
 
  P.G. Gunapadam Department  192
P value and statistical significance:  
  The two-tailed P value is less than 0.0001 
  By conventional criteria, this difference is considered to be extremely statistically 
significant.  
 
Confidence interval: 
  The mean of Group One minus Group Two equals 52.077 
  95% confidence interval of this difference: From 40.564 to 63.590  
 
Intermediate values used in calculations: 
  t = 9.1572 
  df = 38 
  standard error of difference = 5.687  
Table No: 4.5.27 
 
Treatment No of 
Patients 
Mean S.D S.E.M N 
Before 
treatment 
40 94.670 43.975 6.953 40 
After treatment 40 42.846 12.881 2.063 39 
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Table No:4.5.28 
 
Treatment No of 
Patients 
Mean S.D S.E.M N 
Before 
treatment 
40 109.747 22.250 3.518 40 
After treatment 40 96.682 16.886 2.704 39 
 
Bilirubin: 
The mean serum bilirubin values were elevated at the time of the enrolment, in 
all patients in these studies. Cumulative data analysis showed a significant reduction 
in the mean serum bilirubin level,The two-tailed P value is less than 0.0001By 
conventional criteria, this difference is considered to be extremely statistically 
significant. 
P value and statistical significance:  
  The two-tailed P value is less than 0.0001 
  By conventional criteria, this difference is considered to be extremely statistically 
significant.  
 
Confidence interval: 
  The mean of Group One minus Group Two equals 1.0872 
  95% confidence interval of this difference: From 0.9143 to 1.2600  
 
Intermediate values used in calculations: 
  t = 12.7333 
  df = 38 
  standard error of difference = 0.085  
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CONCLUSION 
The test drug Arithiraadhi chooranam was selected from the text 
“Sarabenthira vaithiya rathnavali” for the evaluation of safety, efficacy and 
therapeutic potential in Jaundice.  
All the raw drugs for the preparation of test drug were purchased from 
Tampcol raw drug store and authenticated, then subjected to preparation. 
Physico chemical anatysis, Chemical analysis, was showed that Curcuma 
longa, Picrorhiza kurao, and Terminalia chebula having phytochemicals which are 
hepatoprotecting agents. 
Tannins and flavanoids of Phyllanthus emblica contain anti oxidant and 
hepatoprotective properties. 
From the acute toxicity study as per OECD guideline 425, it was concluded 
that the test drug Arithiraadhi chooranam is a safety drug. 
Arithiraadhi chooranam did not produce any oral acute or sub acute toxicity in 
both female and male rats. Overall results suggest that Arithiraadhi chooranam is 
relatively safe in rats. 
The finding of the pre clinical study suggests that effective role of 
Arithiraadhi chooranam on jaundice. 
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SUMMARY 
The herbo mineral drug Arithiraadhi chooranam was prepared as per siddha 
literature. This drug was subjected to various studies by the author. 
Arithiraadhi chooranam was selected for this study to establish the safety and 
efficacy of its Hepatoprotective activity on Kamalai. 
To collect the information about the drug, various text books, Literature were 
referred. From them, the author came to an idea about the drug and its efficacy on 
Kamalai. 
 Acute and Sub acute toxicological studies show strong evidence of the 
nontoxic effect of the Arithiraadhi chooranam.    
The pharmacological analysis showed that the drug has got significant 
Hepatoprotective Efficacy. 
 In clinical study, the drug has showed improvement in 62% of cases. 
The patients were responding well from the beginning of the treatment and no 
adverse effects were reported. 
This present study suggests that Arithiraadhi chooranam has remarkable 
medicinal value against the disease Kamalai.   
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Form: I 
CONSENT FORM 
 I certify that I have disclosed all the details about the study in the terms readily understood 
by the patient. 
DATE:          SIGNATURE 
          NAME 
CONSENT BY THE PATIENT 
 I have been informed to my satisfaction by the attending physician the purpose of the clinical 
trial and the nature of the drug treatment and follow up including the lab investigations to be 
performed to monitor and safeguard my body functions. 
 I am aware of my right to opt out of the trial at any time during the course of the trial without 
having to give reasons for doing so. 
 I ,exercising  my free power of choice , hereby give my consent to be included as a subject in 
the clinical trial of ………………………….for the treatment 
of…………………………………………….. 
DATE:        SIGNATURE 
        NAME 
xg;Gjy; gbtk; 
Ma;TFwpj;jmj;jidjfty;fisAk; Nehahspvspjpy; Gupe;Jnfhs;Sk; tifapy; 
Nehahspf;Ftpsf;fpAs;Nsd; vd;WcWjpaspf;fpNwd; 
Njjp:     Ma;thsupd; ifnahg;gk;: 
ngau;: 
Nehahspapd; xg;Gjy;; 
 ,e;jMa;TFwpj;j KO jfty;fs;>kUe;jpd; jd;ik>vdJcly; eyd; 
Fwpj;jMa;Tfs;>Ma;Tf;fhdkUj;JtgupNrhjidfs; kw;Wk; rpfpr;irtpguq;fs; Mfpamidj;Jk; 
kUj;Jtuhy; KOikahftpsf;fpf; $wg;gl;Ls;sJ. 
 ,e;jMa;tpypUe;Jve;jepiyapYk;>vt;tpjfhuzKkpd;wptpyfpf;nfhs;svdf;F KO 
Rje;jpuk; cs;sJvd;gijAk; mwpe;jpUf;fpNwd;. 
 ,e;jMa;tpy;>……………………………………………………………………………………….xUgadhspahfvd;idcl;gLj;jpf; 
nfhs;sVt;tpjkhdepu;ge;jKkpd;wpKOkdJld; rk;kjpf;fpNwd; vd;gijj; njuptpj;Jf; 
nfhs;fpNwd;. 
Njjp:       ifnahg;gk;: 
       ngau;: 
1.       DEPARTMENT OF POST GRATUATE GUNAPADAM BRANCH,  
GOVERNMENT SIDDHA MEDICAL COLLEGE,  
CHENNAI - 106. 
ARIGNAR ANNA GOVERNMENT HOSPITAL FOR 
INDIAN MEDICINE AND HOMEOPATHY, ARUMBAKKAM, 
CHENNAI - 106. 
OPEN CLINICAL TRAIL PHASE II B 
ANTI ULCER ACTIVITY OF 
“PANAI POO CHOORANAM” 
FORM II 
1. Centre :  
2. Code no  :      Level of study: OPD/IPD 
3. Name of the patient  :  
4. Address  : 
     
    
5. Age :   :   sex: Male  Female   
6. Educational Status  :  
7. Occupation  :  
8. Income  :  
9. Religion  : H M CH  S 
10. Marital Status  : 
     11. Date of Admission   :  
     12. Date of Discharge   : 
     13Diagnosis   : 
PERSONAL HISTORY: 
11. Food habits  : Veg Non Veg Veg/Egg 
12. Addiction  : None Smoking Snuff 
    Ganja Alcohol Opium 
13. Sleep  : Good Distributed Insomnia 
14. Presence of anxiety  : Yes No 
15. Naadi  : Vatham  Pitham Kapam        Thontham 
FAMILY HISTORY: 
1. Hypertension  : Yes  NO  
2. Diabetes mellitus  : Yes  NO 
3. Tuberculosis  : Yes  NO 
4. IHD/MI/MS/AS  : Yes  NO 
5. If any other disease specify  : Yes   NO 
 PRESENTING SYMPTOMS: 
       Yes    No  Duration (WEEKS) 
1. Pain : 
2. Vomiting : 
3. Indigestion : 
4. Sore tongue : 
5. Diarrhoea : 
6. Constipation : 
7. Haematemesis : 
8. Loss of appetite : 
9. Thirst : 
10. Dysphasia : 
11. Flatulence : 
12. Heart-burn : 
13. If any other disease :  
HISTORY OF PRESENT ILLNESS: 
1. Pain  : 
2. Vomiting  : 
3. Indigestion  :  
4. Sore tongue  : 
5. Diarrhoea  : 
6. Constipation  : 
7. Haematemesis  : 
8. Loss of appetite  : 
9. Thirst  : 
10. Dysphasia  : 
11. Flatulence  : 
12. Heart-burn  : 
13. Bloating & abdominal fullness : 
14. Water brash  : 
15. Nausea and copious vomiting: 
16. Weight loss  : 
17. Melena  : 
18. If any other disease   
PAST HISTORY: 
1. Date of diagnosis  : 
2. Duration of disease  :           months/years 
3. Source of any infection  : 
4. Gastrointestinal bleeding   : Yes    No If Yes, when? 
5. Cancer(GI tract)  : Yes    No 
6. Cancer(other organs)  : Yes    No       
7. Sedentary life style  : Yes    No        
8. Achlorhydria  : Yes    No      
9. Tumours in stomach  : Yes    No     
10. Tuberculosis (GI tract)  : Yes    No        
11. Diabetes  : Yes    No   
12. Nephritis  : Yes    No  
13. Syphilis  : Yes    No 
14. AIDS  : Yes    No  
15. Pt.underwent any surgery  : Yes    No 
16. UTI  : Yes    No  
17. Others  : If Yes , Specify    
HISTORY OF PREVIOUS TREATMENT: Yes   No 
If yes, give details as follows: 
PHYSICAL EXAMINATION: 
1. Height (cm)  :  
2. Weight (cm)  : 
3. Pulse  : 
4. Blood pressure  : 
5. Temperature  : 
6. RR  :  /minute 
7. Anaemia  :  Present   Absent 
8. Lymphadenopathy  :  Present    Absent 
9. Pigmentation  :  Present   Absent 
PRESENTING SIGNS:   
1. Bloating and abdominal fullness    :  Present  Absent 
2. Water brash  (Rush of saliva after 
 an episode of Regurgitation to  
Dilute the Acid in oesophagus)     :  Present  Absent 
3. Nausea and copious vomiting      :  Present  Absent 
4. Loss of appetite and weight loss    :  Present  Absent 
5. Haematmesis         :  Present  Absent 
6. Melena(tarry, foul-smelling faces 
 due to oxidized iron from  
Haemoglobin)         :  Present  Absent 
7. Fatigue   :  Present   Absent 
8. Heartburn   :  Present   Absent 
9. Hunger   :  Present   Absent 
CLINICAL EVALUATION: 
1. Cardio vascular system  :  Normal    Abnormal  Details   
2. Respiratory system  :  Normal      Abnormal Details 
3. Central nervous system  :  Normal  Abnormal Details 
4. Urogenital system  :  Normal  Abnormal Details 
SIDDHA PARAMETERS: 
1. Naa  :  Normal  Abnormal Details 
2. Niram  :  Normal   Abnormal Details 
3. Mozhi  :  Normal   Abnormal Details 
4. Vizhi  :  Normal  Abnormal Details 
5. Malam  :  Normal  Abnormal Details 
6. Moothiram  :  Normal  Abnormal Details 
7. Sparisam  :  Normal  Abnormal Details 
8. Naadi  :  Normal  Abnormal Details 
RESULT: 
1. GOOD  : 
2. FAIR  : 
3. POOR  : 
4. NO RESPONSE  : 
SIGNATURE OF MEDICAL OFFICER   SIGNATURE OF INVESTIGATOR 
LABORATORY INVESTIGATION AND CLINICAL PARAMETERS 
1. Centre :  
2. Code no  :      Level of study: OPD/IPD 
3. Name of the patient  :  
4. Age :   :   sex: Male  Female   
5. Date and month of assessment   : 
CLINICAL PARAMETERS: 
 Urine: Albumin, Sugar, Deposits. 
 MOTION; Ova ,Cyst  
HAEMOGRAM :Total WBC Count, RBC, Hb, ESR, Barium meal,Endoscopy,Ultra sound 
 
                               DEPARTMENT OF POST GRATUATE GUNAPADAM BRANCH,  
GOVERNMENT SIDDHA MEDICAL COLLEGE,  
CHENNAI-106. 
ARIGNAR ANNA GOVERNMENT HOSPITAL FOR 
INDIAN MEDICINE AND HOMEOPATHY, ARUMBAKKAM, 
CHENNAI-106. 
OPEN CLINICAL TRAIL PHASE II B 
HEPATOPROTECTIVE ACTIVITY OF 
“ARITHIRAADHI CHOORANAM” 
FORM II 
16. Centre :  
17. Code no  :      Level of study: OPD/IPD 
18. Name of the patient  :  
19. Address  : 
     
    
20. Age :   :   sex: Male  Female   
21. Educational Status  :  
22. Occupation  :  
23. Income  :  
24. Religion  : H M CH  S 
25. Marital Status  : 
     11. Date of Admission   : 
     12. Date of Discharge   : 
     13. Diagnosis   : 
PERSONAL HISTORY: 
26. Food habits  : Veg Non Veg Veg/Egg 
27. Addiction  : None Smoking Snuff 
    Ganja Alcohol Opium 
28. Sleep  : Good Distributed Insomnia 
29. Presence of anxiety  : Yes No 
30. Naadi  : Vatham  Pitham Kapam        Thontham 
FAMILY HISTORY: 
6. Hypertension  : Yes  NO  
7. Diabetes mellitus  : Yes  NO 
8. Tuberculosis  : Yes  NO 
9. IHD/MI/MS/AS  : Yes  NO 
10. If any other disease specify  : Yes   NO 
PRESENTING SYMPTOMS: 
       Yes    No  Duration (WEEKS) 
14. Anorexia : 
15. Nausea : 
16. Vomiting : 
17. Fatigue : 
18. Insomnia : 
19. Yellow colored eyes : 
20. Yellow colored urine : 
21. Pale coloured motion : 
22. Skin itching : 
23. Pain abdomen : 
24. Fever : 
25. Diarrhoea : 
26. Hematemesis :  
27. If any other disease : 
 
HISTORY OF PRESENT ILLNESS:  
Onset of Jaundice  :      Acute                     Chronic 
 
PAST HISTORY: 
18. Date of diagnosis  : 
19. Duration of disease  :           months/years 
20. Source of HBV infection  : 
21. High risk Group  :  Medical worker         Paramedical worker  
  Sex worker   others  
  Non – High risk group   
22. Alcohol  : Yes    No 
23. Cancer(other organs)  : Yes    No       
24. Sedentary life style  : Yes    No        
25. Achlorhydria  : Yes    No      
26. Tuberculosis  : Yes    No        
27. Diabetes  : Yes    No   
28. Nephritis  : Yes    No  
29. Syphilis  : Yes    No 
30. AIDS  : Yes    No  
31. Pt.underwent any surgery  : Yes    No 
32. UTI  : Yes    No  
33. Others  : If Yes , Specify    
HISTORY OF PREVIOUS TREATMENT: Yes   No 
If yes, give details as follows: 
 
PHYSICAL EXAMINATION: 
10. Height (cm)  :  
11. Weight (cm)  : 
12. Pulse  : 
13. Blood pressure  : 
14. Temperature  : 
15. RR  :  /minute 
16. Anaemia  :  Present  Absent 
17. Lymphadenopathy  :  Present   Absent 
18. Pigmentation  :  Present  Absent 
PRESENTING SIGNS:   
10. Odema feet            :  Present  Absent 
11. Icterus                 : Presen           Absent 
12. Spider      :  Present  Absent 
13. Gynacomastia    :  Present  Absent 
14. Liver    :Palpable  Not palpable 
15. Splenomegaly             :  Present  Absent 
16. Ascites   :  Present   Absent 
17. Encephalopathy   :  Present   Absent 
CLINICAL EVALUATION: 
5. Cardio vascular system  :  Normal  Abnormal  Details   
6. Respiratory system  :  Normal  Abnormal Details 
7. Central nervous system  :  Normal  Abnormal Details 
8. Urogenital system  :  Normal  Abnormal Details 
RESULT: 
5. GOOD  : 
6. FAIR  : 
7. POOR  : 
8. NO RESPONSE  : 
 
SIGNATURE OF MEDICAL OFFICER  SIGNATURE OF INVESTIGATOR 
 
LABORATORY INVESTIGATION AND CLINICAL PARAMETERS 
5. Centre :  
6. Code no  :    
 Level of study                         : OPD/IPD 
7. Name of the patient  :  
8. Age :   :   sex: Male  Female   
5. Date and month of assessment   : 
CLINICAL PARAMETERS: 
 
 Urine: Albumin, Sugar, Deposits,Bile pigments, Bile Salts 
 
Urine: Albumin, Sugar, Deposits. 
 MOTION; Ova ,Cyst  
HAEMOGRAM :Total WBC Count, RBC, Hb, ESR,  
Liver function test: 
AST,ALT,ALP, Bilirubine, total protein, Albumin., Prothrombin time 
 
 
 


